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Amphiphilic in nature, lipids spontaneously self-assemble into various nanostructures in aqueous 
solution. Among lipid self-assembled structures, liposomes and supported lipid bilayers have long held 
scientific interest for their main applications in drug delivery and plasma membrane models, respectively. 
In contrast, lipid multi-layered films on solid supports only recently begun drawing scientists’ attention for 
their potentials to catalyze many substrate-mediated biomedical applications. These applications include 
artificial transplants, stents, scaffolds for tissue engineering, and underlying matrices for surface-based 
drug/gene delivery (also known as macro-scale drug delivery). They all require biocompatible surface 
coatings that function as a reservoir for therapeutic molecules and a regulator for the controlled release of 
cargo. 
My research focused on revealing unique structural characteristics and properties of lipid-based 
thin films to demonstrate their promises as matrices for substrate-mediated small molecule delivery. Lipid 
self-assembly behavior on solid support was studied in comparison with the one in bulk solution. A 
judicious choice of lipid molecules and environmental conditions led to the stabilization of lipid films with 
highly oriented nanostructures of diverse symmetry. The lipid films displayed 3D bicontinuous cubic, 2D 
inverted hexagonal, and 1D lamellar structures yielding X-ray diffraction patterns resembling that of single 
crystals. The genetic materials (small interfering RNA or siRNA) were successfully incorporated into the 
films. Interestingly, highly ordered lipid film structures at the nanoscale offered distinct biomolecule 
diffusion pathways as well as cell penetration capacities. Also, the films were highly responsive to 
environmental conditions, transforming one phase to another which allowed the actuation of siRNA release 
to cells. These findings indicate the importance of controlling the structure of surface materials at the 
nanoscale in order to achieve more efficient siRNA delivery from solid substrates. 
I also investigated new structures of composite lipid-polymer hybrid films that augment the 
functionality of drug-eluting substrates for substrate-mediated delivery applications. Concurrent self-
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assembly of lipids and polymers into the same membrane resulted in hybrid membranes showing peculiar 
phase behavior. A hybrid material composed of phospholipids and block-copolymers was engineered to 
adopt a multi-layered membrane structure supported on a solid surface. It was observed that in each lamella, 
lipids and polymers partition unevenly within the membrane plane segregating into lipid or polymer rich 
domains. Interestingly, like-domains aligned in registry across multilayers, thereby making phase 
separation three-dimensional. Phase boundaries were shown to exist over extended length scales to 
compensate the height mismatch between lipid and polymer molecules. I demonstrated that those 3D micro-
phase separations in hybrid films serve as functional hotspots for transporting drugs across the bilayer 
membranes. The hybrid films revealed much faster release rates of hydrophobic drugs (Paclitaxel) 
compared to single-component films. Plausible mechanisms driving this synergistic release were studied in 
connection with the structure characteristics of the hybrid films. The registered domains and domain 
boundaries contributed to impeding paclitaxel crystallization, increasing the total concentration of 
paclitaxel molecules available for release. 
My thesis research presents lipid- and lipid-polymer thin film phases that are beyond simple 
multilamellar structures with a focus on surface-mediated phase transitions. Engineered lipid-based thin 
films yield unique structural characteristics and properties which cannot be attained from simple multi-
layered structure. Extensive structural characterization supports the findings, performed using atomic force 
microscopy, solid-state NMR, confocal laser scanning microscopy, and grazing incidence small-angle X-
ray scattering. The work offers new perspectives in designing lipid-based nanostructured films that exert 
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1. 1 Motivation 
Lipids are a class of organic compounds consisting of a hydrophilic polar headgroup and 
hydrophobic tail(s). Lipids are biocompatible in nature as they are the primary components of the plasma 
membranes and various cellular organelles. The lipid bilayer of plasma membranes separates the interior 
of cellular components from the external environment, encapsulates membrane proteins, and selectively 
permeates ions or molecules of interest. Specifically, the capabilities to sense, detect, and transport specific 
species of plasma membranes have fascinated scientists, leading to active research on functional lipid 
bilayers.1–3 Enclosed lipid bilayers in an aqueous solution (termed lipid vesicles or liposomes) have been 
extensively used as “carriers” for drug and gene delivery based on their ability to encapsulate both 
hydrophilic and lipophilic molecules into different compartments.4–7 Lipid bilayers supported onto a solid 
surface (termed a supported lipid bilayer) also have been exploited largely as plasma membrane models to 
study basic cellular processes such as lipid-protein interactions.8–10 
Flat lipid bilayers are the most abundant arrangement of lipids found in nature. However, different 
types of lipids can self-arrange into various morphologies differing from the zero-curvature bilayer 
configuration including micellar, hexagonal, and bicontinuous cubic phases.11–13 Lipid polymorphism has 
attracted considerable attention because of the unique phase-dependent properties that it entices. For 
example, lipid cubic phase structures exhibit high internal surface area per volume (≈ 400 m2/g)14 that 
enables high loading and fast release of drug molecules or genes.15,16 In addition, bicontinuous cubic phases 
have negative Gaussian membrane curvature that promotes endosomal fusion and concomitant efficient 
small interfering RNA (siRNA) release and gene knockdown.17,18 Finally the optical properties of isotropic 
bicontinuous phases and optical transparency can be used to detect biomarkers yielding birefringence upon 
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crystallization.19 In general, lipid polymorphism has been leveraged for constructing stimuli-responsive 
self-assembled systems where manipulation of the lipid phases enables “on-demand” release of 
encapsulated agents.15,20,21 Examples include leveraging ultrasound-triggered reversible phase transitions 
between different liquid crystalline lipid phases that regulate the diffusion rates of drug molecules,20 and 
pH-sensitive lipid vesicles that transforms from a lamellar phase into an inverted hexagonal phase in acidic 
conditions, which helps delivering the drug payload of lipid vesicles into the cytoplasm.22 Despite the 
exciting properties rendered by lipid polymorphism, most studies exploiting lipid polymorphism have been 
dedicated to lipid particulate systems.  
However, recent studies have shown that lipid polymorphism can be extended to lipid assemblies 
confined onto surfaces.23–25 Research on supported lipid films and aspects of surface-mediated phase 
transitions is still in an early stage of research. This is partly because the use of supported lipid systems has 
been mostly limited to model membranes where a single bilayer on a solid surface is sufficient to mimic 
most cellular membranes. 
It should be noted that there is a growing interest to develop implantable macroscale drug delivery 
devices,26,27 high throughput biosensing systems,28–30 and substrate-mediated drug/gene delivery.31,32 
Advances in biotechnology such as surface-patterning techniques33–35, along with microfluidics36–38 and 
biodegradable organic electronics39,40, have enriched research on the aforementioned applications. 
Following this trend, the need for bio-interface membranes adsorbed onto solid substrates is rapidly rising 
that serve as matrices or scaffolds and that are capable of exerting spatiotemporal control over the release 
of payloads.41,42   
This dissertation work is motivated from the gap between a growing need for functional bio-
interface membranes and an early stage of the lipid thin film research. The work focuses on unveiling the 
link between the structure of lipid-based thin films and the unique functionalities of such films (e.g. 
diffusion and permeability of payloads). Lipid polymorphism confined on a substrate, responsive film phase 
behavior on a substrate, and functionalization of the lipid films by incorporating bioactive species or 
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additional structural motifs were investigated to yield the desirable properties. Those properties include 
controllable and stimuli-responsive diffusion of bioactive species from the water channels of lipid thin 
films, and synergistic permeability of small molecules across the film membranes. The aim of the work is 
to demonstrate the potential of lipid-based films as emerging materials for the development of substrate-




1. 2 Scope and organization 
The background information is presented in chapter 2. This includes an introduction to the general 
principles governing lipid self-assembly behavior in bulk, followed by lipid self-assembly behavior on a 
solid substrate. Stimuli-responsive lipid phase behavior (phase transition) is covered as it is a central idea 
of the work presented in chapter 4 and 5. Also in chapter 2, previous work on lipid-polymer hybrid 
membranes is described to provide readers a better understanding on the progress of this field, particularly 
in the past five years. 
The experimental methods are described in chapter 3, which were vital experimental techniques to 
prepare and characterize the structure of lipid-based materials in this thesis work. Other experimental 
techniques, along with a detailed description of the setup and conditions not mentioned in chapter 3, can be 
found in separate subchapters of chapter 4, 5, and 6. 
Chapter 4 describes the systems in which liposomes were designed to be ultrasound-sensitive. The 
combination of different types of lipids with different geometry resulted in restructuring of the liposome 
membranes upon ultrasound exposure, giving rise to an increase in drug release. The topological lamellar 
to hexagonal phase transition is discussed in connection with the enhanced permeability of drugs through 
liposomal membranes in response to triggers (ultrasound). 
Chapter 5 explains highly adaptive phase behavior of nanostructured lipid thin-films in response to 
changing environmental conditions (relative humidity), followed by applications of those films in substrate-
mediated gene delivery. The diffusion properties of genes incorporated into various lipid films were 
investigated which turned out to be dependent on the phase of the films. This work underpins the importance 
of controlling lipid-film phase behavior under surface confinement, suggesting a promising design handle 
for achieving lipid films that exert the control over the release of payloads (nucleic acids).   
Chapter 6 illustrates multi-layered lipid-polymer hybrid films of which nanostructures enable 
synergistic and controlled release of payloads (drug molecules). The introduction of block copolymer into 
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lipid films gives rise to interesting phase-separated domain structures. Increased permeability of drug 
molecules from the hybrid films in comparison to the pure lipid and pure polymer films is explained in the 
context of the characteristic hybrid film structure. The thesis ends with chapter 7, which summarizes the 
conclusions driven from my Ph. D. work. The significance and future directions of the thesis work are 
stated.  
The results referred in this dissertation are published in the following journals:  
• Kang, M.; Huang, G.; Leal, C. Role of Lipid Polymorphism in Acoustically Sensitive Liposomes. 
Soft Matter 2014, 10, 8846–8854 
• Kang, M.; Leal, C. Soft Nanostructured Films for Actuated Surface-Based siRNA Delivery. Adv. 
Funct. Mater. 2016, 26, 5610–5620.  
• Kang, M.; Kim, H.; Leal, C. Self-Organization of Nucleic Acids in Lipid Constructs. Curr. Opin. 
Colloid Interface Sci. 2016, 26, 58–65. 
• Steer, D.; Kang, M.; Leal, C. Soft Nanostructured Films for Directing the Assembly of Functional 
Materials. Nanotechnology 2017, 28, 142001 
• Kang, M.; Lee, B.; Leal, C. Three-Dimensional Microphase Separation and Synergistic 
Permeability in Stacked Lipid-Polymer Hybrid Membranes. Chem. Mater. 2017, 29, 9120-9132. 
• Kang, M.; Tuteja, M.; Centrone, A.; Topgaard, D.; Leal, C. Nanostructured Lipid-Based Films for 
Substrate Mediated Biomedical Applications. Adv. Funct. Mater. 2018, 28, 1704356 
In addition to the work outlined in this thesis, I have contributed to other projects where I have 
performed the structure analysis using small angle X-ray scattering or X-ray powder diffraction. Those 
results can be found in the following publications: 
• Cho, S.Y.; Kang, M.; Choi, J.; Lee, M.E.; Yoon, H.J.; Kim, H.J.; Leal, C.; Lee, S.; Jin, H.J.; Yun, 
Y.S. Pyrolytic Carbon Nanosheets for Ultrafast and Ultrastable Sodium-Ion Storage. Small 2018, 
in press. 
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• Shin, J.; Kang, M.; Tsai, T.; Leal, C.; Braun, P.V.; Cahill, D.G. Thermally Functional Liquid 
Crystal Networks by Magnetic Field Driven Molecular Orientation. ACS Macro Lett. 2016, 5, 955–
960. 
• Yun, Y.S.; Lee, S.; Kim, N.R.; Kang, M.; Leal, C.; Park, K.Y.; Jin, H.J. High and Rapid Alkali 
Cation Storage in Ultramicroporous Carbonaceous Materials. J. Power Sources 2016, 313, 142–
151. 
• Kim, N.R.; Yun, Y.S.; Song, M.Y.; Hong, S.J.; Kang, M.; Leal, C.; Park, Y.W.; Jin, H.J. Citrus-
Peel-Derived Nanoporous Carbon Nanosheets Containing Redox-Active Heteroatoms for Sodium-
Ion Storage. ACS Appl. Mater. Interfaces 2016, 8, 3175–3181. 
Some text and figures in Chapters 2-6 are taken from the publications mentioned above. In all cases, 
reuse copyright permissions were obtained from the publishers. Also, at the bottom of the first page of each 
chapter (footnote), the reused published materials are indicated acknowledging the contribution from the 
other authors.  
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In the first subchapter 2.1, the general principles governing lipid self-assembly behavior are 
summarized. The subchapter 2.2 describes lipid phase behavior on confined surfaces focusing on non-
lamellar phases, and subchapter 2.3 gives examples of stimuli-responsive lipid phase transformation. The 
subchapter 2.4 describes research on novel lipid-polymer composite membranes on solid supports that have 
recently begun to be developed.* 
2.1 Lipid self-assembly: general principles 
Lipid molecules are mostly known to self-organize into bilayer structures resembling that of plasma 
membranes. However, depending on a number of intrinsic (e.g. molecular packing and membrane 
curvature) or extrinsic (e.g. salinity, solvent properties, or external cues) properties, lipids offer a rather 
diverse design space of nanostructures. Examples include 2D hexagonal phases and 3D cubic phases of 
multiple symmetries.1  
The pioneering work on fundamental theory of self-assembly of amphiphiles was proposed by 
Tanford2 who quantitatively modeled the standard free energy change associated with the transfer of singly 
dispersed free amphiphiles in solution to self-assembled aggregates. He introduced the concept of opposing 
energy contributions; a negative free energy contribution arising from the hydrophobic effect and a positive 
free energy contribution due to the repulsive interactions emanating from lipid head groups. The 
hydrophobic interaction drives the transfer of hydrophobic lipid tails that disrupt the H-bonding water 
network to the aggregate core which possesses the hydrocarbon-like environment. While the hydrophobic 
                                                 
* Part of this chapter includes the previously published materials – 1) Kang, M.; Kim, H.; Leal, C. Curr. Opin. 
Colloid Interface Sci. 2016, 26, 58–65. Copyright 2016 Elsevier Ltd. 2) Kang, M.; Leal, C. Adv. Funct. Mater. 2018, 
28, 1704356. Copyright 2018 WILEY-VCH. Reprint permissions were acquired from the publisher. 
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effect favors the formation of aggregates, the assembly of lipid molecules entails the repulsive interactions 
such as steric interactions for all types of lipid head groups, dipole–dipole interactions for zwitterionic head 
groups, and ion–ion repulsions for ionic head groups. The competition between the hydrophobic effect and 
repulsive interactions, therefore, explains why the self-assembly process happens, how it is highly tunable 
by environmental conditions, and why the resulting aggregates have a finite size. Although Tanford's model 
explains the basic features of self-assembly, it could not predict the final shape of the equilibrium 
aggregates. 
Israelachvili et al.3 further developed the framework of the Tanford free energy model by 
combining the concept of a molecular packing parameter with thermodynamics to predict the shape of self-
assembly aggregates in equilibrium. To parameterize the geometric constraints imposed by molecular 
packing, a specific packing parameter P was introduced. A molecular packing parameter is defined 
as P = v/(alc), where v = the volume of the hydrocarbon, a = the effective area of the head group, 
and lc = the effective length of the lipid tail. 
The magnitude of packing parameter is related to the shape of aggregate formed. Cone-shaped 
lipids with bulky head group (e.g., lysophosphocholine or LPC) with small P (0–1/3) tend to form spherical 
aggregates such as micelles. Truncated cone-shaped lipids with P value between 1/3 and 1/2 organize into 
cylindrical micelles, and those with packing parameter between 1/2 and 1 prefers to form flexible bilayers 
or vesicles. Cylinder-shaped lipids (e.g., dioleylphosphocholine or DOPC) tend to form the flat bilayer with 
nearly zero curvature, i.e. lamellar phase (P ≈ 1). For lipids with small effective head group area such as 
dioleylphosphatidylethanolamine or DOPE, the relative tail splay becomes wide (P > 1), leading to non-
bilayer lipid phases such as an inverted hexagonal phase. Figure 2.1 schematically represents typical phases 
obtained with lipid systems. 
Although the general principles of lipid self-assembly could be well understood from the pioneering 
work by Tanford2 and Israelachvili,3 it could not capture the complete morphology of all lipid structures. 
As an alternative to the packing parameter, Gruner4 explained nonlamellar phase formation in terms of 
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spontaneous curvature. If a molecule has a preferred average geometry, the deviations from the preferred 
geometry yield a bending energy cost. Often, it is necessary to think about the stabilization of the different 
lipid phases in terms of lipid membrane elasticity that was appropriately described by Helfrich.5,6 The 
Helfrich equation is expressed as the following: the Helfrich energy (E) per area 
(A)=0.5κ(C − C0)2 + κGC1C2 where κ and κG are the bending and the Gaussian modulus respectively. The 
spontaneous curvature C0 represents a tendency of a flat monolayer to bend spontaneously. Practically, it 
means a stress-free state of a monolayer at given geometry. The first term thus describes the energetic cost 
of bending a lipid layer from its spontaneous curvature C0 to the deformed curvature C. The second term 
accounts for the topology of the lipid layer where C1 and C2 are two principal curvatures of the lipid layer 
plane. The Helfrich equation becomes useful when describing for example lipid bicontinuous cubic phases 
that were firstly introduced by Luzzati.7 The failure of explaining the formation of bicontinuous cubic 
phases by the packing parameter concept arises from the negligence of membrane curvature arguments with 
global packing constraints. While the packing parameter P treats geometrical constraints locally, i.e. at the 
single-molecule level, the concept of a membrane curvature extends the packing constraints to be 
macroscopic. In general, the shape of the resulting self-assembly aggregate can be predicted as a function 
of the spontaneous curvature C0 of membranes. 
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2.2 Lipid phase behavior on surfaces 
It is a general observation that the phase diagrams of lipids obtained for bulk systems are translated 
into films. One can attain non-lamellar phases of lipid films using the same composition and temperature 
as determined to bulk systems. This includes inverted hexagonal phases (HII),8,9 inverse discrete micellar 
cubic (Q227, Fd3m),9,10 and inverse bicontinuous cubic (QII) phases of two distinct symmetries  (diamond 
Pn3m and gyroid Ia3d).8,11–13  
However, very little is known about the substrate effects on the lipid film nanostructure such as 
preferential orientation, stability, and phase transformations. One prominent observation is that the presence 
of a solid surface induces the periodic phases to all orient with a high level of regularity in a single direction. 
Examples include oriented stacked lipid membranes in a lamellar phase as well as oriented 3D bicontinuous 
cubic phases. In case of 3D bicontinuous cubic phases, such tendency to align with a preferential orientation 
can be explained in terms of the interfacial energy between the lipid phase and the substrate. When the lipid 
bilayers of the cubic phase are in contact with the surface, they form a closed surface in a way that free 
edges of the lipid bilayer are shielded due to the hydrophobic effect. The closure of the bilayers of the cubic 
periodic surface results in the formation of both positive and negative mean curvatures, which generates 
the bending energy.13,14 Thus, when the lipid cubic phase encounters the substrate interface, it aligns with 
respect to the substrate in a way that minimize the interfacial energy.13,14 The preferential orientation 
adopted by the cubic phase films can be predicted from thermodynamic interfacial energy calculations, and 
is well corroborated by experimental observations.13 Those oriented films could provide a good model 
system to study the pathways of lipid phase transitions, unveiling the epitaxial relationships during 
transformations.15–17  
In the category of “non-lamellar” films, the preparation of lipid bicontinuous cubic phase films is 
of particular interest. These structures comprise a continuous lipid bilayer where the mid-planes conform 
to periodic minimal surface with the negative Gaussian curvature.11,18 The bilayer is in contact with two 
inter-woven yet unconnected networks of water channels (Figure 2.2). Such inherent structure of the lipid 
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cubic phase yields large surface area to volume ratios with uniform water channels and 3D isotropic 
diffusion.19 Bicontinuous lipid cubic phases in bulk have been utilized for various applications including 
membrane protein crystallization and drug/gene delivery.19–23 Monoolein (MO) and phytantriol, well known 
as cubic-phase forming lipids in bulk, form cubic-phases in supported thin films.12,13 In chapter 4, a 
positively charged gyroid phase (QIIG) is described where the positive charge was introduced to incorporate 
negatively charged siRNA in the lipid films, by including a cationic lipid, 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) to the MO mixtures.8 
Nylander et al.9 investigated the layer dynamics in the cubic (Fd3m) phase and hexagonal (HII) 
phase at a Si substrate surface. The cubic phase layers appeared more rigid at the substrate interface 
compared to the hexagonal phase layers based on neutron reflectometry and grazing incidence neutron spin 
echo spectroscopy (GINESES) experiments. The rigidity of the Fd3m phase is attributed to the suppressed 
undulations at the interface whereas the HII phase experiences undulations coming from the hydrodynamic 
interactions between the HII phase cylinders and the substrate. It is notable that the distance from the 
substrate to the first HII layer seemed to affect the length of the hexagonally ordered cylinders with their 
long axis parallel to the surface. Further studies on the surface effect could provide a valuable design handle 
in controlling the domain size of lipid HII phase films. 
Very little work has been carried out towards the effect of different substrates on the lipid film 
structure. It would be interesting to understand the role of hydrophilic/hydrophobic functionalization of the 
surface in determining the structure of lipid phase on solid supports (e.g. domain alignment, flexibility of 
the layers, and shift in phase boundaries). Understanding self-assembly, thermodynamics and dynamics of 
lipid films onto solid supports will allow for their rational design of functional films with tunable 
polymorphic properties.  
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2.3 Lipid phase transformation and applications 
Lipid constructs can be tuned to quickly respond to external stimuli and convert from one structure 
to another phase. Different lipid phases have distinct optical properties (e.g. lamellar and 2D hexagonal 
phases are birefringent while 3D bicontinuous cubic phases are isotropic) as well as molecular diffusion 
properties. Hence, one can envisage that it is possible to manufacture responsive lipid constructs with 
optoelectronic properties evolving as a response to a changing environment. Also, it is possible to design 
lipid assemblies that reorganize their structures upon external stimuli, allowing to control the release of 
payloads incorporated into the lipid assemblies. The literature reported for controlling lipid equilibrium 
phases in bulk is vast. Examples include addition of additives such as glycerol,24,25 cholesterol,26 and salt 
solutions.27 Additional control over the lipid phase is often achieved by changes of water content,28 
temperature,29 pH,30 or even ultrasound.31 Specific case studies can be easily found in lipid-nucleic acid 
complexes. When lipid assemblies are utilized as carriers to deliver nucleic acids, those assemblies are 
effectively designed to release nucleic acids. K. Oumzil et al.30 included pH-cleavable lipids in lipid-nucleic 
acid complexes. Under a weak acidic condition, pH-cleavable lipids released fatty alcohols into 
phospholipid bilayers, promoting the destabilization of liposomes and transition into a lamellar phase. Such 
phase destabilization and transition at the lower endosomal pH led to a successful release of nucleic acids 
into cellular cytoplasm. The chapter 4 describes the project in which lipid polymorphism responsive to 
ultrasound has been applied to control the release of drug molecules encapsulated inside liposomes. 
Unlike bulk systems, the control of lipid film phase behavior under surface confinement is much 
less explored. In light of the importance of lipid polymorphism in bulk, the lipid phase behavior– when 
they are confined to a surface–is also expected to play an important role in the function of the lipid films. 
The chapter 5 describes the project in which responsive phase behavior of lipids on a substrate has been 
studied and applied to substrate-mediated gene delivery. 
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2.4 Lipid-polymer hybrid membranes 
Block copolymers composed of hydrophilic and hydrophobic groups can self-assemble into various 
structures in a similar manner to lipids such as micelles, vesicles, and tubes.32,33 Despite the similarities 
between lipids and block copolymers in terms of their amphiphilic nature and the ability to self-assemble 
into various morphologies, research on lipid assemblies and block copolymer assemblies have followed 
separate routes. 
Polymer assemblies and lipid assemblies show different physicochemical properties. Polymersome 
membranes are usually thicker (≈ 8 nm to 50 nm per single bilayer) than that of liposomes (≈ 5 nm per 
single bilayer) because of the higher molecular weight of the polymer blocks, leading to better stability and 
higher mechanical strength compared to liposomes.34–37 However, thick membranes also yield poor 
membrane permeability which can limit the diffusion of small molecules that are encapsulated inside 
polymersomes, 36 as well as poor membrane-fusion capabilities. The synthetic nature of block copolymers 
allows versatility to modulate chemical functionality but simultaneously results in lack of biocompatibility. 
In contrast, lipid membranes found in all cell membranes are biocompatible.34,35 
In an effort to combine the benefits of the two materials, hybrid systems, composed by lipid-
polymer mixtures have been recently explored38–40,35,41–43. By mixing lipids and block copolymers in the 
same membrane, one can expect to obtain hybrid membranes with tunable structural properties and good 
biocompatibility. A broader range of chemical compositions, molecular weight, hydrophobicity, and 
surface charge of assembling building blocks (i.e. block copolymer and lipids) would enable modulation of 
the hybrid membranes physicochemical properties including permeability, mechanical stability, and 
solubility of encapsulated molecules. Moreover, from a materials science perspective, hybrid systems of 
two different materials are exciting as they may give rise to new structures and properties otherwise not 
attainable with single component systems. 
Research on lipid-polymer hybrid membranes is at a very early stage of development with just a 
few studies reported so far. However, previous work already alludes to numerous potential applications of 
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hybrid membranes. This includes model systems mimicking plasma membranes, sensors, and small 
molecule (drug, genes, and proteins) delivery platforms. Hybrid vesicles, composed of mixtures of 
phospholipids and block copolymers, have been shown to form various membrane phases with different 
miscibility.34,41 Molecular and macroscopic parameters such as copolymer architecture, lipid fluidity, 
hydrophobic mismatch or chemical compatibility between lipids and polymers determine the final phase of 
the hybrid vesicles. Both lateral phase separation at the nanoscale and micrometer scale or complete fission 
into separate vesicles have been reported.34,35 Careful selection of lipid and copolymer molecules with 
engineering parameters such as temperature, cooling rate, and osmotic control enables the modulation of 
phase separation at the micro- and nano-scale.42–45 Such complicated but diverse phase behavior of lipid-
polymer hybrid systems may offer new insights to understand complex plasma membrane systems where 
the presence of phase separated domains goes beyond classical liquid-ordered and -disordered lipid-only 
phases. Also, the compositional variety of hybrid membranes could possibly confer advanced 
functionalities such as control over membrane compartmentalization, diffusion rates of membrane 
components, and mechanical stability. 
The original studies on lipid-polymer hybrid membranes were performed on GUVs because of the 
ease of optical characterization. Besides GUVs, recent work has explored other systems including large 
unilamellar vesicles (LUVs),45 tubular vesicles,46 planar membranes,47,48 and most recently from our group, 
multi-layered films.49 In this section, we will review the lipid-polymer hybrid systems focusing on planar 
membranes in the form of suspended monolayers, solid-supported bilayers, or multi-layered films on solid 
supports. We will highlight the approaches to construct hybrid membranes, followed by the structure, 
function, and possible applications of the newly assembled structures.  
2.4.1 Suspended lipid-polymer monolayer 
A mixed lipid-polymer monolayer at the air/water interface has been studied as a platform for 
directed membrane protein insertion and for controlled localization of polymer-functionalized nanoparticles 
in the membranes. Two important features of the mixed lipid-polymer monolayer give rise to controlled 
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distribution of molecules embedded into the hydrophobic region: surface hydrophobicity and heterogeneity 
(phase-separated domains).48,50 
Kowal et al.48 combined amphiphilic copolymer poly(dimethyliloxane)-block-poly(2-methyl-2-
oxazoline) or PDMS-b-PMOXA with various phospholipids to investigate the tunability of membrane 
protein incorporation into the monolayer. The mixtures of lipids and polymers resulted in phase separation 
of two components into different domains, of which the size and shape were affected by the type of lipids 
and lipid/polymer compositions. Interestingly, membrane proteins were preferentially located into the more 
fluid regions of the monolayer. When saturated lipids (1,2-dipalmitoyl-sn-glycero-3-phophocholine 
(DPPC), DPPE) were mixed with PDMS-b-PMOXA, proteins favored the polymer-rich domains over lipid-
rich domains while the opposite trend was observed for unsaturated lipid (DOPC)-polymer mixtures. This 
work raises a possibility of achieving model membranes that are biologically relevant by introducing 
controlled distribution of membrane proteins at the desired sites. 
The work by Olubummo et al.50 also demonstrates the localization of molecules of interest 
(polymer-coated nanoparticles) into mixed lipid/polymer monolayers. The mixture of block copolymer 
poly(isobutylene)-block-poly(ethylene oxide) or PIB-b-PEO and phospholipid DPPC formed a monolayer 
at the air/water interface. It was observed that the presence of PIB-b-PEO in the hybrid layer disturbs the 
lipid packing, inducing rearrangement of lipid molecules followed by changes in the LE (liquid-
expanded)/LC (liquid-condensed) transition plateau. In addition, the lipid-polymer system phase separated 
into different domains with the size of the polymer domains increasing with the polymer content. Surface 
functionalization of CdSe nanoparticles played a pivotal role in controlling the location of those 
nanoparticles in the monolayer.  The particles coated with PIB were homogeneously distributed whereas 
the ones coated with PIB-b-PEO showed heterogeneous distribution (preferentially embedded into the 
polymer domains). 
Partitioning molecules into selective membrane regions is an interesting outcome enabled by the 
mixing of different self-assembling building blocks: lipids and block-co-polymers. The factors driving 
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phase-separation of lipid-polymer mixtures should be further explored to fine-control the layer structure 
and the distribution of molecules of interest. Hybrid monolayer systems may be useful to the development 
of membranes where spatial control of embedded components is required. 
2.4.2 Supported lipid-polymer bilayer  
Supported lipid-polymer bilayers (SLPB) are analogues to supported lipid bilayers (SLB) but 
differing with respect to composition, comprising block copolymers in addition to lipids. It should be noted 
that SLPBs are different systems than polymer cushioned lipid bilayers where a hydrophilic polymer brush 
is located between a (polymerized) lipid bilayer and the solid support. While polymer brush-SLB systems 
utilize polymers to fill the space between lipid bilayers and the substrates, polymers in SLPBs interact with 
the lipids within the same bilayer thus providing new biophysical/biochemical properties to the membrane. 
The concept of introducing heterogeneity into the membrane is inspired by nature. Cell membranes 
comprise a vast class of lipids and proteins and heterogeneities are known to mediate various cellular 
processes. 
The work by Gettel et al.47 demonstrates the construction of SLPBs and their use as model 
membranes for studying obstructed diffusion. They have exploited UV photochemical techniques to pattern 
surfaces. The substrates were patterned by exposing n-octadecyltrichlorosilane (OTS) covered substrates 
with a photomask to ozone-generating, short-wavelength UV light (187 nm to 254 nm). Two different 
approaches were developed to form the SLPBs: 1) mixtures of lipid-polymer hybrid vesicles were adsorbed 
and fused into the patterned substrates, resulting in the formation of a monolayer or a bilayer on the 
hydrophobic and hydrophilic regions, respectively; and 2) designated regions of surfaces all filled with 
polymer bilayers were selectively removed and backfilled with lipid bilayers through patterning. 
Interestingly, the mixtures of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 
poly(butadiene-b-ethylene oxide) (PBDPEO) did not show lateral phase-separation at the macroscopic level 
when adsorbed onto amphiphilic surfaces as observed by epifluorescence images. Such seemingly 
homogenous distribution of lipid and polymer was unexpected because of the height mismatch between the 
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POPC (≈ 5 nm thick) bilayer and the PBDPEO (10 nm to 12 nm thick) bilayer. Indeed, phase-separation 
was observed for GUVs made of comparable mixtures.  
As presented in Figure 2.3, the observed membrane homogeneity implies an irreversible adsorption 
of components which was investigated by measuring the lateral diffusion coefficient of POPC in the SLPB. 
The POPC lateral diffusion was clearly hindered by the presence of PBDPEO on solid supports. The 
diffusion behavior of POPC in the SLPB clearly differs from the one in freely floating membranes (e.g. 
GUVs). The mechanism of substrate-mediated fusion of PBDPEO is thought to be responsible for bringing 
irreversibility in the SLPB, which needs to be further investigated. The implication of this study on SLPBs 
is that it allows the investigation of obstructed diffusion behavior of transmembrane proteins and lipids in 
plasma membranes,51 a process that is still not well understood. 
Besides block copolymers, another type of synthetic polymer (dendrimer) was employed to form 
lipid-dendrimer co-assembly structures on solid supports.52 The hybrid dendrimer/POPC vesicles were 
exposed to the hydrophilic substrates and incubated in an aqueous environment to allow them to form a 
well-defined supported bilayer. The fluidity and stability of the membrane could be modulated by 
controlling the generation (the number of repeated branching cycles) and concentration of the dendrimer. 
Also, the versatility of the functional end groups in the dendrimers eased the conjugation of biological 
recognition ligands to the membrane, offering new opportunities to develop powerful sensors. 
Beyond single bilayer systems, the chapter 6 describes my contribution to the lipid-polymer hybrid 






Figure 2.1. Schematic representation of various lipid self-assembled structures. Lipids in the presence of water can 





Figure 2.2 Schematic representation of the unit cell of the double gyroid lipid cubic phase. Blue and orange channels 




Figure 2.3 Diffusion constants of probe lipids in supported lipid-polymer hybrid membranes at different molar ratios. 
The inset shows the relative diffusion constant of the probe lipids per area fraction of polymers. Adapted from Gettel 
et al.47 Reuse permission was granted from ACS Publications. Copyright 2014 American Chemical Society.  
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 EXPERIMENTAL METHODS 
 
 
The aim of this chapter is to provide detailed experimental procedures and helpful resources for 
lipid-based sample preparation and structure characterization. Also, I share tips from my experience that 
may be helpful for a complete novice in this field. Other experimental techniques, along with a detailed 
description of the setup and conditions not mentioned in this chapter, can be found in separate subchapters 
of chapter 4, 5, and 6. 
3.1 Sample preparation 
3.1.1 Preparation of liposomes 
Lipids self-assemble in aqueous solutions. Lipids have very poor solubility in water compared to 
surfactants. The critical micelle concentration of lipids is of the order of 10-10 to 10-12 M.1 Consequently, 
lipids are almost never present as monomers. Self-assembly of lipids spontaneously occur and thus making 
lipid self-assemblies is not a difficult process. It is a natural process. The difficult part is to control the 
experimental conditions so that one gets the controlled structures. 
There are various ways to fabricate liposomes but they share the general elements. The solvents 
dissolving lipid molecules should be evaporated first and then lipids need to be hydrated with proper 
agitation. The final sizing procedure determines the lamellarity and distribution of vesicles. For a 
comprehensive review on the methods of liposome preparation, see the references.2,3  
When one prepares liposomes with mixed composition, the lipids should be dissolved in an organic 
solvent. Chloroform is a popular solvent to dissolve lipids but other organic solvents also dissolve lipids 
including hexane, benzene, acetone, etc. It is very important to thoroughly mix lipids in an organic solvent 
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to start with. The homogeneous mixture in a solution later yields the homogeneous lipid thin films (often 
called lipid cakes), leading to the formation of vesicles that are uniform in composition. The importance of 
mixing also applies when one dissolves hydrophobic payloads (small molecules) together with lipids in an 
organic solvent.  
Next step is to remove the solvent. A dry nitrogen is commonly used to remove small volumes. For 
larger volumes, a rotary evaporator can be used. One should ensure the homogenous mixing of lipids while 
removing the solvent. Using a vortex mixer can be helpful. Also, using a conical vial helps to get uniform 
lipid cakes. Conical vials have a conical interior bottom so one can avoid the agglomeration of lipid cake 
often formed in the edge of the conventional vials with a round bottom. The thickness of the lipid cake 
should be less than the diameter of the vials or flask (the container to be used for the lipid cake hydration). 
This is because thick films prevent the uniform swelling of lipids during hydration. To assure the complete 
solvent evaporation, the lipid films need to be placed in a desiccator with a vacuum pump overnight. Note 
that residual organic solvent can alter the structure and packing of the lipid bilayer.4 
Hydration conditions (e.g. hydrating medium, temperature, and incubation time) vary depending 
on the type of lipids and application of the final vesicles. The important point is to maintain the hydrating 
temperature above the lipid melting temperature so that lipids are in their fluid phase during hydration. The 
hydrating medium (e.g. the presence of salts) can greatly affect the final structure of lipid assemblies. 
Therefore, it is important to consider the final application of liposomes before preparation and structure 
characterization. Gentle or vigorous agitation is often required during hydration. Turbidity helps to get a 
rough idea of the size of liposomes. The final step is to downsize the liposomes. The suspensions are 
typically downsized by means of extrusion or sonication. For more information on the extrusion and 
sonication, refer the Avanti Lipids Website or Morrissey Lab Protocol online. On a side note, for 
preparation of cubosomes, see the references.5,6 
3.1.2 Preparation of lipid-thin films 
Supported lipid layers on solid substrates can be prepared using various methods: Langmuir-
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Blodgett,7 vesicle fusion,8,9 direct spreading,10 and spin coating.11 To build multi-layered lipid films, I used 
either direct spreading or spin coating method, which allow the formation of large-scale lipid films. Both 
methods require the preparation of stock solution in which lipids are dissolved. 
Direct spreading (also termed drop casting) allows one to know the exact amount and ratio of 
materials being deposited. Spin coating, on the other hand, cannot assure the mass of materials built onto 
the substrate. The advantage of spin coating method is that one can control the film thickness (i.e., the 
number of bilayers) by controlling spin coating parameters (spinning speed and time). For AFM 
experiments, spin coating method is advised because it yields uniform films minimizing AFM cantilever 
crashing.  
When the solution is applied to the substrate, it should be assured that the entire surface gets wet 
with the solution. Otherwise, local de-wetting due to autophobicity occurs with a high probability. 
Chloroform is often not an ideal solvent to spread out lipids on a solid surface. The wetting motion of lipids 
on solid substrates is disturbed by the fast evaporation of chloroform. A mixture of chloroform and other 
solvent such as methanol or ethanol helps to slow down the solvent evaporation speed while lipids self-
assemble as a planar film. Lipid spreading on hydrophilic substrates (e.g. Si) is influenced by the 
electrostatic interactions between lipid molecules and substrates. Lipid spreading on hydrophobic substrates 
is governed by hydration and the van der Waals forces.12 I observed that inclusion of charged lipids 
improves the wettability. The prepared lipid films are sensitive to environment conditions such as relative 
air humidity. It is advised to store the samples under a controlled-humidity environment. In terms of slowing 
down the dynamics of lipids, samples may be stored at low temperature (4 ºC). 
3.1.3 Preparation of giant unilamellar vesicles (GUVs) 
Giant unilamellar vesicles (GUVs) refer to micron-sized vesicles or larger. The micron-scale of 
GUVs enables the direct optical microscopic observation. Thus GUVs became an important tool to study 
the phase behavior of lipid membranes.  
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Following is a description of how I fabricate giant unilamellar vesicles (up to tens of µm in 
diameter) using a electroformation method. During hydration, an alternating (AC) electric field is applied 
to the lipid film. Both the direction and magnitude of the electric field intensity change, which forces lipid 
molecules to move and presumably induces lipids to adopt bilayer packing.13 The preparation procedures 
are thoroughly described in the following references.13–17 
• Prepare a lipid stock solution in chloroform:methanol or chloroform:ethanol (3:1 v/v). The 
concentration of the stock solution may vary from 10 to 20 mg/mL. 
• Use a needle to spread lipids on the charged surface of ITO glass. Check with a multi-meter which 
side of ITO glass is charged. Uniformly spreading out lipid solution to the glass slide is the most 
critical step for successful GUV preparation. Pipette 10 µL to the side of the glass substrate and 
repeat 3 times.  
• Put glass slides into the desiccator for an hour. This is to ensure the complete solvent evaporation. 
• Prepare the low ionic buffer solution (100 mM sucrose or 1.5 mM PBS). The concentration depends 
on the type of lipid molecules. 
• Add a buffer solution to the chamber. Make sure no bubbles are formed. Secure the top slide with 
a rubber band and connect the alligator clips to the both slides. 
• Turn on the function generator. For sucrose buffer, I applied 10Hz and 10V for 2 hour. 
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3.2 Sample characterization 
3.2.1 Small angle X-ray scattering (SAXS) 
In this dissertation work, SAXS was used as the main tool to characterize the lipid assembly 
structures. The scattering data is the results of Fourier transform of the real space structure. One can almost 
reconstruct the real space structure with some limitations (phase problem). The scattering data is 
representative and statistically significant as the scattering volume covers the significant portion of the 
samples compared to microscopy techniques.  
For lipid film research, grazing incidence SAXS (GISAXS) in reflection geometry was employed. 
GISAXS provides structural information in both parallel and perpendicular directions to the thin film 
surface. Averaged information on the lipid films regarding the symmetry (space group), unit cell size, 
alignment on surfaces can be readily obtained from the GISAXS measurements. In GISAXS experiments, 
grazing-incidence angle should be carefully chosen as the scattering data depends on the degree of incident 
angles. The ideal sample size for GISAXS experiments is 10 mm × 10 mm (advised from beamline 
scientists). The GISAXS community website managed by Dr. Kevin Yanger provides tutorials on GISAXS 
sample requirements, experiment procedures, and data analysis. Also, one should be aware of Yoneda 
peak18 when analyzing the scattering peaks. When the exit angle of the scattered beam matches the critical 
angle, scattering intensity is enhanced due to the refraction effects.  
3.2.2 Atomic force microscopy (AFM) 
AFM measurements can provide complementary information on the structure of the lipid films with 
X-ray scattering measurements. AFM allows direct visualization of domain size, individual water channels, 
and epitaxy in the lipid films.19 In other words, AFM also allows to visualize local structure details at nm 
scale. The AFM data presented in this dissertation were obtained using an Asylum Research MFP-3D AFM 
in Materials Research Laboratory, University of Illinois at Urbana-Champaign. Lipid samples are tricky to 
measure using AFM because of their softness and stickiness. The AFM cantilevers are easily contaminated 
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because lipid molecules easily stick to the cantilevers. To capture height (topography) profile is relatively 
easy but to obtain high-quality phase profile can be tough. For successful imaging in tapping mode, one 
would lower the setpoint value and increase the drive amplitude. Phase values should be maintained around 
50 – 60 for reliability. The scan rate can be set to 0.8 Hz if sample is uniform. If the samples keep damaging 
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 ROLE OF LIPID POLYMORPHISM IN ACOUSTICALLY 
SENSITIVE LIPOSOMES 
 
This chapter describes the work on developing liposomes that are ultrasound-sensitive for triggered 
drug delivery applications. The design approach to making ultrasound-sensitive liposomes is explained in 
terms of lipid polymorphism. 
4.1 Introduction 
Conventional drug delivery systems have slight control over delivering the required drug load at 
an optimal spatiotemporal condition. Thus, advanced delivery systems have been developed that deliver 
payloads when exposed to an external stimulus.1-2 Ultrasound (US) appears as a promising stimulus handle 
for attaining triggered drug release. The thermal and mechanical effects lead to transient disruption of the 
drug carrier without harming healthy tissues.3-4  US allows non-invasive control while offering capability 
to regulate tissue penetration depth by tuning frequency, duty cycle, and exposure time. 
One strategy to make effective US responsive drug capsules is to add gas-containing microbubbles 
into capsules. However, this approach has limitations such as short lifetime and non-viable size, restraining 
efficient extravasation at tumor.5 Alternative strategies have been developed to overcome those limitations. 
Examples include nanoscale emulsions functionalized with aptamers6 and liposomes containing air 
pockets.7-11 Nearly all liposomes are not sensitive to acoustic energy. There have not been much efforts to 
develop ultrasound-sensitive liposomes despite their importance as drug delivery carriers. Liposomes allow 
control over size, type of cargo to be encapsulated, and compositions that can be tailored to respond to 
                                                 
 Part of this chapter includes the previously published material – Kang, M.; Huang, G.; Leal, C. Soft Matter 2014, 
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external stimuli such as pH, temperature, and light.2  
Conventional liposome formulations have been used to test ultrasound release but they were only 
responsive to low frequency ultrasound.12 It should be noted that liposomes used for triggered drug delivery 
take advantage of membrane phase transition under external stimuli. Such phase transformations include 
lipid hydrophobic tail transition from crystalline to liquid crystalline giving rise to an increased bilayer 
permeability and topological restricting from a lamellar phase to an inverted hexagonal phase. It was 
reported that in acidic conditions, the liposome bilayer transform into an inverted hexagonal phase, 
applicable for pH driven drug delivery.13 Indeed, membrane restructuring by phase transition effectively 
triggers drug release from lipid systems.14-15  
In this work, I investigate the structure and mechanisms of liposomal membrane restructuring upon 
ultrasound. Leal and co-workers suggested that liposomes can be tuned to be ultrasound-sensitive by 
introducing local instabilities to the lipid membrane. In these studies, classical liposomal formulations 
composed of phosphatidylcholines (PC), cholesterol, and PE lipids covalently linked with polyethylene 
glycol have been modified by adding different types of PE molecules or hexanol.16-17 The incorporation of 
medium chain length alcohols (hexanol) or conically shaped lipids such as phosphoethanolamines (PE) 
resulted in changes in membrane bending rigidity or local membrane curvature, respectively. It was 
speculated that induced local stresses in the membrane led to an increase in sonosensitivity and drug release. 
Indeed, liposomes containing dioleoylphosphoethanolamine (DOPE) successfully released siRNA to skin 
melanocytic lesions when low-frequency ultrasounds were applied.18 However, the exact mechanism of 
liposomal membrane sonosensitivity is not fully established lacking experimental evidence. It was 
suggested that the collapse of air bubbles near the surface of the liposomes induces pore formation near the 
surface of the liposomes.19-20 
PE molecules have negative mean spontaneous curvature and belong to the category of lipids that 
self-assemble into reversed phases where the bulky hydrophobic tails are exposed to an aqueous phase. 
DOPE lipids spontaneously form an inversed hexagonal structure (HII) at temperatures above 10 C.21 
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Below 10 C, DOPE lipids form a lamellar phase. The degree of chain unsaturation and temperature 
determine the conditions when DOPE forms HII phases.22 A lamellar to an inverted hexagonal phase 
transition is noteworthy because during transition, the holes are first formed in the lipid bilayer with the 
size of ca. 3 nm in diameter.23 The hole size is big enough for most drug molecules to escape out of the 
liposomal membranes. Other types of phase transitions also have implications for drug delivery if phase 
transitions involve a topological membrane restructuring. For example, Lin and Thomas24 included lipids 
that are prone to form micelles when making liposomes, which resulted in an increased sonosensitivity. We 
hypothesize that a formulation including “non-lamellar” lipids within the liposome membrane is an 
effective way of introducing local instabilities to the membrane, leading to an increased sonosensitivity. 
The amount of non-lamellar lipids should be not enough to disturb membrane integrity before US is on but 
enough to induce phase transition once US is applied. The drug release profiles of liposomal system are 
relatively easy to obtain25 but the transient membrane restructuring as a response to US exposure is 
unexplored. In this work, I demonstrate the membrane restructuring as a function of DOPE amounts upon 
US exposure using a combination of Small Angle X-ray Scattering (SAXS) and Fluorescence Microscopy 
(FM). I presence clear evidence that when an appropriate amount of DOPE is added, liposomes phase-
transform into an inverted hexagonal phase in response to applied acoustic energy. 
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4.2 Results 
I investigate the lipid membrane properties that control the sensitivity of liposomes to ultrasound 
(US) energy. Leal and coworkers17 observed that the incorporation of phosophoethanolamine lipids (PE) in 
model drug loaded stealth liposomes resulted in more efficient drug release as triggered by US energy when 
compared to parent phosphocholine (PC) systems. Pure PE lipid structures are known for self-assembling 
into non-lamellar aggregates of negative preferred mean curvature (H) when compared to PC lipids that 
typically form lamellar phases of H = 0. It was suggested that PE lipids introduce “non-lamellar” structural 
instabilities in the liposome membrane that locally help nucleating transient pores that facilitate drug 
escape. A later report confirmed that 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)-containing 
liposomes showed nine times more efficient Doxorubicin release for the same US exposure time and 
frequency, compared to reference PC-based liposomes.25 Here I also performed a model drug (calcein) 
leakage assay on DOPE-containing liposomes and reference liposomes to check the drug release profiles 
as a function of US exposure time. Specifically, two formulations were prepared containing: i) DOPE 62 
mole%, DOPC 15 mole %, Cholesterol 20 mole %, and DOPE-P3G 3 mole % and ii) DOPC 77 mole %, 
Cholesterol 20 mole %, and DOPE-PEG 3 mole %. Figure 4.1 shows the calcein release as a function of 
US exposure time. Only after 0.5 min of exposure, already 20% of the calcein was released from DOPE-
based liposomes. It is clear that for the formulations containing DOPE (full squares), the US sensitivity was 
dramatically increased with respect to an equivalent sample made of DOPC (full dots). 
Inertial cavitation is generally accepted to induce leakage in lipid membranes and cell walls.20 
However, while it is evident that incorporation of DOPE lipids favors drug release, a clear understanding 
of the molecular mechanisms responsible for the increased sensitivity of PE-containing liposomes to 
ultrasound is at the present still lacking. This is mostly because it is extremely challenging to probe the 
formation of transient phase transitions, topologic transformations, or changes in curvature of lipid 
membranes as these perturbations are expected to self-heal in a time scale much faster than standard 
experimental techniques. 
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In this work, I investigated the effect of PE lipids on liposome membrane restructuring upon 
ultrasound exposure by utilizing two robust complementary techniques: Small Angle X-ray Scattering 
(SAXS) and Fluorescence Microscopy (FM). This enabled us to acquire a complete picture of liposome 
membrane sonosensitivity at different length scales. The time required for a lipid membrane phase transition 
or general perturbation is affected by the concentration of lipid as well as the viscosity of the solvent.26 In 
order to evaluate the structural response of liposome solutions by FM, I promptly imaged liposomes after 
sonication in a sample where liposomes were dispersed in a highly viscous medium (Glycerol/Water). For 
SAXS measurements samples were analyzed quickly after ultrasound exposure in a highly concentrated 
regime. 
4.2.1 SAXS measurements of DOPE-based liposomes before and after sonication 
SAXS was used to investigate the details of structural changes of DOPE-based stealth liposomes 
induced by ultrasound energy. Figure 4.2A shows the SAXS diffraction patterns of DOPE-based liposomes 
(DOPE:DOPC:Cholesterol:DOPE-PEG; 30:47:20:3 mole%) at DOPE=0.3 before (bottom black line) and 
after (top red line) sonication. Before any US energy is applied the samples showed three sharp reflections 
at the q vector positions of q
001
=0.065 Å-1 , q
002
=0.13 Å-1, and q
003
=0.195 Å-1 resulting from a classic 
lamellar structure of lipid bilayers (Lα). The interlayer spacing can be calculated as a = 2π/q001= 96.7 Å = 
δm+ dw, where δ𝒎 is the bilayer thickness and dw is the size of the water layer. The bilayer thickness can 
be estimated from the equation δm≈1.6 l , where l  is the maximum length (nm) of a fully extended 
hydrocarbon chain. l can be also predicted by the equation l = 0.15 + 0.127 nc ,
27 where  nc  is the total 
number of carbon atoms per chain. The estimated value for the membrane thickness δ𝒎 is 40 Å leaving the 
thickness of water between bilayers dw to be around 56 Å. This indicates that even though the SAXS 
experiments are conducted in a high concentration regime (1 M), there is still a considerable amount of 
water within the lipid bilayers and the system is far from being in a compact state. Two additional small 
reflections at q
11
= 0.210 Å-1 and q
20
= 0.252 Å-1 were also observed and are consistent with the presence of 
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residual amounts of another phase. The q positions of these two peaks are correlated to an inverted 
hexagonal phase (HII). It should be noted that the (10) reflection expected to the hexagonal phase appears 
to be convoluted with the (002) peak for the lamellar phase. As a matter of fact a careful inspection of the 
(002) reflection in the lamellar phase reveals that this peak is asymmetric to towards the lower q regime, 
most likely due to the presence a convoluted (10) peak characteristic of the HII phase. The unit cell 
dimensions of HII phases can be calculated as a = 4π/[√1q11] = 59.8 Å. The SAXS diffraction peaks for 
sonicated DOPE-based liposomes at DOPE=0.3, is presented in Fig. 4.2A, top red line. Two reflections at 
q
001
= 0.073 Å-1 and q
002
= 0.144 Å-1 are observed which indicates the presence of a lamellar phase of a = 86 
Å which corresponds to a reduction in lamellar spacing after sonication. Three other pronounced peaks at 
q
10
= 0.124 Å-1, q
11
= 0.215 Å-1, q
20
=0.247 Å-1, are completely consistent with the coexistence of a HII phase 
with lattice size dimensions of a = 4π/ [√3q10] = 58.5 Å. 
DOPE-based liposomes at DOPE=0.62 (DOPE:DOPC:Cholesterol:DOPE-PEG; 62:15:20:3 
mole%) showed the similar trend to that obtained for liposomes at DOPE=0.30. The SAXS scans obtained 
for unsonicated DOPE-based liposomes at DOPE=0.62 are shown in Fig. 4.2B (bottom, black line). Five 
sharp reflections at q
001
= 0.043 Å-1 , q
002
 = 0.0872 Å-1, q
003
= 0.131 Å-1  q
004
= 0.173 Å-1 , q
005
= 0.217 Å-1 , 
result from a lamellar phase with lattice spacing of a = 2π/q
001
= 146 Å. This indicates that DOPE=0.62 
system contains more water than DOPE=0.30. Also for this case, the lamellar phase is present in coexistence 
with a residual HII phase with peaks at q10= 0.0774  Å
-1 , q
11
= 0.117 Å-1 , and a lattice spacing of 
a = 4π/ [√3q10] = 93.7 Å. This spacing is considerably bigger than that obtained for DOPE=0.30. From 
lattice spacing calculations, it can be concluded that higher DOPE content drives more water rich lipid 
phases. The SAXS results obtained for sonicated DOPE-based liposomes at DOPE=0.62 are shown in Fig. 
4.2B, top red line. The majority of observed peaks are consistent with the presence of a dominant HII phase 
with peak positions at q
10
= 0.0725 Å-1 , q
11
= 0.126 Å-1 , q
20
= 0.141 Å-1  and unit cell dimensions of 




= 0.0455 Å-1, q
002
= 0.0872 Å-1, q
005
= 0.215 Å-1, with unit cell dimensions of a = 2π/q
001
=138 Å.These 
results show that DOPE containing liposomes mostly adopt a lamellar phase (L) before US is applied and 
the inverted hexagonal phase (HII) after US is applied, as depicted schematically in Fig. 4.2, bottom right. 
This fact is most prominent for samples containing higher amounts of DOPE. As a reference state, 
liposomes containing all lipids except DOPE (DOPE:DOPC:Cholesterol:DOPE-PEG; 0:77:20:3 mole%, 
Fig. 4.2C) were measured by Synchrotron SAXS before (black line) and after (red line) ultrasound energy 
was applied. Except for the change in lamellar spacing as observed in the other systems, US is not capable 
of inducing membrane restructuring for systems where DOPE is not present. It should also be noted that 
for DOPE containing systems, there seems to be a significant form factor contribution to the SAXS signal 
in addition to the structure facture peaks. To clearly identify the origin of this signal is out of scope of this 
work. Considering the q range at which it is present (ca. 30 Å) it is likely due to the presence of PEG-PE 
micelles in the bulk. Liposomes containing PEG-PE lipids are often observed in coexistence with PEG-PE 
based micelles in solution.28  
After four days, all samples were re-measured and it was observed that the sonicated concentrated 
lipid samples containing DOPE recovered into their original morphology displaying mostly lamellar 
phases. This corroborates that lipid membrane perturbations upon US exposure is expected to self-heal 
given enough time. At this point I did not conduct a careful time dependent study to evaluate the minimum 
required time for the systems to revert to the original structure before ultrasound exposure is employed. 
4.2.2 FM studies of DOPE-based liposomes 
Fluorescence Microscopy was employed to investigate the effect of sonication of stealth liposomes 
containing DOPE at the dilute regime. In order to be able to evaluate membrane structure rearrangements, 
the liposomes were prepared in a highly viscous environment where the time scale of defect formation and 
healing is significantly increased so observation by microscopy techniques is potentially possible. Figure 
4.3 shows representative FM images of giant unilamellar vesicles (GUVs) of DOPE-based formulations at 
different compositions in the absence and presence of US energy. When the DOPE content is DOPE=0.30, 
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it is observed that most GUVs are spherically shaped vesicles with dimensions ranging from 1-10 m as 
depicted in Fig. 3A. Figure 3B shows a DOPE based GUV at higher DOPE molar fractions (DOPE=0.62). 
The vesicle is perfectly spherical but, most interestingly, the existence of long tubular protrusions of about 
1μm in diameter can be observed growing out from the GUV membrane (white arrow in Fig. 4.3B). The 
presence of lipid tubes indicates that the lipid composition of this formulation with higher DOPE content 
is able to self-assemble into aggregates that deviate from the expected spherical shape. 
After US treatment, both GUV samples displayed dramatically different structures. Figure 4.3C 
shows the system prepared with DOPE=0.30 after 5 minutes exposure to US. The aggregates observed are 
on average considerably smaller (ca. 2 m) than those obtained for the parent unsonicated system, the 
shapes of the aggregates are more diverse consisting of ellipsoidal and tubular structures (in addition to 
spheres), and the particles seem to be connected as in a pearl necklace configuration. A similar result is 
obtained to the system with higher DOPE content (DOPE=0.62) presented in Fig. 4.3D except that the 
aggregates obtained after US exposure are an order of magnitude smaller (ca. 0.1 m) than those obtained 
for sonicated DOPE=0.30 samples. The “pearling” effect after US exposure can clearly be observed and 
shown on Fig. 4.3D inset with tens of m long strings of connected sub-micron lipid vesicles. The general 
observation of the US effect on the GUVs is that the aggregate size is reduced. In addition, the smaller 
aggregates seem to be linked as in a pearl necklace configuration. This effect is observed for both DOPE 
containing samples but it is much more pronounced when the content of DOPE is higher. Pearling of GUVs 
in response to external stimuli has been previously investigated. Examples include nanoparticles adsorbed 
onto GUVs inner membrane leaflets mediating links between vesicles,29 polymer anchoring onto the 





The effect of increasing amounts of DOPE (DOPE=0, DOPE=0.30, and DOPE=0.62) on the 
sensitivity of stealth liposomal formulations to ultrasound energy comprising Cholesterol, DOPC, and 
DOPE-PEG was investigated by Small-Angle X-ray Scattering and Fluorescence Microscopy. Ultrasounds 
can lead to cavitation events that are known to provoke leakage of liposome membranes and cells in vitro 
as well as vivo.19-20 The exact mechanism responsible for membrane perturbation is still not clear but it may 
involve the formation of small pores induced by the bursting of air bubbles on membrane surfaces. Other 
effects that have been considered include temperature rising,12 however membrane leakage induced by 
ultrasound is observed even when the average temperature is kept low. Another factor to consider is that 
increasing pressure leads to phase transformations in lipid systems,32-33 however, for DOPE based 
membranes at room temperature pressures of around 40 MPa are required for a transformation from a 
lamellar to reversed hexagonal phase.34 The molecular mechanism associated with sonosensitivity of 
liposomes membranes might be a combination of many factors. In this work, I focus on membrane physico-
chemical properties, in particular the effect of curvature stress. The inclusion of such local instabilities 
lowers the free energy cost associated with creating a pore in a membrane and thus the effect of inertial 
cavitation might be more pronounced in membranes that include components that perturb the average mean 
curvature of liposomal membranes. The main finding of this paper is that in the absence of DOPE the lipid 
membranes display the typical lamellar structure that remains stable upon ultrasound exposure and the only 
observation is reduction in bilayer spacing of about 10 Å. Changes in membrane thickness are often 
associated with a modification of the effective area per lipid head group. One example includes the increase 
in membrane thickness upon interaction with DNA that screens the electrostatic repulsion between the 
oppositely charged lipid head groups resulting in a smaller head group area and concomitant increase in the 
length occupied by the lipid tails.35 In the case of lipid bilayers exposed to ultrasound, the thinning of the 
membrane could be explained by a higher mobility of lipid head groups at the bilayer/water interface, 
leading to an overall lowering of the membrane thickness as means to conserve lipid molecular volume. It 
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should be noted that this argument is consistent with the fact that the same degree (ca. 10 Å) of thinning of 
the membrane is observed for all three systems irrespective of amount of DOPE. The incorporation of 
DOPE in the lipid membranes promotes membrane restructuring upon ultrasound exposure and the 
dominant trend is the transformation of a lamellar phase into a reversed hexagonal structure that is most 
prevalent as the content of DOPE is increased. DOPE is a lipid with inversed conical molecular shape that 
is typically responsible for self-assembly into reverse structures (e.g. type II hexagonal-HII) of negative 
preferred curvature H < 0. This property can be estimated by the “packing parameter”,36 P= V/ (l∙A), where 
V is the volume of the hydrophobic portion of the surfactant molecules that can be estimated by the number 
of carbons in the chain (V = 0.54 nm3 for an 18 carbon chain length), l is the length of the hydrocarbon 
chains (l = 2.4 nm for a 18 carbon chain length), and A is the effective area per head group. The head group 
area of DOPC corresponds to ADOPC = 68.3 Å
2 and that of DOPE equals ADOPE = 50 Å
2, 37 taking into 
account the molar fractions of the systems (DOPE=0, DOPE=0.30, and DOPE=0.62), the packing parameter 
without DOPE is close to unity (P = 1.05) as expected for lipids that prefer to assemble into flat bilayers. 
For the system with 30 mole % of DOPE, the packing parameter is raised above unity as predicted for 
molecules that tend to self-assemble into reversed structures (P = 1.2 for DOPE=0.30 and P = 1.4 for 
DOPE=0.62). It is clear that the incorporation of DOPE into a liposome formulation will induce local 
instabilities in the lipid bilayer membrane resulting in membrane restructuring upon an applied stress such 
as ultrasound energy. The transformation of the lamellar phase into a reversed hexagonal phase is 
characterized by the onset of membrane fusion and formation of pores which locally have negative 
curvature H < 0.23 It should be noted that the hexagonal HII phase is simply a collection of lipid tubes of the 
reverse type (H < 0, lipid molecule hydrocarbon chains pointing outwardly) concentrated and packed in a 
2D hexagonal lattice. In the context of drug release, membrane instabilities that facilitate formation of 
reversed structures, i.e. pores, can be extremely beneficial, as perforations within the liposome membrane 
promoted by external stimuli will tremendously enhance drug permeation from the liposome aqueous 
interior to the exterior. This concept is depicted schematically in Fig. 4.4. It is our belief that the 
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sonosensitivity of liposomal formulations relies on this exact principle of membrane instabilities such as 
the insertion of DOPE, an intrinsically negative curvature lipid (H < 0), embedded in a flat, zero curvature 
(H = 0) liposomal membrane. These instabilities nucleate and propagate as energy (i.e. ultrasound) is 
applied to the system resulting in membrane restructuring such as the formation of pores and/or tubular 
aggregates. In addition to the membrane local phase transformations, the fact that I observed membranes 
after ultrasound become thinner should also add to the enhanced permeability of drugs through liposomal 
membranes upon ultrasound exposure, even without any formation of pores. In addition, the bending 
rigidity of lipid membranes display a quadratic scaling with the membrane thickness δ𝒎 (  δm
2
)38 hence 
one can expect the liposome membranes to be easier to bend after ultrasound energy has been applied.  
The content of DOPE should be kept at moderate levels so that the membrane instabilities are only 
stimulated upon external stimuli or else one can expect excessive leakage and poor shelf-life stability of the 
formulations. In fact, our fluorescence microscopy investigations within the dilute regime using GUVs at 
different molar fractions of DOPE indicate that even before any ultrasound energy is applied, the GUVs 
with molar fractions of DOPE as high as DOPE=0.62 already display the presence of other structures in 
addition to the regular flat liposome membrane. Long tubular structures protruding out of the GUV 
membrane are readily noted in Fig. 4.3B. This result completely corroborates the SAXS data where before 
US is applied to the concentrated lipid system with DOPE=0.62, non-lamellar phases such as inverted lipid 
tubules packed in a 2D hexagonal array-HII, are clearly coexisting with the flat bilayer lamellar phase-L.  
In the dilute regime, the results shown in Fig. 4.3 indicate that the general structural response of 
GUVs containing DOPE to ultrasound is essentially the formation of much smaller aggregates mediated by 
the recognized phenomenon of GUV pearling. Smaller aggregates of diverse shapes are stringed together 
as in a pearl-necklace configuration. The main difference that higher amounts of DOPE (DOPE=0.62) 
confer to the system is essentially the bead-size of the pearl-necklace structure to be dramatically smaller 
when compared to what is obtained for DOPE=0.30. It should be noted that these formulations contain 20 
moles% of cholesterol (as most liposome formulations do in pharmacological applications). Cholesterol 
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has been recognized for decades to induce lateral segregations within the membrane.39-41 The domains are 
often called lipid rafts and refer to uneven molecular mixing of the bilayer with particular lipid species 
segregated in domains that will have different mobility, ordering, and elasticity compared to the rest of the 
membrane. Fluorescence microscopy is a useful technology to observe raft formation in GUVs42 and the 
most popular lipid composition yielding lipid segregation is the inclusion of Cholesterol and sphingomyelin 
(SMP) in combination with a variety of phospholipids including DOPE:DOPC based.43 However, 
cholesterol is known to promote segregation of liquid ordered and liquid disordered domains for lipid 
bilayers in general41, 44 and rafts have been reported to exist and have specific functions in real molecularly 
diverse biological membranes.45 In a more general sense, lipid segregation is strongly related with liposome 
self-assembly and it has been suggested that non-spherical vesicles observed in certain lipid systems 
comprise membranes where lipids demix and reorganize according to preferred mean curvature (with 
rectangular shaped lipids concentrated in the flat lipid membranes and conically shaped lipids gathering at 
the tubular membrane domains). This curvature-driven lipid sorting into populations is based on a balance 
of relative energy (bending, mixing entropy, and interactions between species) costs of forming bent 
membranes at thermal equilibrium.46 There is currently strong evidence that this lipid reorganization is the 
underlying mechanism of highly curved transport intermediates in cells; for example, tubules emerging 
from endosomes47 and vesicle budding from the Golgi apparatus48 both show different lipid compositions 
than from where they stemmed. In light of these findings, it is conceivable that the DOPE molecules in the 
GUV membranes are also sorted according to preferred mean curvature and the tubular protrusions 
observed in GUVs at DOPE=0.62 depicted in Fig. 4.3B are most likely DOPE rich. Figure 4.5A shows the 
image of a GUV at DOPE=0.30 before ultrasound energy is applied. It was observed that the lipid membrane 
region is not perfectly homogeneous indicating that different domains or lateral lipid segregations may 
indeed be present. I could not identify if these domains are simply liquid ordered/liquid disordered rafts 
promoted by the presence of cholesterol and/or curvature induced lipid sorting. In any case, when 
ultrasound energy is applied to such system one observes a transition of the GUV into smaller aggregates 
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connected in a string (commonly referred as vesicle pearling), which is likely initiated at these domains or 
membrane instabilities. A schematic representation of the pearling mechanism is depicted in Fig. 4.5B. It 
should also be noted that ultrasound induces thinning of the lipid membrane rendering it more likely to 
bend. The higher the DOPE content the lower the elastic free energy of the membrane is and GUV pearling 
should occur easier. Consequently it was observed that for GUVs with DOPE=0.62 the aggregates undergo 
higher degree of pearling resulting in the formation of considerably smaller aggregates when compared to 
GUVs containing the intermediate DOPE content (DOPE=0.30).
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4.4 Conclusions 
The structural change of liposomal membranes in response to ultrasound was investigated using 
the combination of Small Angle X-ray Scattering and Fluorescence Microscopy techniques. Additives that 
intentionally perturb lipid packing within the lipid bilayer were introduced to induce the sonosensitivity of 
liposomes. DOPE lipids have intrinsically preferred negative curvature which affects the elastic free energy 
of the membrane. When acoustic energy is applied, DOPE lipids promote topological transformations from 
flat to perforated membranes, inducing drugs to permeate out of the liposomes. The response of the 
liposomal membrane to acoustic energy depends on the amount of the “non-lamellar” lipid additive 
(DOPE). When DOPE is absent, the liposomal membrane displays a clear lamellar phase Lα with (001), 
(002), and (003) SAXS reflections that responds to ultrasound by thinning ca. 10 Å. When DOPE is raised 
to intermediate fractions of 30 mole % the membranes remain mostly in their original lamellar Lα state, but 
exposure to ultrasound promotes restructuring and the rise of a reversed hexagonal phase (HII). This can 
clearly be detected by the SAXS (10), (11), and (20) reflections. When DOPE contents are as high as 62 
mole %, the membrane shows signs of the presence of non-lamellar phases (HII) even prior to ultrasound 
exposure. I argue that the inclusion of non-lamellar forming lipids induces instabilities in the liposome 
membrane, lowering the elastic free energy of the system rendering the bilayer more bendable as well as 
more prone to experience topological phase transitions. In the dilute regime, Giant Unilamellar Vesicles 
observed by Fluorescence microscopy reveal that at high contents of DOPE (62 mole %) the system is 
composed of spherical vesicles in combination with tubular structures, indicating that there might be 
curvature-driven lipid sorting in the liposomal membranes where DOPE would be most likely localized to 
the tubular domains of negative curvature. In response to ultrasound, the GUVs displayed a transition to a 
pearl-necklace like configuration. I argue that the onset of pearling is initiated at sites of curvature stress 
comprising DOPE membrane domains. This work gives a fundamental understanding for the mechanism 
of the lipid membrane restructuring upon US exposure, providing useful guidelines for the design of 
sonosensitive liposomes for targeted drug delivery applications. 
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4.5 Experimental Section 
4.5.1 Materials 
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-2000] (DOPE-PEG2000), Cholesterol (purity >98%) were purchased from Avanti Polar Lipids 
(Alabaster, AL). All lipids were used without further purification. The fluorescent lipid, 1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (Texas Red® DHPE) was 
purchased from Life Technologies (Grand Island, NY). Glycerol, HEPES and sucrose were purchased from 
Sigma-Aldrich (St. Louis, MO). The liposomes were passively loaded with a drug model substance calcein. 
Calcein was purchased by Sigma-Aldrich and used to prepare a 50 mM stock solution in HEPES (10 mM). 
Triton X was obtained by Sigma-Aldrich and used as received. 
4.5.2 Small Angle X-ray Scattering (SAXS) 
Liposomes were prepared using the thin film hydration method.49 In summary, stock solutions of 
DOPC, DOPE, DOPE-PEG and Cholesterol dissolved in chloroform (25 mg/ml) were mixed at the desired 
mole ratio. The mixtures were dried under N2, desiccated under vacuum for overnight, and hydrated with 
Millipore water at 50°C for 24 h to a final lipid concentration of 1 M. Liposomes were prepared in 1.5 mm 
quartz X-ray capillaries (Hilgenberg Glas, Germany). SAXS experiments were conducted in a home built 
(Forvis Technologies, Santa Barbara) equipment composed of a Xenocs GeniX3D CuKα Ultra Low 
Divergence X-ray source (1.54Å / 8 keV), with a divergence of ~ 1.3 mrad. The 2D diffraction data were 
radially averaged upon acquisition on a Pilatus 300K 20 Hz hybrid pixel Detector (Dectris) and integrated 
using FIT2D software (http://www.esrf.eu/computing/scientific/FIT2D) from ESRF. The reference 
samples without DOPE were measured by Synchrotron SAXS at the Stanford Synchrotron Radiation Light 
source, beamline 4-2. The 2D powder diffraction data was acquired on a MX-225 CCD detector (Rayonics). 
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4.5.3 Preparation and observation of GUVs 
Giant unilamellar vesicles (GUVs) were prepared by the electroformation method.50 Briefly, 
mixtures of DOPC, DOPE, DOPE-PEG, Cholesterol, and fluorescent label Texas Red® DHPE (1 mol%) 
were dissolved in a 2:1 (v/v) chloroform/methanol mixture and deposited onto clean ITO-coated glass (30 
μl at 10 mg/ml). The cast film was dried under vacuum for an hour and then filled with ~2.7 ml of aqueous 
buffer containing 100 mM sucrose in a 2:1 (v/v) glycerol/water mixture. The two ITO glasses were secured 
together tightly by rubber bands. An AC voltage of 10V (2V/mm) at a frequency of 7Hz was applied 
between the electrodes from a function generator (Hewlitt Packard). After 2 hours, the function generator 
was turned off and the vesicles were let to relax overnight in the preparation chamber and then were drawn 
out carefully. Images of the GUVs were obtained using a home-built epifluorescence imaging microscope 
equipped with a Nd:YVO4 laser of 532 nm excitation wavelength. 
4.5.4 Sonication 
To test the effect of ultrasound, samples were indirectly sonicated via a sonicator equipped with a 
cup horn attachment (Qsonica) at controlled temperature (25°C) using a chiller (Fisher Scientific). The 
ultrasound frequency was 20 kHz and exposure time was 10 min. The average energy applied to liposomes 
during sonication is 70 kJ. Pressure measurements were conducted with a Bruel and Kjaer hydrophone type 
8103. At 20% amplitude, acoustic pressure measurements in the sample chamber gave 430 kPa (pk-pk).  
The release assessment of calcein is based on the following well-established methodology: Intact 
liposomes containing calcein will display low fluorescence intensity due to self-quenching caused by the 
high intraliposomal concentration of material. Ultrasosund mediated release of material into the 
extraliposomal phase can be determined by a marked increase in fluorescence intensity due to a reduced 







Where Fb and Fu are, respectively, the fluorescence intensities of the liposome sample before and 
after ultrasound application. FT is the fluorescence intensity of the liposome sample after solubilization with 
surfactant (Triton-X 100). Studies have shown that the solubilization step must be performed at high 
temperature, above the phase transition temperature of the phospholipid mixture. 
Fluorescence measurements were carried out in a The Horiba FluoroMax® 4 spectrometer equipped 
with 150 W xenon, continuous output, ozone-free lamp. The excitation monochrometer has an optical range 





Figure 4.1. Calcein release (%) from liposomes measured by fluorescence. The full squares are for a sample containing 
ФPE=0.62 (DOPE:DOPC:Cholesterol:DOPE-PEG; 62:15:20:3 mole%). The full dots are for a sample containing 
ФPE =0 (DOPE:DOPC:Cholesterol:DOPE-PEG; 0:77:20:3 mole%). Liposomes containing DOPE are much more 
responsive to US during the time range of exposure.
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Figure 4.2. Small angle X-ray scattering (SAXS) data obtained for DOPE-based liposomes at (A) ФPE =0.3 
(DOPE:DOPC:Cholesterol:DOPE-PEG; 30:47:20:3 mole%) (B) ФPE=0.62 (DOPE:DOPC:Cholesterol:DOPE-PEG; 
62:15:20:3 mole%) (C) ФPE =0 (DOPE:DOPC:Cholesterol:DOPE-PEG; 0:77:20:3 mole%) before US treatment 
(bottom black line) and after US treatment (top red line). DOPE-based liposomes (A, B) mostly adopt a lamellar phase 
before US energy is applied and after US treatment, an inverted hexagonal phase (HII) becomes the dominant phase 
for both cases. Reference liposomes (C) which do not contain DOPE only show a lamellar phase that responds to US 
treatment by thinning ca. 10 Å. This indicates that DOPE lipids are responsible for HII phase appearance in DOPE-
containing liposomes (A, B).
 52 
 
Figure 4.3. Fluorescence images of giant unilamellar vesicles (GUVs) of DOPE-based liposomes at (A) ФPE=0.3 
before US treatment (B) ФPE=0.62 before US treatment (C) ФPE=0.3 after US treatment (D) ФPE=0.62 after US 
treatment. Liposomes before US treatment (A, B) are mostly spherical but for higher contents of DOPE, tubular 
aggregates are present as well as indicated by the white arrow. After US treatment, liposomes (C, D) restructure into 




Figure 4.4. Illustration of the proposed mechanism for the restructuring of DOPE-based liposomal membranes upon 
ultrasound stimuli. The incorporation of DOPE within the flat liposomal membrane (H = 0) is a source of negative 
curvature (H < 0) stresses that lower the membrane elastic free energy of the system. When US energy is applied, the 
membrane system responds by a topological phase transition where pores with local negative membrane curvature (H 
< 0) are generated. This will lead to rapid permeation of small drugs from the liposome interior.
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Figure 4.5. (A) To the left: image of a giant unilamellar vesicle (GUV) at DOPE=0.30 before ultrasound exposure 
is applied, which shows an inhomogeneous lipid membrane suggesting the existence of lipid membrane segregations. 
To the right: suggested lipid domain formation based on curvature-driven lipid sorting with DOPE rich (red) regions 
of negative curvature embedded in DOPC of zero mean curvature (blue). (B) Schematic illustration of the shape 
change in GUVs upon ultrasound stimuli. DOPE rich regions of higher curvature promote the onset of GUV pearling. 
The higher the DOPE content, the easier it is to bend the membrane and pearling leads to the transformation of the 
GUVs into much smaller aggregates when compared to intermediate contents of DOPE.
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CHAPTER 5 
 SOFT NANOSTRUCTURED LIPID FILMS FOR ACTUATED 
SUBSTRATE MEDIATED SMALL INTERFERING RNA 
DELIVERY 
 
This chapter describes the work on lipid-thin films with adaptive nanostructures for substrate-
mediated gene delivery.* The nanostructures of lipid films were explored and applied to deliver small 
interfering RNA (siRNA) into cells via actuated phase transformations. The lipid cubic phase oriented with 
respect to the substrate is of great interest in this work. The geometry of the cubic phase films in relation to 
its endosomolytic properties are carefully studied.  
5.1 Introduction 
RNA interference (RNAi) is going through phase 2 and 3 clinical trials, thanks to refinements in 
small nucleic acid lipid particles.1,2 Recent reports show 100- to 1,000-fold improvements in therapeutic 
index.1,2 The success of RNAi originates from tissue-specific delivery without off-target toxicity. Most 
research efforts so far have given emphasis to systemic strategies of siRNA delivery. An alternative 
approach is substrate-mediated delivery of siRNA which allows spatial control and sustainability of gene 
release, locally high gene concentration, and enhanced cell contact. This type of delivery enables the 
treatment of localized diseases,3 high-throughput genomic and proteomic studies,4,5 tuning of cellular 
activities in stem cell reprograming6,7 and implants,8 as well as wound healing applications. With currently 
emerging electronic devices that are bioresorbable and wirelessly controllable9–12 it is a timely opportunity 
to investigate new coating materials with therapeutic functionalities.  
                                                 
* Part of this chapter includes the previously published material – Kang, M.; Leal, C. Adv. Funct. Mater. 2016, 26, 
5610–5620. Copyright 2016 WILEY-VCH. Reprint permission was acquired from the publisher. 
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At present, most developed therapeutic films are unstructured polymer based substrates that 
degrade or expand/contract, in some cases upon a stimulus, leading to diffusion controlled release 
mechanisms.13 Interestingly, there is a lack of structured coating therapeutic materials even though 
hierarchic nanoscale organization has a great impact on molecular transport.14–16 Previous studies on 
substrate-mediated gene delivery have used a variety of methods to immobilize genes on surfaces via either 
specific or non-specific adsorption. Specific adsorption methods involve complementary functional group 
interactions (e.g., antigen-antibody interactions17,18) or specific surface chemical interactions (e.g., self-
assembled monolayers (SAM)19,20). Non-specific adsorption methods make use of hydrophobic 
interactions, van der Waals forces, and electrostatic interactions among the surface, the gene carriers and 
the genes themselves.21,22  
One of the most common methods for gene immobilization is layer-by-layer (LBL) self-
assembly.23,24 This technique builds up multi-layer films by depositing alternating layers of oppositely 
charged materials, allowing precise control of gene loading by controlling the number of layers.24 However, 
this technique is often a slow (although not always25) process and requires the use of charged materials. In 
addition, the inherent layered morphology of the LBL self-assembly does not provide a platform where 
elution or diffusion modes can be activated. Genes located within the inner layer of LBL films cannot be 
released easily from passive diffusion or spontaneous release,26 lowering the overall gene delivery 
efficiency.  
Lipid particulate systems and their structures and have been extensively used for cellular 
delivery.27–30 However, despite the fact that lipids have the capacity to display a rich phase behavior when 
supported onto surfaces,12,31,32 their use has been mostly reserved as cell membrane models (and a few 
reports for surface-based DNA delivery3,33) in the form of supported lipid bilayers. In this work I utilize the 
ability of lipids to self-assemble into a variety of nanostructures to explore surface-based delivery materials 
that can be activated by transformations between phases with distinct diffusion and cell membrane 
penetration properties instead of relying on swelling or degradation.13 I especially focused our efforts on 
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constructing lipid-siRNA complex films exhibiting 3D bicontinuous cubic structures motivated by previous 
findings34–37 that bolus type siRNA-mediated gene silencing is enhanced by the use of such topologically 
active phases. 
In this work, I demonstrate that a judicious choice of lipid molecules and environmental conditions 
gives rise to the stabilization of lipid films with highly oriented nanostructures of diverse symmetry. The 
lipid films displayed 3D bicontinuous cubic, 2D inverted hexagonal, and 1D lamellar structures yielding 
grazing incidence small/wide angle X-ray diffraction (GISWAXD) patterns resembling that of single 
crystals. All lipid nanostructured films are able to incorporate large amounts of siRNA and the 
transformations amongst them can be tuned by temperature and humidity in order to achieve efficient 
siRNA delivery to HeLa cells and concomitant specific gene knockdown. This work is of fundamental 
nature but highlights new design principles, such as controlling the nanostructure of surface-mediated 
siRNA delivery materials, which can be put to use in biological applications such as stem cell reprograming 
and wound healing bandages.    
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5.2 Results and Discussion 
5.2.1 The formation of diverse lipid film structures 
Most of the existing films used in substrate-mediated gene delivery are assembled in layer-by-layer 
structures. This is also the case for lipid-based gene delivery where adsorbed films are stabilized in 1D 
lamellar stacks of bilayers.33 One of primary goals in this study was to investigate how the dynamic bulk 
lipid phase behavior translates to surface confinement and if we can utilize it for improved surface-based 
delivery. We intend to investigate the conditions enabling the formation of diverse film morphologies and 
their ability to accommodate biomolecules such as siRNA to investigate the influence of the substrate 
structure on surface-based gene silencing. To bring structural diversity and functionality to the films, I used 
lipid molecules having molecular structures leading to diverse polymorphism as well as carrying positive 
charge to electrostatically pin siRNA. Specifically, three different lipids were used in the film design: a 
classic bicontinuous cubic phase-forming neutral lipid glycerol monooleate (GMO), a lamellar phase-
forming neutral lipid 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and the univalent cationic lipid 
1,2-dioleoyl-3-trimethylammonium-propane chloride salt (DOTAP) that has electrostatic affinity for 
siRNA. 
The ordering and spatial arrangements of lipid films at varied compositions and environmental 
conditions of temperature and humidity were characterized by GISWAXD and Polarized light microscopy. 
Figure 5.1 shows GISWAXD diffraction patterns of self-assembled lipid films with the corresponding 
polarized light microscopy images. The measured scattering patterns were analyzed using NANOCELL 
software38 that simulates the GISWAXD diffraction reflections of all space groups. Simulated patterns were 
matched and overlaid on the measured data to elucidate the structure, orientation, and order of the samples. 
Figure 5.1A shows calculated NANOCELL patterns for each phase and the raw GISWAXD data 
is represented in Fig. 5.1B. GISWAXD images are represented with two different perpendicular projections 
of scattering vector q, namely, q
x




out-of-plane direction normal to the sample surface (c.f. schematics in Fig. 5.2). Each film was 
characterized by both small and wide angle modes, and the complete data set of each phase can be found 
in supplementary Fig. 5.3. Figure 5.1C displays the overlaid experimental and simulated patterns of space 
groups Ia3d (bicontinuous cubic gyroid), p6mm (2D hexagonal) and 1D lamellar from left to right. The 
predicted diffraction patterns align perfectly with the experimental GISWAXD data revealing that fine 
tuning of lipid composition, temperature, and humidity result in a very rich phase behavior of lipid 
nanostructures confined to solid substrates. Figure 5.1 (top) shows a schematic representation of the 3D, 
2D, and 1D phases obtained for each lipid system. 
Table 5.1 summarizes the phase behavior of lipid films at different conditions. The 3D 
bicontinuous cubic gyroid QIIG, lipids is obtained from GMO/DOTAP systems when the molar fraction of 
DOTAP (GMO)  0.6 at 37C, 955% relative humidity (RH). This nanostructure consists of a lipid 
membrane (the yellow surface represents the bilayer mid-plane) that separates two interconnected but non-
penetrating water channels (represented in orange and blue). Diffraction spots from highly ordered 3D cubic 
phases should be carefully matched because they are highly dependent upon the orientation of the sample 
and the patterns obtained from different cubic space groups can be quite similar. However, the simulated 
NANOCELL38 patterns of other possible cubic phase symmetry groups do not at all match to the 
experimental GISAXD data (c.f. Fig. 5.4). In this case, an analysis of the integrated diffraction patterns 




=  √6/√8=0.866 which fully matches with the expected ratio 
for an Ia3d (bicontinuous cubic gyroid) space group. The unit cell dimensions of the thin film QIIG, lipids 
phase is aQ = 92.8 Å which is in the same order of what is obtained for bulk systems where siRNA could 
be fully incorporated.34 It is noteworthy that the soft lipid substrates give rise to a diffraction pattern that is 
not the expected powder sample ring. Instead, diffraction patterns resembling those that are observed for 
single crystals are obtained.39 The NANOCELL fitting reveals that the lipid film comprises large domains 
that are highly oriented along the [211] axis perpendicular to the substrate i.e. (211) lattice planes are 
preferentially oriented parallel to the substrate. This preferential alignment of cubic phases in films was 
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recently explained by theoretical calculations based on the minimization of interfacial energy40 where films 
of lipid cubic phases adopt the crystallographic orientations in accordance with the lowest energy facet. 
The 2D hexagonal phase (HIIlipids) was obtained for GMO/DOTAP systems when GMO  0.75 and for 
DOPC/DOTAP systems of all compositions at 25C and room humidity (20-40% RH) conditions (c.f. 
Table 5.1). The HIIlipids phase has lattice dimensions corresponding to the distance between lipid tubes of 
aH= 40.3 Å. Also in this case, the diffraction patterns reveal an extremely well oriented sample where a 
honeycomb array of lipid tubes (schematically represented on top of Fig. 5.1) is preferentially aligned 
parallel to the substrate. When the lipid composition is GMO ≥ 0.75 and the temperature and humidity are 
kept at 25C and 20-40% RH, a lamellar stack (Llipids) of lipid bilayers (represented on top of Fig. 5.1) is 
observed with the bilayers oriented parallel to the solid support. At GMO  ≤ 0.5 and all compositions of 
DOPC/DOTAP systems at  37C, 955% RH, a lamellar phase is obtained as well (c.f. Table 5.1). The 
orientation of the bilayers is very well defined suggested by the spot patterns arising from large domains of 
(100) planes oriented parallel to the substrate. The relative positions of the second-, third- and fourth order 
peaks to the first-order peaks, 1:2:3:4 in integrated I vs q data is characteristic of a lamellar morphology 
with the lattice dimensions of aL= 44.4 Å. 
Another technique used to characterize the film structure was polarized light microscopy (POM). 
Under crossed polarizers, birefringent lamellar or hexagonal phases show unique optical textures enabling 
distinction of each phase. Conversely, cubic phases are not birefringent, and appear dark under polarized 
light. Figure 1D represents the POM images of the bicontinuous cubic gyroid QIIG, lipids, inverted hexagonal 
(HIIlipids), and lamellar (Llipids) lipid film phases (from left to right). The optical characteristics of Lα—oily 
streak, maltese-cross pattern or uniaxial texture41—were observed in the (Llipids) phase film. The hexagonal 
phase film exhibited the characteristic focal conic textures or spherulitic morphology.42,43 These features 
corroborate the X-ray diffraction results and indicate that the lipid film nanostructures are present over a 
wide surface area. 
With proper control of lipid composition and the environmental conditions (temperature and 
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relative humidity), we could reproducibly synthesize three different lipid film phases on solid supports: a 
1D lamellar (Llipids), a 2D inverted hexagonal (HIIlipids), and a 3D bicontinuous cubic gyroid QIIG, lipids. The 
rich phase behavior is enabled by the inclusion of GMO which is a lipid prone to form bicontinuous cubic 
phases.44 When only phospholipids are used such as DOPC and DOTAP the observed phases are either an 
inverted hexagonal phase (HIIlipids) in dry conditions (20-40%RH) or the lamellar phase (Llipids) in wet 
conditions (955% RH) regardless of the lipid composition. It should be emphasized that all lipid films 
formed on solid supports showed lattice dimensions that are appropriate for the inclusion of small molecules 
and nucleic acids such as siRNA. Moreover, the different phases arise from a combination of lipid 
compositions and environmental conditions enabling the design of highly responsive surface materials for 
surface-based delivery. The phase transformations were reversible and stable for multiple cycles of wetting 
and drying having a transition time scale of a few minutes. 
It is noteworthy that the number of surface lifted materials when lipids films are immersed in water 
is negligible during time periods relevant for the cell culture experiments to be discussed in further sections 
(hours). Figure 5.5 shows fluorescence imaging of regular liposomes in solution versus the supernatant of 
films exposed to bulk water where no significant amount of particles in solution could be found. In addition, 
confocal microcopy images of adherent cell lines show that cells are in fact embedded within the lipid film 
matrix. The next section shows how the surface-based phase behavior is affected by siRNA incorporation. 
5.2.2 siRNA addition and complex formation 
Having validated the lipid films can have various structures, we examined whether all three 
different phases can maintain the structure after incorporating siRNA. Figure 5.6A shows two-dimensional 
GISWAXD images of self-assembled lipid films with siRNA integrated. The scattering data displays an 
equally rich phase behavior when siRNA is included when lipid composition and environmental conditions 
as for materials discussed in Fig. 5.1 are maintained. The diffraction patterns of Fig. 5.1A (left) can be 
completely matched to the bicontinuous gyroid cubic phase (QIIG,siRNA) represented on top of Fig. 5.6 and 
consists of a lipid bilayer separating two water channels where siRNA is located. This type of phase has 
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been carefully characterized for bulk materials in the past34 and it is conserved under surface confinement 
as well. As the conditions of lipid composition, temperature, and humidity are tuned, the scattering patterns 
are consistent with the other two phases 2D hexagonal (middle, HIIsiRNA ) and 1D lamellar (right, LsiRNA) 
emerging when siRNA is incorporated in the films. A summary of all phases when siRNA is incorporated 
is also included in Table 5.1. The orientation of the lipid-siRNA films is analogous to what was observed 
with lipid-only analogues but some degree of order is lost as indicated by the more elongated diffraction 
patterns. Firstly, this a prominent indication that indeed siRNA is included in the lipid nanostructure and 
secondly, there is still a preferred orientation of the lipid-siRNA domains as a fully disordered array would 
give rise to scattering rings of uniform intensity. Peak broadening and increased disorder is a typical 
observation as siRNA is incorporated in lipid mesophases.34,45 For further analysis, the one-dimensional I 
vs q scattering curves were obtained by azimuthal integration of radial slices from the GISWAXD pattern 
as shown in Fig. 5.6B. When the 3D QIIG,siRNA  phase is present the indexing matches perfectly to the 
expected [211], [220], [321], [400], [420], [332] reflections, in HIIsiRNA the indexing corresponds to the [10], 
[11], [20], [21], [30] diffraction peaks, and for the 1D LsiRNA the [001], [002], [003], [004] peaks are 
observed, as indicated in Fig. 5.6B. As siRNA is added (red lines) the diffraction peaks broaden and the 
lattice spacing changes. The lattice spacing of HIIsiRNA phase is 40.3 Å before adding siRNA and 40 Å after 
adding siRNA, indicating that siRNA is simply incorporated inside the aqueous domain of lipid tubes. The 
lattice spacing of Lα  phase is 44.4 Å before adding siRNA and 42.6 Å after adding siRNA. A slight 
compression is often seen in lamellar phases due to electrostatic screening as negatively charged siRNA is 
incorporated in the water domain separating the two positively charged lipid bilayers. For the QIIG,siRNA 
phase, however, there is a 30% increase in lattice spacing after siRNA addition from 92.8 Å to 118.3 Å. 
This fact has been observed before for bulk systems equilibrated at high relative humidity but with no 
excess water.34 In bulk systems in excess of water, cubic phases tend to slightly shrink with siRNA 
addition.35 High humidity environments should be theoretically comparable to excess water conditions, 
however cubic phase lattice dimensions are extremely sensitive to water content34 and only a few percent 
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below full saturation (100% RH) is enough to significantly impact the unit cell values. At this point we 
believe that the lattice spacing dimension differences observed in film form are more a description of 
slightly different water contents before and after siRNA addition. We also noticed that the bicontinuous 
cubic phase lattice spacing and ordering was dependent on the amount of siRNA loaded with the film. As 
the ratio of the positive charges of the lipids to the negative charges of siRNA (𝜌) decreased, the domains 
tend to orient more randomly. In this work, we present the 𝜌 = 10 data which represents the operating 
conditions of the cell experiments to be described below. 
Self-assembled lipid-siRNA structures were also studied at dry and wet conditions and several 
GMO/DOTAP ratios (c.f. Table 5.1). When siRNA is incorporated, the bicontinuous cubic phase is present 
at a narrower compositional area and as DOTAP contents increase in the range of ΦDOTAP = 0.30 - 0.40 the 
HIIsiRNA coexists with the QIIG,siRNA phase. This phenomenon has been observed in bulk samples too [35] and 
arises from the fact that siRNA is a rod-like stiff molecule and its electrostatic interaction with lipid films 
imposes curvature constraints with flat elongated tubes being preferred instead of the curved QIIG ones.[36]  
The spatial distribution of siRNA within wide areas of lipid films was evaluated by Confocal 
Microscopy with siRNA tagged by green fluorescence signals and the lipid material with red. Figure 5.6C 
shows 3D confocal microscopy images at several slices (H) through a thick deposited lipid film. All mid 
sections display yellow signals indicating the siRNA and lipid domains are completely co-localized. As the 
slices through the film approach the solid support (H = 7.11 μm) they appear more red (mainly lipid) and 
at the air/film interface (H = 22.91 μm) the fluorescence is prominently green (more siRNA). The 
encapsulation power of the lipid films was quantitatively determined by UV/VIS (Table 5.2) to be 97.6%. 
To evaluate the topography of the films we conducted taping mode AFM before (left) and after 
(right) siRNA addition for a sample comprising ΦGMO= 0.5 and ΦDOTAP= 0.5 shown in Fig. 5.6D. The 
AFM images of the dry films for other phases is presented in Fig. 5.7. Lower areas yield darker images and 
higher areas result into brighter contrasts. The height difference appearing among layers in the lipid-only 
films originates from the film formation process at fast evaporation. The films prepared by drop cast or spin 
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coating display a rather smooth surface with the height difference ranging in just a few tens of nm. 
Furthermore, AFM images clearly show that lipids cover the entire substrate with no formation of patches 
or domains. Films comprising siRNA appear less smooth with higher differences in height but the surface 
coverage appears to be analogous to that of lipid-only films. Film thickness can be modulated by depositing 
technique with drop cast yielding films of several micrometers thick in contrast to spin coating where film 
thicknesses are an order of magnitude thinner. Ellipsometry data as a function of spinning speed (Fig. 5.8) 
reveals that the film thickness can be controlled between 180 - 300 nm. 
The fact that the lipid-only and lipid-siRNA complexes display a rich phase behavior when 
adsorbed onto surfaces, and that a transformation of phases occurs when external conditions change from 
dry, room temperature to wet and 37 °C provides a remarkable potential to the design of responsive surface-
based delivery systems. This is of particular importance because the nanostructures are perfectly oriented 
with respect to the solid substrate. For example, in the dry state (25 °C, room humidity) a lamellar phase 
exists where biomolecules are confined and sandwiched within 1D stacks of bilayers aligned parallel to the 
surface. In this configuration there is only one-dimensional pathway (parallel to the substrate) for the 
biomolecule to diffuse out of the lipid host. As the film is hydrated at 37 °C there is a transformation to a 
3D bicontinuous gyroid cubic where the nanochannels containing the biomolecules are now exposed to the 
outer surface permitting the activation of three-dimensional diffusion pathways. A schematic representation 
of such phenomena is depicted in Fig. 5.9. Each nanostructure illustration represents their orientation with 
respect to the solid support as determined by X-ray scattering. 
5.2.3 Gene knockdown and cell viability 
The next goal was to demonstrate successful siRNA delivery from self-assembled lipid-siRNA 
films as well as cell viability. The results are shown in Fig. 5.10. For these gene knockdown studies, 
luciferase targeting siRNA was delivered to the HeLa-Luc cell line that stably expresses the luciferase. 
Gene knockdown levels were determined using luminescence from luciferase as a quantitative measure, 
normalized to the total amount of cellular protein present. Lipofectamine 2000, commercial reagent for 
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bolus type gene delivery, was used as a positive control. Scrambled siRNA was used as a negative control 
to test non-specific knockdown. We first performed a series of parallel experiments to optimize the ratio of 
the positive charges of the lipids to the negative charges of siRNA (ρ). The ratio of 10 was the optimum 
value yielding high knockdown efficiency and minimizing off-target effects (c.f. Fig. 5.11). This ratio was 
used in all subsequent experiments. 
Overall, all lipid films showed gene silencing capacity compared to the control (yellow bars in Fig. 
5.10A). It is noteworthy that even though the lipid-siRNA films are deposited and stored as dry films 
adsorbed to a glass substrate having only internal hydration water, there seems to be no decomposition of 
siRNA and its biological functionality. In Fig. 5.10A, six different lipid films were used in siRNA 
knockdown experiments for the purpose of revealing the relationship between the structure and knockdown 
efficiencies. As mentioned in the section 5.2.2, GMO/DOTAP system shows three different phases 
QIIG,siRNA, HIIsiRNA, LαsiRNA depending on the content of cationic lipid DOTAP  (ΦDOTAP). DOPC/DOTAP 
systems always show Lα at 37°C, 955% RH. 
Among the various nanostructured films, the QIIG,siRNA phase film showed the best specific gene 
knockdown efficiency (45-50% compared to the negative control). In addition, non-specific knockdown 
(blue bars) assessed by scrambled siRNA was the lowest. When the conditions are such that there is 
coexistence of the QIIG,siRNA and HIIsiRNA phases the knockdown efficiency is slight lower (30-40%) and the 
LαsiRNA nanostructured films display the lowest knockdown efficiency ranging from 20-30%. As expected, 
lipid-siRNA films that orient in the QIIG,siRNA phase permit an enhancement of specific gene knockdown 
compared to LαsiRNA phase. In addition there is also a lowering of the non-specific knockdown compared to 
the HIIsiRNA phase. It is noteworthy that the cubic phase is more efficient than a lamellar phase even if the 
contents of cationic lipids are lower. The QIIG,siRNA (ΦDOTAP=0.25) shows better knockdown efficiency than 
the LαsiRNA at ΦDOTAP=0.25 and ΦDOTAP=0.50 for systems where the neutral lipid is DOPC and GMO, 
respectively (this result  is statistically significant on unpaired Student’s t-test with p=0.05, n=3). 
Interestingly, LαsiRNA phases from GMO/DOTAP-siRNA systems showed slightly more favorable 
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gene knockdown performance than those LαsiRNA phases formed by DOPC/DOTAP-siRNA but this result 
is not statistically significant. Nevertheless, it should be noted that such behavior has been observed before 
for bulk systems[34] and may be attributed to the fact that GMO is a lipid that is able to lower the free energy 
cost of membrane fusion events (even when embedded in a lamellar phase), which is beneficial for 
endosomal escape. I also noticed that GMO/DOTAP films are mechanically stronger than DOPC/DOTAP 
films sticking the surface more strongly when they are exposed to cell media.  
Two types of assays were employed to test the toxicity and cell viability of lipid-siRNA films to 
Hela-Luc cells. Figure 5.10B compares the plasma membrane integrity and Fig. 5.10C shows viability of 
cells as they are exposed to GMO/DOTAP and DOPC/DOTAP lipid films at increasing contents of 
DOTAP. Overall, DOPC/DOTAP lipid films exhibited better cell viability compared to GMO/DOTAP 
films. The cell viability was at least 90% for DOPC/DOTAP films in plasma membrane integrity assay and 
75% in MTS (viability) assay. However the cell toxicity and viability obtained by GMO/DOTAP films is 
still rather high showing 70-80% in terms of plasma membrane integrity 75-90% in cell viability MTS 
assay. 
It should be noted that lipid-siRNA films were in the dry state before adding to cells. Lipid-nucleic 
acid materials are virtually insoluble in water swelling up to a finite amount of water content within the 
lipid-nucleic acid complex layers.46 This “hydration” water shell is in equilibrium with excess bulk water. 
Under thermodynamic equilibrium, there should be no difference between the lipid-nucleic acid phases 
observed at 100% RH or in excess water. However, it should be noted that cell media is not a pure water 
state. In addition, kinetic effects may pay a role as well. We argue nevertheless that the phase transitions 
obtained when cells are added to the dried lipid films will be analogous to that observed in high humidity 
conditions and in bulk (c.f. Table 5.1). Phase transformations of the lipid film are expected to facilitate the 
siRNA entering into the cells and increase the siRNA delivery efficiency.  
5.2.4 Uptake mechanism and endosomal release 
A successful siRNA delivery involves a number of different steps and barriers including: binding 
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to the cell surface, traversing the cell membrane, and escaping from the endosomes. In order to gain insight 
of the mechanism responsible for the differences in gene knockdown efficiency of the various lipid-siRNA 
film nanostructures we attempted to compare their cellular uptake mechanism and endosomal escape 
capability.  
Uptake pathways via endocytosis can be experimentally determined by treating cells with certain 
small molecules that inhibit cell internalization. We used three agents that are known to interfere with 
endocytosis, namely: cytochalasin D that blocks actin polymerization and macropinocytosis,47 filipin that 
inhibits caveaolae-mediated endocytosis,48 and chlorpromazine that prevents clathrin-mediated 
endocytosis.49 After pre-treating the cells with one of these agents, luciferase reporter activity was evaluated 
to check its influence on internalization and siRNA knockdown efficiency.  
Figure 5.12 shows the luciferase expression obtained after cell exposure to lipid-siRNA films 
oriented in the bicontinuous cubic phase (red bars-GMO/DOTAP-QIIG) and in the lamellar phase (green 
bars-DOPC/DOTAP-Lα) as increasing concentrations of the different cellular uptake inhibitors are added. 
In this experiment, I utilized luciferase knockdown power as an indirect indication of siRNA cellular uptake 
efficiency. We are aware that these can be decoupled in some systems but in terms of relative comparisons 
between different structures, correlating cellular internalization with knockdown efficiency is a valid 
approach. 
The macropinocytosis inhibitor “cytochalasin D” (Fig. 5.12B) did not affect the cellular uptake 
provided by either the lamellar or the cubic phase films. Conversely, the clathrin-mediated endocytosis 
inhibitor “chlorpromazine” (Fig. 5.12C) and the caveolae-mediated endocytosis inhibitor “filipin” (Fig. 
5.12D) significantly decreased the cell internalization capacity obtained by both the lamellar and cubic 
phase lipid-siRNA films. It is noteworthy that even though both films yield luciferase expressions indicating 
clathrin- and caveolae-mediated endocytosis, lamellar phase films performance is clearly more influenced 
as the concentration of endocytosis inhibitors is increased when compared to bicontinuous cubic phase 
films. This suggests that cubic phase films may permit cell entry via endocytic and non-endocytic pathways. 
 71 
Although endocytosis seems to be the major uptake mechanism for lipid-siRNA films as is in general for 
gene delivery systems,50,51 it is also known that lipids can deliver genes through fusion with the cell 
membrane.52,53 Bicontinuous cubic phases may have a stronger ability to be taken up by the cells also via 
membrane fusion when compared to lamellar phases. This can be understood in terms of Helfrich’s 
membrane elasticity theory.54 The elasticity of lipid layers can be expressed in terms of the Helfrich energy 
(E) per area (A) as   where  and G are the bending and the Gaussian 
modulus respectively. The first term is associated with the cost of bending a lipid layer having curvature C 
away from its spontaneous curvature C0. The spontaneous curvature relates to the packing parameter of 
lipid molecules that dictates the most probable self-assembled structure (e.g. flat layers, spherical 
aggregates, or rod-like shapes).55 The second term in the Helfrich expression relates to the topology of the 
lipid layer. Bicontinuous cubic phases enabled by certain lipid molecules such as GMO have principal 
curvatures C1 and C2 of similar value but opposite sign. This implies that bicontinuous cubic membranes 
have positive Gaussian modulus (G) and can significantly lower the elastic energy cost of bending 
membranes which is the central mechanism associated with membrane fusion. 
Even though bicontinuous cubic phase films may also permit cell entry via non-endocytic pathways 
it is clear by the data that endocytosis is the main uptake mechanism. After the internalization via 
endocytosis, the internalized molecules exist in endosomes with no access to the cytoplasm. These 
endosomes either fuse with lysosomes for degradation or recycle their contents back to the cell surface. 
Therefore, escape from endosomes is essential for efficient gene delivery. Our hypothesis is that the release 
of GMO/DOTAP-siRNA lipid materials from endosomal compartments may be more effective compared 
to DOPC/DOTAP-siRNA systems. This has been observed for bolus type delivery[35] and is related with 
the fact that GMO lipids have a tendency to stabilize non-lamellar “porous” assemblies such as bicontinuous 
cubic (C1C2<0) or reversed hexagonal (C0<0) phases that are favorable to endosomal membrane fusion 
events. GMO containing materials readily fuse with endosomal membranes and reduce the cost of forming 
membrane pores leading to more efficient endosomal escape. To verify this hypothesis, we performed 
E
A
= 0.5k(C -C0 )
2 +kGC1C2
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luciferase assays on cells exposed to lipid-siRNA films where cells have been treated with increasing 
amounts of “chloroquine” (Figure 5A), a well-known inhibitor of endosome acidification and lysosome 
fusion. This property, commonly called endosomolytic property, is critical to enhancing gene delivery 
efficiency by preventing the entrapment of siRNA within endosomes. If the bicontinuous cubic phase films 
allow for the delivery of materials with preferred endosomolytic properties, the addition of chloroquine to 
cells would not make much difference on the gene silencing efficiency. Figure 5 shows the activity 
luciferase assay data in the presence of increasing amounts of chloroquine as cells are exposed to 
bicontinuous cubic phase films (red bars) and lamellar films (green bars). As predicted, while the lamellar 
phase films yield a luciferase activity that is highly dependent on chloroquine addition, the cubic phase 
analogue is essentially unaffected. This indicates that the materials delivered by bicontinuous cubic phase 
films are able to escape the endosome without the aid of chloroquine due to their intrinsic efficiency on 
escaping endosomes. While the gene silencing was significantly increased with the combination of the 
lamellar phase film and chloroquine (4-fold), cubic phase films showed only a slight decrease (1.3-fold). 
This implies that the cubic phase film has indeed the capacity to deliver materials to the cell that possess 




Successful siRNA silencing was demonstrated through lipid films on solid supports with 
efficiencies that greatly depend on film nanostructure. By judicious choice of environmental conditions and 
lipid components including glycerol monooleate (GMO) in combination with charged and uncharged 
phospholipids, three different phases of lipid films: 3D bicontinuous cubic - Q
II
G, 2D hexagonal - HII, and 
1D lamellar - Lα were fabricated via self-assembly with high reproducibility. Analysis of the films by 
GISWAXD, polarizing light microscopy, AFM and confocal microscopy shows that the self-assembled 
lipid films are smooth, highly ordered, and with large domains oriented along specific planes with respect 
to the solid supports. Specifically, the  Q
II
G  orients with the (211) plane parallel to the substrate and is stable 
in a humidified environment, the HII phase consists of lipid tubes laying flat on the solid substrate and is 
mostly stable in dry conditions, and finally the Lα comprising bilayers stacked parallel to the subtracting 
existing in dry and wet conditions depending on lipid composition. The self-assembled lipid films 
maintained a well-ordered and oriented structure even after siRNA incorporation. The fact that lipid-siRNA 
films display a phase behavior that is highly responsive to humidity and temperature (e.g. transformations 
from 1D lamellar to 3D bicontinuous cubic) confers the possibility of designing actuated surface-based 
delivery films where the diffusion of molecules out of the lipid host is enhanced from one-dimensional 
pathways (in the 1D lamellar state) to three dimensional (in the 3D bicontinuous cubic).  
We investigated the potential of applying lipid films to deliver siRNA to HeLa cells in vitro and 
elucidated how film nanostructure controls siRNA delivery efficiency. Overall, lipid-siRNA films allowed 
for successful specific gene knockdown. The Q
II
G phase showed superior siRNA silencing capacity when 
compared to other phases with the absolute silencing efficiency 50% which is comparable to the most 
efficient surface-based delivery systems reported so far.56 Mechanism studies in the presence of endocytosis 
inhibitors (filipin and chlorpromazine) and endosomolytic facilitators (chloroquine) reveals that the main 
process of cellular uptake mediated by the lipid films is endocytosis however the Q
II
G phase possesses the 
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ability to also fuse with the plasma cell membrane. In addition, the Q
II
G  phase offers superior endosomolytic 
properties compared to Lα phase. We propose that the intrinsic structural properties of GMO containing 
aggregates such as the Q
II
G  phase comprising membranes of positive Gaussian modulus facilitates 
membrane fusion and pore formation of endosomal membranes leading to more efficient siRNA delivery 
and concomitant gene knockdown. 
Here we propose a new concept for substrate-mediated cellular delivery that is based on soft 
adsorbed lipid materials possessing highly ordered structures at the nanoscale that offer distinct biomolecule 
diffusion pathways as well as cell penetration capacities. The films are highly responsive to environmental 
conditions allowing the design of actuated siRNA silencing via the topological transition of the lipid film 
as a function of humidity and temperature from 1D lamellar to 3D bicontinuous cubic morphologies.  
The in vitro siRNA release profile for each phase is very distinct (Fig. 5.13) with the transformation 
to the  Q
II
G  phase yielding the most efficient release. Even though the amount of released siRNA is 
comparable to that obtained with polyelectrolyte LBL systems56 in the range of 10 g/cm2 (and ca 50% 
efficiency), the release kinetics and profiles are rather distinct. It is noteworthy that lipid-based siRNA 
release is cued by a phase transformation and is thus likely to result in release behaviors diverging from 
those based on matrix degradation such as LBL polyelectrolyte systems.   
The results presented in this chapter highlight the importance of controlling the structure of surface 
materials at the nanoscale in order to achieve more efficient siRNA delivery from solid substrates. These 
findings open up new perspectives in the film design for substrate-mediated cellular delivery.
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5.4 Experimental Section 
5.4.1 Materials 
Glyceryl monooleate (GMO) was purchased from NU-CHEK PREP, Inc (Elysian, MN). 1,2-
dioleoyl-3-trimethylammonium-propane (DOTAP) and 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) were purchased from Avanti Polar Lipids (Alabaster, AL). The fluorescent lipid 1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (Texas Red® DHPE) was 
purchased from Life Technologies (Grand Island, NY). All lipids were used without further purification. 
Scrambled siRNA was purchased from Qiagen (Valencia, CA) and pGL2 siRNA that targets luciferase 
siRNA was purchased from Dharmacon (Lafayette, CO). siRNA labeling reagent Label IT® siRNA Tracker 
was purchased from Mirus (Madison, WI). Endocytosis inhibitors chloroquine, chlorpromazine, filipin, and 
cytochalasin D and all solvents were purchased from Sigma Aldrich (St. Louis, MO).  Luciferase Reporter 
1000, CytoTOX-ONE and CellTiter 96 Aqueous One Solution Cell Proliferation assays were purchase from 
Promega (Madison, WI). Pierce BCA Protein Assay Kit was purchased from Thermo Scientific (Waltham, 
MA). All water used in this study was purified using a Milli-Q purification system (Millipore) to a resistivity 
greater than 18 MΩ cm. 
5.4.2 Preparation of lipid films 
Lipid films were prepared by drop-casting method to know the exact amount of lipids contained in 
films. The main principle of film formation is based on evaporation-induced self-assembly. A stock solution 
of lipids dissolved in organic solvent (chloroform, methanol, and ethanol) is dropped onto the substrate and 
allowed to dry freely in air. Upon evaporation of the solvent, the lipid molecules (precursors) become 
concentrated leading to spontaneous self-assembly of individual molecules into an organized, 
nanostructured thin film. The substrates used in all experiments are coverslips with a diameter of 12 mm 
(German Glass, EMS). The coverslips were washed before use in a sonication bath using ethanol and Milli-
Q water for 15 min, respectively, and then dried using a nitrogen gun. The mole of lipids needed to yield 
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the required 𝜌 value (the ratio of the positive charges of DOTAP lipids to the negative charges of siRNA) 
was calculated with a fixed mass of siRNA (0.266 μg). The exact amount of lipids was dissolved in a 
mixture of 3:1 (v/v) chloroform and methanol. A volume of 30 µL was applied to the substrate and wetted 
the whole substrate. When dewetting occurred, methanol or ethanol (30 µL) was added to the substrate to 
spread out lipids again. Solvents in films were evaporated under the hood and then films were put in the 
desiccator overnight for complete solvent evaporation. The films were visually smooth. The samples were 
kept refrigerated until use. For each film, 0.266 μg of siRNA in 5 μL of DEPC-treated water (Invitrogen) 
was dropped onto the lipid films. SiRNA-loaded lipid films were gently rotated to spread out siRNAs 
evenly. Complex films were then incubated for 1 h at 37°C in a humidified atmosphere with 5% CO2. 
During the incubation time, films were dried. 
5.4.3 Characterization of lipid films 
Grazing incidence small/wide angle x-ray diffraction (GISWAXD): To characterize the film 
structure and orientation, we used GISWAXD conducted in a custom built (with Forvis Technologies, Santa 
Barbara) equipment composed of a Xenocs GeniX3D CuKα Ultra Low Divergence X-ray source (1.54 Å/8 
keV), with a divergence of 1.3 mrad. The measurement set-up is schematically shown in Fig. 5.2. The 
humidity and temperature control chamber was built by Forvis Technologies. Incidence grazing angles 
were in the range of 0.25-0.40°, larger than the critical angle of the substrate to avoid refraction and 
diffraction from the reflected beam. Multiple measurements were carried on the same sample, varying the 
incidence angle to determine the most appropriate operating angle. The sample-to-detector distance was 
calibrated using a silver behenate powder standard. The specular beam intensity was attenuated along the z 
axis with a strip beam stop. The 2D diffraction data were radially averaged upon acquisition on a Pilatus 
300 K 20 Hz hybrid pixel Detector (Dectris). The measured scattering patterns were analyzed using 
NANOCELL simulation tool developed by Tate et al1.[38] Detailed information can be found at 
http://faculty.washington.edu/h2/simulation.html. 
Polarized Light Microscopy: The texture of the lipid liquid crystalline phases was visualized using 
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a polarized light microscope (Zeiss Jenavert inverted microscope). The samples were prepared the same 
way as prepared for GISWAXD measurements. Crossed polarizers enabled to distinguish the distinct 
patterns of birefringent lipid phases.  
Confocal Microscopy: Morphology of lipid films before and after siRNA addition was studied 
using a confocal microscope (Zeiss LSM 700 confocal scanning laser microscope). The samples were 
prepared the same way as prepared for GISWAXD measurements except that lipids were labeled with 0.1 
mol % DHPE-Texas Red and siRNA was labeled with Label IT®  siRNA Tracker. Image stacks were 
processed using Zen software (2010, Zeiss). 
Atomic Force Microscopy: Imaging of the lipid thin films with and without siRNA was performed 
with an atomic force microscope (AFM-Asylum Research MFP-3D) operated in tapping mode in air. The 
relative humidity (RH) during AFM measurements was 30-40%. For those measurements, I used Budget 
Sensors Tap300AL-G cantilevers with a resonance frequency of 300 kHz and a force constant of 40 N/m. 
5.4.4 Functionality test of lipid films 
Cell culture: Luciferase overexpression HeLa stable cell line (HeLa-Luc) was purchased from 
Signosis, Inc (Santa Clara, CA). This cell line represents a high level of luciferase expression and can be 
used as a positive control for luciferase activity. The cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM, Gibco), supplemented with 10% (v/v) fetal bovine serum (FBS, ATCC), 1% (v/v) 
penicillin-streptomycin (Lonza) and 100 μg/ml of Hygromicin B (Roche) at 37°C in a humidified 
atmosphere with 5% CO2. 
Gene silencing: HeLa-Luc cells were seeded into 24 well plates at 50,000 cells per well and 24 h 
before the silencing experiments. Prior to adding the lipid-siRNA films, the cells were washed once with 
0.5 mL phosphate buffered saline (PBS, Gibco). The prepared lipid-siRNA complex films containing 
siRNA (0.266 μg) targeting the firefly luciferase were then gently placed on top of the cells. OptiMem (200 
μL) was added to the wells afterwards. Positive control samples were prepared with Lipofectamine 2000 
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from Invitrogen (Grand Island, NY) and the optimized ratio of lipofectamine to siRNA was 4:1. The 
Lipofectamine positive control was delivered via bolus delivery. Negative control samples were prepared 
using scrambled siRNA (Qiagen). After 4h of incubation, all wells were washed with PBS and replenished 
with DMEM (0.5 mL), but films were remained in the wells. After 20h-24h, wells were washed with PBS 
again and then cells were completely lysed with 150 µL of 1X Reporter Lysis buffer (Promega) that required 
a single free-thaw cycle. Then lysate extract (25 µL) was transferred to a 96 well plate and used in the 
Luciferase assay (Promega). Firefly luciferase gene expression was measured by a microplate reader 
(Perkin Elmer, VictorTM
3
, Waltham, MA) and the observed luminescence signal was normalized with 
respect to total cellular protein, as determined by a BCA assay (Thermo scientific). For experiments 
involving endocytosis inhibitors, a designated amount of inhibitor was added to cells 1 h prior to putting 
lipid-siRNA complexes. Chloroquine was added at concentration of 0, 10, 20, 50 µM, chlorpromazine was 
added at concentration of 0, 20, 30 µM, Cytochalasin D and filipin was added at concentration of 0, 5, 10, 
20 µM in DMEM (0.5 mL). 
Cytotoxicity of lipid films: Cytotoxicity was tested using CytoTOX ONE assay (Promega) for 
membrane integrity and CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega) for cell 
viability. The experimental conditions were kept same as in silencing experiments. Cells were incubated 
with lipid-siRNA films for 24 h. As controls, some wells were left untreated to allow for normalization. 
After incubation, the recommended volumes of assay were added to each well, and cell viability/toxicity 
was measured as per the assay manufacturer’s instructions. 
5.4.5 Statistical analysis 
Statistical analysis was performed using an unpaired Student’s t-test. The normalized luciferase 
activity from experiments performed in triplicate was compared between the experimental and control 





Figure 5.1. (A) Reciprocal space patterns of different space groups simulated by NANOCELL[38]: Ia3d with [211] 
direction perpendicular to the substrate, p6mm with the six-fold axis parallel to the substrate, lamellar with each plane 
stacked parallel to the substrate, from left to right. (B) Two-dimensional GISWAXD patterns for self-assembled lipid 
films of a bicontinuous cubic gyroid (Q
II
G, lipids), an inverted hexagonal (HII
 lipids
), and a lamellar Lαlipids structure from 
left to right. The GMO/DOTAP lipid composition from left to right is GMO=0.75 at 37C, 955% RH, GMO = 
0.6 at 25C, 20-40% RH, and GMO = 0.5 at 37C, 955% RH, respectively. Films have highly ordered structures 
as indicated by spot patterns instead of rings. (C) NANOCELL simulation overlaid onto the GISWAXD data. The fact 
that simulated patterns perfectly match with actual data proves that lipid self-assembled films have well-characterized 
structures. (D) Polarized light microscope images of lipid films with distinct textures. Optically isotropic cubic phase 
appears as a black background under the polarizer while an inverted hexagonal phase (HII) shows focal conical texture 
and a lamellar phase (Lα) represents oily streaks with uniaxial texture. An illustration of each film nanostructure is 
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Figure 5.2. Schematic representation of GISWAXD geometry. The sample is placed vertically in a 
temperature/humidity-controlled chamber. The scattering patterns are collected by a 2D Pilatus detector. The specular 
beam is shielded with a rod beam stop added along z=0 to prevent damage to the detector. The detected scattering 
pattern shows distinct diffraction patterns of (211) oriented Ia3d nanostructured thin films.











Figure 5.3. GISWAXD data of self-assembled lipid films before and after siRNA incorporation. The first row and the 
second row represent the data collected at small angle mode and wide angle mode. From the left to right, scattering 
patterns correspond to Q
II
G, HII, and Lα  phase, respectively. QII
G  phase is obtained from GMO/DOTAP films when 
GMO  0.6 at 37C, 955% RH conditions. HII phase is obtained for GMO/DOTAP systems when GMO  0.75 and 
DOPC/DOTAP systems of all composition at 25C, room humidity (20-40% RH) conditions. Lα phase is obtained 
when the lipid composition is GMO  0.25 and the temperature and humidity are kept at 25C, room humidity (20-
40% RH) or GMO 0.5 at 37C, 955% RH. For DOPC/DOTAP systems,  Lα phase is observed in all composition at 
37C, 955% RH conditions. Grazing-incidence experiments collecting data at large angles (wide angle mode) cover 
larger reciprocal space vector q showing higher order reflection peaks. Spot patterns indicate high ordering of domains 







(mol% / mol%) 
Dry Film 
(25°C, 20~40% RH) 
Wet Film 
(37°C, 95±5% RH) 
Bulk Solution 
(37°C) 
GMO/DOTAP - siRNA + siRNA - siRNA + siRNA - siRNA + siRNA 
85/15 Lα Lα QIIG QIIG QIIG QIIG 
75/25 Lα/HII Lα/HII QIIG QIIG QIIG QIIG 
70/30 HII HII QIIG QIIG+HII QIIG HII 
60/40 HII HII QIIG QIIG+HII QIIG HII+Lα 
50/50 HII HII Lα Lα Lα Lα 
25/75 HII HII Lα Lα Lα Lα 
DOPC/DOTAP - siRNA + siRNA - siRNA + siRNA - siRNA + siRNA 
All Ratio HII HII Lα Lα+HII Lα Lα 
 
Table 5.1. Phase diagram of GMO/DOTAP and DOPC/DOTAP lipid films with and without siRNA as a function of 
lipid ratio, temperature (°C), and relative air humidity (RH). “Bulk solution” regards materials in bulk with excess of 
water. Q
II




Figure 5.4. Examples of simulated NANOCELL patterns of other possible cubic phases. Two-dimensional GISAXD 
patterns simulated by NANOCELL[1] for (A) Ia3d space group with [211] orientation (B) Pn3m space group with [211] 
orientation (C) Im3m space group with [211] orientation (D) Pn3m space group with [110] orientation (E) Im3m space 
group with [110] orientation. According to the phase diagram of monoolein, monoolein can form two different cubic 
phases either Ia3d or Pn3m. Also bicontinuous cubic phases with most common space groups are Ia3d (gyroid), Im3m 
(primitive), and Pn3m (diamond). The corresponding NANOCELL[1] simulation overlays are shown. While the Ia3d 
space group with [211] orientation perpendicular to the substrate perfectly fits to the experimental patterns, other space 
groups with different orientations do not match up.
Ia3d [211] Im3m [110]Pn3m [110]Pn3m [211] Im3m [211]




Figure 5.5. Confocal microscopy images of films exposed to hydration media in the absence (top) and presence 
(bottom) of cells. (A) lipid vesicles in a water solution (B) supernatant solution of lipid films extracted after 4 hours 
of immersion in water. The vesicles in (A) were prepared in a glass vial using the same mass of lipids and hydrated 
with the same volume of water as used in (B), but additionally vigorous shaking was followed. In both cases, lipids 
were labeled with 0.5 mol% Texas Red dye. The absence of lipid vesicles in (B) suggests the retarded vesicle formation 
from the lipid films prepared onto solid substrates. (C, D) Mesenchymal human cells seeded onto the lipid films after 
24 hours. Cells were fixed after 24 hours and stained with DAPI for nuclei (blue) and FITC for actin (green). Lipid 
films were stained with 0.1 mol% Texas Red dye (red).  Cells are embedded within lipid matrix or surrounded by the 
lipid matrix, showing the direct contact of cells with lipid films. A good lipid coverage of the film surface is notable. 
 






Figure 5.6. GISWAXD data of self-assembled lipid-siRNA films. The ratio of charged lipids to siRNA charge is 10 
(=10). The GMO/DOTAP lipid composition from left to right is GMO=0.75 at 37C, 955% RH, GMO = 0.6 at 
25C, 20-40% RH, and GMO = 0.5 at 37C, 955% RH, respectively. (A) The two-dimensional diffraction patterns 
resemble those observed in lipid-only films where siRNA containing bicontinuous gyroid cubic (Q
II
G, siRNA), inverted 
hexagonal (HII
 siRNA) and lamellar LαsiRNA structures can be stabilized. (B) One-dimensional GISWAXD I vs q profiles 
of lipid films before and after siRNA integration. The peak indexing corresponds to Q
II
G , HII , and Lα  structures, 
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(Continued – Figure 5.6.) 
fluorescence images of self-assembled lipid-siRNA thick films. Evenly distributed siRNAs are seen throughout the 
lipid film height (H). A series of confocal images with height variation demonstrate deep penetration of siRNA into 
the film. (D) AFM images of lipid films (left) and lipid-siRNA films (right) at dry conditions. Scan size = 15 μm. 
AFM images clearly show that lipids form a smooth surface with good coverage. siRNA inclusion enhances the 
topography of the films.  
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Table 5.2. The encapsulation efficiency of siRNA incorporated lipid films. To confirm successful siRNA 
incorporation into lipid films, I washed siRNA-lipid films in water and measured the amount of siRNA being released 
from films using a UV-Vis spectrophotometer. siRNA-loaded lipid films and control films (siRNA deposited onto 
substrates and lipid only films on substrates) were put into a 24 well plate and 200 µl of RNase-free water was added 
to each well. Lipid-siRNA films were prepared as stated in section 4.2 but with 200-fold increased mass to ensure 
high signal-to-noise ratio for UV-Vis measurements. In other words, the lipid-siRNA films used in cell experiments 
contain 0.266 µg of siRNA per each film which yields not enough concentration to be detected in 200 µl water. The 
well plate was shaken at 100 strokes/min at 37ºC for 5 min. After 5 min, the samples were withdrawn and solutions 
were taken. The concentration of siRNA in the solution was measured using a NanoDrop 2000c UV-Vis 
spectrophotometer (Thermo Fisher Scientific, Inc) which is suitable for RNA quantification with a low detection limit. 
Table S1 clearly shows the encapsulation power of lipid-siRNA films compared to bare siRNA control samples. 
Assuming that detected signals from lipid only films are noise, the encapsulation efficiency of siRNAs into lipid films 
can be calculated as in the following equation: 
{292.4-(12.8-5.9)}
292.4
×100 = 97.6 %. The encapsulation efficiency is about 
97.6 % and the rest of 2.4 % siRNA is thought as being quickly released from the surface of films in contact with 
water.




Lipid-siRNA complex films 
(ρ = 10) 
Average concentration 
(ng/µl) 
292.4 5.9 12.8 






Figure 5.7. AFM images of (A) lipid films of an inverted hexagonal structure (HII
 lipids
 ) (B) lipid-siRNA films of an 
inverted hexagonal structure (HII
 siRNA  ) (C) lipid films of a lamellar structure (Lαlipids) (D) lipid-siRNA films of a 
lamellar structure (LαsiRNA) at dry conditions. (QII do not exist until hydration media is added to films). Lipid films 
deposited onto solid substrates show a smooth surface on a large scale (12 – 20 μm) without significant defects. The 
films containing siRNA appear less smooth with higher differences in height but the surface coverage is analogous to 




















Figure 5.8. Spectroscopic ellipsometry data for a lipid thin film in air at room temperature. (A) the measured amplitude 
ratio Ψ and the phase difference ∆ as a function of wavelength (dashed lines) and the corresponding Cauchy model fit 
(red lines) to the ellipsometric parameters (B) the refractive index values (the real part is presented) upon measured 
wavelength range (C) the fitted film thickness as a function of spin coating speed. 
Spectroscopic ellipsometry was used to determine the lipid thin film layer thickness and the layer index of refraction. 
For ellipsometry measurements, lipid films were prepared by spin coating the stock solution (25 mg/ml lipids dissolved 
in 90/10 (v/v) chloroform/ethanol) onto clean silica substrates (~1cm2). Silica substrates were pre-cleaned with acetone, 
IPA, and deionized water. Spinning speed of 1000, 2000, and 3000 RPM was applied for 30s. 
Variable angle measurements enabled to measure both the thickness and refractive index of lipid film. A change in 
polarization was recorded at three different angles of incidence (AOI) 50°, 60°, and 70° in the spectral range of 300-
1000 nm. The polarization change is represented as an amplitude ratio Ψ and the phase difference ∆. (A) shows the 
measured ellipsometric parameters ∆ and Ψ depending on the wavelength and AOI for lipid film spin-coated at 1000 
RPM for 30s. J. A. Woollam Co. variable-angle spectroscopic ellipsometer instrument (Lincoln, NE) was used for all 
spectroscopic scans of samples and WVASE32 software was used to fit the acquired data to a model. A Cauchy model 
was applied to fit the  lipid film assuming a single optical layer on top of the substrate. A single optical Cauchy layer 
gave good fit to the experimental data as shown in (A). The mean square error (MSE) was obtained during the fitting 
process and the fit with a MSE < 10 was considered reasonably close to the data. A silicon oxide layer on silica bulk 
substrate was fixed as 20 Å. (B) represents the refractive index values (the real part is presented) upon measured 
wavelength range. The fitted thickness as a function of spin coating speed is shown in (C). At spinning speed 1000, 
2000, and 3000RPM with spinning time 30s, 268 nm, 213nm, and 183 nm thick lipid film was obtained, respectively. 






























Figure 5.9. Illustration of different nanostructures as oriented onto solid substrates as lipid composition and 
environmental conditions change. This highlights the potential of using lipid film transformations for actuated surface-
based cellular delivery. The diffusion of biomolecules is enhanced from 1D in lamellar phases to 3D in bicontinuous 
cubic phases by substrate hydration at 37 °C. The phase transitions are perfectly reversible demonstrating the 















Figure 5.10. (A) In vitro gene silencing efficiencies of the lipid-siRNA films in Hela-Luc cells expressing firefly 
luciferase as a function of lipid composition as depicted in figure. Yellow bars and blue dashed bars represent specific 
gene knockdown by luciferase targeting siRNA and non-specific gene knockdown by scrambled siRNA, respectively.  
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(Continued – Figure 5.10.) 
Lipofectamine 2000 was used as a positive control. The charge ratio of film/siRNA (ρ) was 10, and the concentration 
of siRNA was 100 nM. Cubic phases (Q
II
G) show improved specific gene silencing compared to hexagonal (HII) and 
lamellar (Lα) phases with lower contents of cationic lipids (*p=0.05 on an unpaired Student’s t-test, n=3).  Knockdown 
efficiencies after 24 h were determined by measuring luciferase activities (RLU/mg Protein). (B) Membrane integrity 
and (C) Viability of HeLa cells incubated with lipid-siRNA films for 24 h at different cationic lipid DOTAP content. 
Both membrane integrity and cell viability remain around 80-90% for all systems.
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Figure 5.11. The knockdown efficiency of lipid-siRNA films with varying charge ratio of film/siRNA (ρ) (A) In vitro 
gene silencing efficiencies of the lipid-siRNA films (ΦGMO= 0.75 and ΦDOTAP= 0.25)  in Hela-Luc cells expressing 
firefly luciferase as a function of the charge ratio ρ as depicted in figure. Yellow bars and blue dashed bars represent 
specific gene knockdown by luciferase targeting siRNA and non-specific gene knockdown by scrambled siRNA, 
respectively. The concentration of siRNA was fixed to 100 nM in all samples. All values are expressed as the mean  
standard deviation (S.D.) and n = 3. I optimized the charge ratio ρ by testing the silencing efficacy of lipid-siRNA 
films with various ρ values. According to luciferase reporter assays, the charge ratio ρ = 10 was found yielding the 
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Figure 5.12. Effects of endocytosis inhibitors on luciferase reporter assay in Hela-Luc cells: (A) Cytochalasin D that 
inhibits micropinocytosis (B) Chlorpromazine that inhibits clathrin-mediated endocytosis (C) Filipin that inhibits 
caveolae-mediated endocytosis (D) Chloroquine that inhibits endosome acidification and lysosome fusion. Both 
DOPC/DOTAP and GMO/DOTAP films are dependent on clathrin- and caveolae-mediated endocytosis (treated 
samples versus controls; *p<0.05, n=3; **p<0.01, n=3; ***p<0.005, n=3; unpaired two-tailed Student’s t-test), but 
GMO/DOTAP films may be taken up by cells through non-endocytic pathways as well. The performance of Lα phases 
is highly dependent on the presence of Chloroquine which is not the case for the Q
II
G phase (treated samples versus 
controls; *p<0.05, n=3; ***p<0.005, n=3; unpaired Student’s t-test). This indicates that Q
II
G phase films have a higher 
capacity to deliver materials to the cell that escape out of endosomes before being digested by lysosomes. All values 
are expressed as the mean  standard deviation (S.D.).
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Figure 5.13. The cumulative release of siRNA over 24 hour period from lipid-siRNA films. Percent siRNA released 
over time from the gyroid cubic phase QIIG,siRNA (black squares), mixture of cubic and hexagonal phase QIIG,siRNA + 
HIIsiRNA (red circles), and lamellar phase LαsiRNA (blue triangles) lipid-siRNA films. All values are expressed as the 
mean  standard deviation (S.D.) and n = 3. To achieve the siRNA release profile, different nanostructured lipid films 
containing siRNA were placed into a 24 well plate and 200 µl of RNase-free water was added to each well. Lipid-
siRNA films were prepared as stated in section 4.2 but with 200-fold increased mass and the charge ratio ρ = 1 to 
ensure high signal-to-noise ratio for UV-Vis measurements. At certain time points, the supernatant was withdrawn 
and the concentration of siRNA in the solution was measured using a NanoDrop 2000c UV-Vis spectrophotometer 
(Thermo Fisher Scientific, Inc) which is suitable for RNA quantification with a low detection limit. The release rate 
and amount of siRNA released are different among different nanostructured lipid films. The cubic phase film appeared 
the most efficient structure releasing siRNA incorporated into the lipid matrix. 
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CHAPTER 6 
 SYNERGISTIC PERMEABILITY IN STACKED LIPID-
POLYMER HYBRID FILMS 
 
This chapter describes the work on new structures of lipid-polymer thin films. The multi-layered 
lipid-polymer hybrid membranes supported onto solid substrate was studied for the first time. Two different 
components (phospholipids and amphiphilic block copolymer) show peculiar phase behavior that augment 
the functionality of substrate-mediated drug delivery. Extensive structure characterization was performed 
on this system, revealing unprecedented structures of lipid-polymer hybrid membranes. 
6.1 Introduction 
The cell membrane was perceived as an assembly of randomly distributed phospholipids and 
membrane proteins in 1970s.1 However, extensive research on cell membranes has changed such 
perception. Previous studies on model membranes comprising different types of lipids contributed to 
revealing the presence of local heterogeneities in cell membranes. Now it is widely acknowledged that cell 
membranes contain local heterogeneities that differ in compositions and structures.2–6 The suggested role 
of local heterogeneities in cell membranes is diverse including selective partitioning of membrane proteins 
such as K+,7 Na+,8 Ca+ ion9 channels and linker for activation of T cells (LAT),10 regulating diffusion of 
proteins,10 and entry of viruses.11–13 
The functional roles of those local heterogeneities in cell membranes inspired scientists, leading to 
advance in self-assembly structures. A lot of efforts towards have been made to make self-assemblies 
                                                 
 Part of this chapter includes the previously published material – 1) Kang, M.; Lee, B.; Leal, C. Chem. Mater. 
2017, 29, 9120–9132. Copyright 2017 American Chemical Society. 2) Kang, M.; Leal, C. Adv. Funct. Mater. 2018, 
28, 1704356. Copyright 2018 WILEY-VCH. Reprint permissions were acquired from the publisher. 
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mimicking in-plane segregated domains.14–17 A noteworthy approach is to mix phospholipids and 
amphiphilic block copolymers into a single membrane. Beyond self-assembly of single type of amphiphiles 
that has been established,18–20 concurrent self-assembly of multiple amphiphiles has emerged as an approach 
to build more complex architectures with functionalities not achievable by single components.21–24 Upon 
certain conditions, lipid and polymer molecules self-organize into a mixed hybrid membrane in the form of 
vesicles25–31, monolayers at the air-water interface16 or solid-supported bilayers32 where phase-separated 
domains are often found. 
Interestingly, phase-separated domains in these biomimetic hybrid membranes resemble the lateral 
heterogeneities in cell membranes in terms of their functions: controlling the localization and diffusion rates 
of molecules embedded into the membranes,15,16,33 and controlling the entry of materials into cells.34 For 
example, Olubummo et al. demonstrated that polymer-functionalization of CdSe nanoparticles could guide 
the particles to selectively locate within polymer domains over lipid domains in a mixed lipid-polymer 
monolayer.15 In a similar vein, controlling fluidity of the lipid-polymer membrane was shown to direct the 
preferential insertion of membrane proteins into one domain over the other.16 
Previous studies on lipid-polymer hybrid membranes have demonstrated the possibilities of the 
hybrids to serve as a new functional membrane platform. It is especially promising that the domains can be 
engineered to have the desired size, morphologies, and mechanical properties.35,36 Studies on hybrid 
membranes so far have been focused in two-dimensional single membranes.15,16,32,33,37 However, in nature 
there exists a wide variety of membrane systems where the three-dimensional (3D) structure of lipid 
membranes mediates functionality and adaptability to external conditions.38,39 One interesting example is 
the stacked lipid membranes (thylakoids) in the chloroplast of plant cells. The lateral heterogeneity of 
thylakoid membranes40 denotes the non-random distribution of photosystem II, light-harvesting complex 
II, photosystem I and ATP synthase complexes in the thylakoids. It is speculated that these lateral 
heterogeneities stack up (and un-stack) in registry as a response to changing environmental conditions (e.g. 
moisture and light) 41,42 as a nature’s effort to optimize the light capture and energy transport efficiencies.  
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Such indications of the membrane stacked domains in nature–being present in 3D membrane 
assemblies and exerting an influence on the functions–intrigued us to work on stacked membranes of lipid-
polymer hybrids with phase-separated domains. While lipid-polymer hybrid single membranes with lateral 
phase-separated domains have been studied before, domain stacking events in 3D and their exploitation for 
membrane permeability have not been investigated before. 
The goal in this study was twofold. First, multi-layered lipid-polymer hybrid membranes were 
constructed and characterized focusing on intralayer and interlayer domain structures. Second, the 
functionality of hybrid films was tested as a new class of substrate-mediated drug delivery platform. 
Substrate- (or surface-) mediated drug delivery is a novel research direction in the field of biomedical 
engineering and health care devices.43 In contrast to systemic particulate drug delivery, surface-mediated 
drug delivery delivers drugs at the localized treatment site, allowing great spatial control over the release 
of therapeutic cargo.44 Developing functional matrices43–45 is crucial for a broad range of biomedical 
applications including drug eluting stents,46,47 therapeutic implants,20,48 and tissue engineering.49–51  
The second part of the work was followed by interesting observations from the first part that 
presented the possibility of hybrid films serving as active drug release matrices beyond simple depots of 
the embedded drug molecules. In each plane of bilayers, mixtures of lipids and polymers phase-separate 
into different domains induced by a hydrophobic mismatch between lipid and polymer chains. The steep 
hydrophobic mismatch between chains results in the propagation of domain phase boundaries over large 
length scales. Interestingly, the phase-separated domains between neighboring layers were shown to align 
on top of each other, representing a smectic ordering that continues across the stacks of layers. Analogous 
behavior has been observed in stacked bilayers of ternary lipid mixtures studied by Tayebi et al.52 These 
observations prompted my conjecture that domains aligned in registry, as well as large domain boundary 
areas in the hybrid films, may affect the transport of drugs across films. Indeed, an enhanced permeability 
effect of hydrophobic drugs was observed from hybrid films, attributed to membrane domain structures. 
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6.2 Results and Discussion 
6.2.1 Phase-separation in multi-lamellar hybrid systems 
To investigate the mixing behavior of polymers and lipids, I employed CLSM to films deposited 
on a solid support. NBD-DPPE fluorescent probes were added to the lipid/polymer mixture as a means to 
distinguish between lipid (DPPC) and polymer (PBD-b-PEO) phases as they are known to favorably 
partition into DPPC domains. Such preference was reported previously for systems of model membranes 
composed of saturated lipids (e.g. DPPC) and unsaturated lipids with cholesterol,53 and lipid-polymer 
hybrid giant unilamellar vesicles (DPPC/PBD-b-PEO).27 Figure 6.1A shows the series of the hybrid film 
images taken at different focal depth (z) positions. Coexistence of lipid and polymer phases was readily 
observed from binary fluorescence patterns. In each image, the green regions indicate phase separated 
domains enriched in DPPC lipids while the dark regions show the domains enriched in PBD-b-PEO 
polymers. The size of the lipid domains was on the order of several microns when the entire film thickness 
was on the order of 20 µm (measured by CLSM). Such observation was carried out at room temperature. 
The domain sizes would vary upon temperature changes.54,55 The lipid domains display either quasi-circular 
or elongated line shapes. These types of morphology have been previously observed in solid-phase lipid 
domains.56 Additional fluorescence patterns obtained from hybrid films can be found in Fig. 6.2. 
Surprisingly, the fluorescence patterns were almost identical at different depths of the films, 
suggesting that there is alignment of like-domains on top of each other across the layers. It should be noted 
that the stacking of domains applies only to the optically observable domains (µm scale). It is possible that 
optically unresolvable small domains randomly locate across multilayers. 
Figure 6.1B schematically depicts the possibilities of domain alignment across stacked bilayers. 
When lipid (or polymer) domains stack in registry onto lipid (or polymer) domains, a schematic 
configuration of the domain alignment would be close to (B-1). In contrast, if the domains randomly stack 
not coupling across layers, the cross-section of the films would correspond to (B-2). The depth-resolved 
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CLSM images suggest the domain alignment to be the case of (B-1). 
To better understand the domain alignment in the direction normal (z) to the membrane, I carried 
out GISAXS experiments on the stacked membranes. Figure 6.1C shows the two-dimensional GISAXS 
data (left) and the corresponding radial averaged intensity versus q profiles (right) of the stacked 
membranes. The 2D GISAXS data displays an array of distinct and periodic patterns indicative of a 
multilamellar arrangement within the film depth direction (qz). The fact that the diffraction patterns have 
higher intensity along qz further suggests that multilayers are highly oriented parallel to the substrate. The 
1D line cut profiles show the diffraction pattern of a lamellar phase which can be recognized by a series of 
peaks at equal inter-peak distance. The interlayer spacing of the lamellar structure can be calculated from 
the position of the peaks by a = 2πn/qn, where qn denotes the position of the nth order peak. Sharp diffraction 
patterns from the pure lipid phase (red line) and the pure polymer phase (blue line) yield a lamellar spacing 
alipid = 55.6 Å (q001, lipid = 0.113 Å-1) and apolymer = 124 Å (q001, polymer = 0.0506 Å-1), respectively. The lipid-
polymer hybrid films showed two sets of diffraction peaks arising from the lipid lamellar phase and the 
polymer lamellar phase. The lamellar spacing of lipid phase in hybrid films increased to aHlipid = 57.4 Å 
compared to that of single-component lipid films (alipid = 55.6 Å) while polymer phase in hybrid films 
maintained the same lamellar spacing aHpolymer = apolymer = 124 Å. An increase in the lamellar spacing a
H
lipid 
can be attributed from several factors including changes in the lipid chain configuration and membrane-
membrane interactions of lipids. For example, long-range steric repulsion due to membrane fluctuations 
(undulations resulting from increased flexibility of bilayers) would lead to an increased lamellar spacing of 
lipids.57–59 I observed structural changes of lipids at the molecular level using GIWAXS (details presented 
in detail at later sections), which substantiates increased flexibility of bilayers. Upon the presence of 
polymer, the long-range ordering of lipid headgroups was lost, and some portion of lipid tails were shown 
to re-arrange their configuration from tilted chains to untilted chains along the bilayer normal. 
The two sets of lamellar repeat distances in the hybrid films would most likely not be as well-
resolved if the domains would stack randomly or alternating (lipid after polymer or polymer after lipid) 
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between neighboring layers. Figure 6.3 shows GISAXS data obtained for the hybrid films equilibrated at 
different temperatures (25 ºC, 37 ºC, and 50 ºC). I observed a reversible response of the lipid and polymer 
phases upon heating and cooling cycles further supporting the presence of in-plane domains that are 
registered across layers. The GISAXS data combined with the CLSM images are only consistent with a 
picture where lateral in-plane lipid domains (or polymer domains) align with the lipid domains (or polymer 
domains) across the water layer in the neighboring bilayers (illustration B-1 in Fig. 6.1). I speculate that 
interlayer stacking of alike domains may originate from the different hydrogen bonding networks between 
the hydrophilic PEO chains of PBD-b-PEO and the hydrophilic headgroups of DPPC lipids, and a 
concomitant hydrophobic effect drive for registry. 
It is noteworthy that the repeat distances obtained for polymer (124 Å) and lipid (57.4 Å) bilayers 
are dramatically different. I find it intriguing that despite the large height mismatch between lipid and 
polymer molecules there is still a preference for the system to adopt a micro phase-separated state. The 
height mismatch at the phase boundary would cause a large hydrophobic surface being exposed to water, 
which is energetically unfavorable. The surface tension of hydrocarbon-water surfaces is reported60 to be 
50 erg/cm2. A thickness mismatch of only 1 nm results in an energetic cost per unit length of interface of ≈ 
10 kT/nm. To alleviate the energy of unfavorable hydrophobic interactions at the interface, elastic 
deformations of lipid and polymer chains should occur near the phase boundary. However, it is hard to 
imagine how such significant height mismatch would be compensated by membrane deformations in lipid-
polymer hybrid films especially because the lipid components are expected to be in a gel state.61,62 The 
CLSM images could only provide qualitative hints on phase-separation of the hybrid films because of the 
resolution limit. In order to gain further information of the morphology of domains in hybrid films I 
investigated the surface structures by means of topographical and phase contrast imaging in AFM. 
6.2.2 Phase boundary regions induced by hydrophobic mismatch in hybrid films 
The nanoscopic structures of the hybrid film could be clarified via simultaneous measurements of 
AFM height (topography) and phase data. AFM phase imaging allows the distinction between different 
 105 
material domains as the phase signals are sensitive to variations in material properties such as viscoelasticity 
and adhesion.63,64 Figure 6.4A shows the AFM data obtained from hybrid films where the phase color 
contrast was overlaid onto the pseuso-3D construction of the height image. The AFM images on hybrid 
films presented interesting structures that could not be distinguished clearly from CLSM images. From the 
CLSM studies, I could identify a microphase separation behavior of polymers and lipids. The AFM phase 
images (Fig. 6.4B and 6.4C) also indicate the presence of two distinctive islands of domains, which can be 
inferred from the color (phase) contrast. Interestingly, each prominent domain seems to be connected by 
intermediate regions. The light yellow colored domains (phase angle 70-80°) and the dark purple colored 
domains (phase angle 50-60°) are thought to designate lipid and polymer domains, respectively. This was 
inferred from the morphology and height of each domain. The purple domains occupy a higher surface area 
on average, which agrees with the larger lamellar repeat spacing of polymers compared to lipids as 
measured from GISAXS experiments.  
The intermediate regions (phase angle 60-70°) seem to comprise two parts, orange and light purple, 
although the boundaries are not clear. The intermediate areas bridge the lipid domains and polymer 
domains. The direct connections between lipid domains (light yellow) and polymer domains (dark purple) 
were very rare. These observations suggest that the intermediate regions are the microphase-separated 
regions comprised of mixtures of lipids and polymers, i.e. lipid-rich area (orange) and polymer-rich area 
(light purple). Intriguingly, these microphase-separated regions occupy a larger area than the domains of 
lipid and polymer themselves. This can be attributed to the efforts of the hybrid systems to adjust the large 
height mismatch between lipid and polymer bilayers.  
The area fraction of the purple domains was calculated from the total scan area. For 4:1 molar ratio 
of lipid to polymer films, the area occupied by the purple and light purple region (polymer-rich) was 27.6 
± 6 % of the scan area. For 1:1 molar ratio of lipid to polymer films, the area fraction of the polymer 
domains was 57.2 ± 7 % and for the 1:4 molar ratio of lipid to polymer films, it was 72.5 ± 9 %. The 
molecular area of lipid DPPC is 0.65 nm2 65 and that of polymer PBD-b-PEO is 1.2 nm2.66 When the 
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molecular area differences are taken into account, the calculated area of polymer region is 32%, 65%, and 
88% for 4:1, 1:1, and 1:4 molar ratio of lipid to polymer films, respectively. It should be noted that the area 
interpretation is qualitative because domain boundaries between lipid and polymer are continuous. 
Additional AFM images on hybrid films of different lipid to polymer molar ratios are presented in Fig. 6.5. 
Coexistence of macro phase-separated regions and micro phase-separated regions was also found in hybrid 
films of different lipid to polymer molar ratios (4:1, 1:1, 1:4).  
To further characterize the region connecting different domains, the cross-section profiles of the 
phase and height data have been examined as shown in Fig 6.4D. The phase profile (Fig. 6.4D, top) and 
corresponding height profile (Fig. 6.4D, bottom) clarify the distinction between lipid/polymer domains and 
lipid-rich/polymer-rich regions. The lipid and polymer domains remain at a nearly constant height while 
the intermediate regions show gradual height changes. This supports our interpretation that the intermediate 
regions (phase angle 60-70°) represent an interfacial area where the membrane elastic deformations occur 
in a gradual way to mitigate line tension at the domain interface. Non-constant phase values in the interface 
region also indicate that in this domain, lipid and polymer molecules co-exist in a mixed state which extends 
over a micron meter scale. 
AFM phase imaging revealed large phase boundaries between polymers and lipids in the hybrid 
films. From a materials science perspective, such observations are interesting because phase boundaries are 
the sites where one often attains unexpected material properties. For example, Yang et al.13 recently 
revealed that the phase boundaries between ordered and disordered lipid domains in plasma membranes are 
the preferred sites for HIV entry, and the line tension at the phase boundary is a significant driving force of 
gp41(HIV fusion peptide)-mediated fusion.  
6.2.3 Coexisting lipids and polymers in hybrid films: structural changes at the molecular 
level 
To investigate the changes in molecular configuration that lipid molecules adopts upon polymer 
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incorporation, I performed 13C ssNMR experiments which can provide atomically resolved information 
about molecular conformations and reorientational dynamics. The results are presented in Fig. 6.6. Three 
different 13C NMR measurements were combined: DP (direct-polarization), CP (cross-polarization),67 and 
refocused INEPT (insensitive nuclei enhanced by polarization transfer).68 The two different methods of 1H-
13C polarization transfer used for enhancing the 13C signals (CP and INEPT) complement each other as they 
respond differently to the reorientational dynamics of the C-H bonds (which can be quantified with the 
correlation time τC and order parameter SCH
69). Solids (τC > 0.1 µs and/or |SCH| > 0.5) yield intense CP 
signals without INEPT while anisotropic liquids (τC < 10 ns and 0.05 < |SCH| <0.2) give comparable CP and 
INEPT signals.70,71 For isotropic liquids (τC < 10 ns and |SCH| < 0.01), strong INEPT with vanishing CP is 
observed.70,71  Thus from the relative ratios of INEPT and CP signals, one can readily obtain qualitative 
information about molecular segment mobility. 
Figure 6.6A shows the DP-CP-INEPT set of 13C spectra of DPPC (bottom), DPPC/PBD-b-PEO 
hybrids (middle), and PBD-b-PEO (top). The DP, CP, and INEPT spectra were superimposed and color-
coded in gray, blue, and red, respectively. The peaks were assigned based on single-component control 
samples of DPPC and PBD-b-PEO, of which values agree with the previous references.72–74 For DPPC 
measured at 25 °C, the polarization transfer efficiency ICP > IDP>>IINEPT ≈ 0 was observed as expected for 
the solid gel phase75 (Tm, DPPC = 41°C). An opposite trend was found for PBD-b-PEO, suggesting that 
polymer carbon chains are liquid-like and mobile. DPPC/PBD-b-PEO hybrids display peaks associated 
with DPPC and PBD-b-PEO which seem to be the simple overlap of two phases at first glance. A closer 
look, however, reveals two characteristic differences between hybrids and single-component samples. 
Figure 6.6B shows the magnified region of 54 ppm to 56 ppm corresponding to the lipid headgroup moiety 
(γ). The relative intensities of DP, CP, and INEPT of the carbon γ clearly show the changes in lipid 
headgroup dynamics when polymer is present. For DPPC, the polarization transfer efficiency follows the 
order IINEPT ≈ IDP >> ICP > 0 but as the PBD-b-PEO content increases, the relative intensities become IINEPT 
> IDP >> ICP ≈ 0. Such increase in INEPT/DP ratios and absence of CP signals70,71 indicate that the segment 
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γ  in DPPC which has some degree of anisotropy in its pure phase undergoes complete isotropic 
reorientation when PBD-b-PEO co-exists. This is a clear indication that the system assembles as hybrid 
polymer-lipid membranes and not as two completely phase-separated sets of polymers and lipids. 
Other notable differences between pure and hybrid phases are shown in Fig. 6.6C and 6.6D. Figure 
6.6C compares normalized CP scans of DPPC and DPPC/PBD-b-PEO hybrids in a range of 28 ppm to 38 
ppm. One can easily distinguish whether the lipid tail hydrocarbon chains are in an all-trans conformation 
or chain configurations containing gauche forms by looking at the acyl chain peak positions. The broad 
peak centered at 33 ppm originates from the central segment of the acyl chains (C4-13) in all-trans 
conformation75 whereas liquid acyl chains with a distribution of trans- and gauche conformations show the 
peak at 31 ppm.76 Interestingly, DPPC/PBD-b-PEO hybrids exhibit the acyl chain peak with a broad 
shoulder in comparison to DPPC, indicating that some portions of the acyl chains are in not only all-trans 
but acquires a distribution of trans- and gauche conformations. Such behavior on the conformational 
distribution of the acyl chains can only be understood as a perturbation of lipid chain packing due to the 
coexistence of polymer molecules within the membrane. 
To further investigate the characteristics of different chain conformations in DPPC/PBD-b-PEO 
hybrids, I compared DPPC and DPPC/PBD-b-PEO hybrids at 37 °C at which DPPC is in the ripple phase 
(Pβ
' ). The ripple phase is characterized by periodically undulated bilayers with troughs and ridges.77 Figure 
6.6D shows the 37 °C data obtained for DPPC where an upfield shift of the C4-13 peak with a broadened 
shoulder can be observed. Notably, the peak shape clearly differs from that obtained for DPPC/PBD-b-PEO 
at 25 °C, indicating that the broadened C4-13 peak of DPPC/PBD-b-PEO is not just a simple result of the 
DPPC phase transition from the gel to ripple (Lβ
'  to Pβ
' ). Continuous resonances of DPPC/PBD-b-PEO in 
the 31 ppm to 33 ppm region rather reflect a wide distribution of chain conformations in the DPPC acyl 
chains. At 37 °C, the shoulder of the main acyl chain peak at 33 ppm of DPPC/PBD-b-PEO separates out 
to another peak centered at 31 ppm, indicating that an elevated temperature causes some of the hydrocarbon 
chains to acquire a liquid-like distribution of conformations. Taken all together, the DPPC acyl chains go 
 109 
through conformational changes when PBD-b-PEO molecules are incorporated and such distribution of 
different conformations in DPPC/PBD-b-PEO differs from the ones seen in pure DPPC phases (Lβ
'  or Pβ
' ). 
In AFM phase imaging (Fig. 6.4), I observed gradual AFM topography and phase changes between lipid 
domains and polymer domains, likely indicating the presence of mixed domains where lipid and polymer 
molecules co-exist. In line with the AFM phase data, the continuous resonances from 31 ppm to 33 ppm of 
DPPC/PBD-b-PEO may come from the wide range of (or gradual conformational changes in) the molecular 
states that DPPC adapt in the presence of PBD-b-PEO molecules. 
The structural changes of lipid molecules in hybrid films were also observed from GIWAXS 
experiments. Figure 6.7A displays the 2D X-ray diffraction maps of films where the curvature of the Ewald 
sphere has taken into account.78,79 The pure lipid film (a) shows well-developed in-plane diffraction spots 
along the qxy axis. These rod-shaped diffraction patterns that manifestly appear in (a) are typical diffraction 
patterns of two-dimensional lattice systems. Pure polymer films (b) did not show well-defined in-plane 
diffraction patterns because polybutadiene chain blocks are amorphous. Lipid-polymer hybrid films (c) 
show diffraction patterns similar to those of the lipid films. 
To closely look at the in-plane scattering signals, the 2D data were converted into 1D I(q) profiles. 
Figure 6.7B clearly presents the correlation spacing from the lipid headgroups and chains. Multiple peaks 
in (a) correspond to the diffraction patterns typical of the lipid planar gel phase (Lβ
' ). It is well known that 
saturated phospholipids such as DPPC form the Lβ
'  phase below the melting temperature where lipid chains 
are tilted with respect to the membrane normal and the lipid headgroups and tails form two different 2D 
molecular lattices.80–82  
The Bragg peaks in (a) were best fitted to an orthorhombic lattice for lipid headgroups with lattice 
parameters aH = 9.5 Å and bH = 8.7 Å (γ = 90º). Lipid tail peaks are hard to be distinguished from the 
headgroup peaks in (a) but well-packed lipid molecules are known to constitute two different lattices from 
headgroups and tails.81,83,84 
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The sharp reflection peak in (c) at q ≈ 1.5 Å-1 (also note that the peak reaches to qxy = 0) comes 
from the lipid tails that are packed into a 2-D hexagonal lattice. The q value agrees with the literature 
references, a characteristic peak of a gel phase Lβ comprising un-tilted chains,
84,85 sometimes referred to a 
disordered gel phase.86 The Lβ  phase has been found in mixtures of DPPC/cholesterol or DPPC/1,2-
Dioleoyl-sn-glycero-3-phosphocholine (DOPC) lipids.86,87 
The lipid-polymer hybrid films present the diffraction peaks of both Lβ
'  and Lβ phases coming from 
lipid tail ordering. This indicates that polymers induced configuration changes of some lipid molecules 
from tilted to un-tilted. Also, long-range order coming from the lipid head groups was significantly 
suppressed in the hybrid films.  
The scattering curves were further analyzed focusing on the DPPC gel phase peaks. The integrated 
peak intensity (i.e., area under the peak) was obtained from the background subtracted scattering curves. 
Fig. 6.7C (left) shows the integrated peak intensity as a function of molar fraction of DPPC in the hybrid 
films. The red dashed line indicates the case where a decreased amount of the gel phase peak area is in 
proportion to the decreased molar fraction of DPPC lipids in the hybrid films. If all DPPC lipids remain as 
the gel phase in the hybrid films, the corresponding gel phase peak area should lie on the red dashed line 
(e.g. 50% decrease in the DPPC content should result in 50% decrease in the integrated peak intensity). 
However, the calculated gel phase peak area from the hybrid films was only one-fourth of the expected 
area. Such loss of peak scattering area in the hybrid films is attributed to a large amount of scattering that 
did not contribute to the gel phase peak scattering. This scattering could be identified as diffuse scattering 
which appears very broad with no sharp peaks. Such diffuse scattering is indicative of the breakdown of 
molecular ordering into shorter distances. Various factors such as the rotations of the molecules and 
reorganization of the acyl chain configurations, and/or the packing perturbations at the domain boundaries 
may have accounted for about 75% loss of the peak scattering. 
The observations in the AFM phase image that lipid-rich regions (termed interphases) occupy larger 
area than lipid domains (Fig. 6.4) are in a good agreement with the GIWAXS peak intensity analysis where 
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only ≈ 25% lipids seem to maintain the gel phase and the other ≈ 75% undergoes a phase transition into a 
more disordered, fluid-like phase due to the presence of polymer in the stacked membranes. Combining the 
GIWAXS data (Fig. 6.7C) and AFM data (Fig. 6.4), I deduce that lipid molecules located in the lipid 
domains far away from the polymer domains are packed in a well-ordered manner over large distances (≈ 
25%) while the lipid molecules in the lipid-rich regions mixed with the polymer molecules are in a 
disordered molecular arrangement (≈ 75%). Also, the GIWAXS data align coherently with the observations 
from ssNMR experiments. When block copolymer PBD-b-PEO and phospholipid DPPC co-exist in the 
membrane, lipid packing is perturbed and as a result, lipids go through conformational transitions.  
The observations of the unique structures in hybrid films–phase separation, large phase boundary 
area, and molecular conformational changes–led to the next question of whether membrane-loaded drug 
molecules would display drug release behavior deviating from that of single-component films. The 
experiments performed to address this question are described in the next section. 
6.2.4 Effect of Paclitaxel incorporation on the film structure 
I chose Paclitaxel (PTX)–hydrophobic drug to test the release behavior from hybrid films because 
of the following reasons. Firstly, the local delivery of PTX through thin-film matrices has not been explored 
with enough detail despite its potential in circumventing the adverse effects of systemic particulate delivery. 
PTX is known as one of the most effective anti-cancer drug for the treatment of breast and ovarian cancer. 
88–90 It has been commonly administered through long-term systemic injection, which brings unwanted 
adverse reactions.91 The most common adverse effects include infusion-related reactions and 
neutropenia.91,92 Accordingly, local drug delivery to a targeted and focal site of disease (termed surface- or 
substrate-mediated drug delivery) can be a preferable option for delivering PTX, as in drug-eluting medical 
implants.48,93,94 Secondly, we hypothesized that the unique structure of PTX would maximize the benefit of 
having domain structures in films. The local delivery of PTX has limited clinical applications due to the 
crystallization of PTX within the delivery matrix.95,96 Such crystallization has been the bottleneck in 
effectively encapsulating PTX into the drug-carrier systems.97 When PTX molecules are individually 
 112 
entrapped within the hydrophobic region of bilayers they are in a metastable state,98 and tend to self-
aggregate precipitating out into solution to form a more stable crystalline form.97–101 
In films composed of single components, the local environment that PTX molecules experience is 
expected to be similar to the bilayer case described above, i.e. there is no effective barrier to hamper the 
self-aggregation of PTX molecules. CLSM and AFM imaging shown above reveals that the coexistence of 
polymer-rich and lipid-rich domains in hybrid films generates phase boundaries. Such heterogeneous 
environment is likely to impose alterations to PTX intermolecular interactions compared to that observed 
in single-component systems and concomitantly affect PTX crystallization behavior. Indeed, Kan et al. 
reported that liposomes made of multi-component lipids that phase-separate into domains exhibited a high 
encapsulation efficiency of PTX up to 15 % PTX to lipid molar ratio.102  
PTX drugs were incorporated into the hybrid films and the control films (single-component) at 
various PTX molar ratios. Figure 6.8 – 6.11 summarize the effect of PTX incorporation on the structures 
of films. Fig. 6.8A shows the AFM data of the hybrid films with PTX where phase color contrast was 
overlaid onto the peusdo-3D height reconstruction. The white-yellow domains associated with lipid phase 
could be clearly differentiated from the purple domains associated with the polymer phase. While the 
polymer-rich domains (phase angle 55-62°) display a rather circular morphology, the shape of lipid-rich 
domains (phase angle 74-81°) is more diverse showing oval and irregular shapes. Additional AFM images 
of the pure films and hybrid films loaded with PTX can be found in Fig. 6.9. 
Figure 6.8B shows GISAXS I(q) profiles for the hybrid films without PTX (solid black line) and 
with PTX (gray dotted line). Each profile is composed of two sets of diffraction peaks arising from periodic 
spacing of polymer-rich and lipid-rich domains. The lamellar peaks associated with polymers are indicated 
by blue inverted triangles while that of lipids are denoted by red circles. The location of the diffraction 
peaks was not changed by the addition of PTX molecules, indicating that the lamellar repeat spacing of the 
hybrid film was maintained, with a periodicity of alipid = 57.4 Å and apolymer = 124 Å. Several orders of 
diffraction peaks (up to ten orders for the polymer phase and up to four orders for the lipid phase) point the 
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high degree of registration in the hybrid films comprising two coexisting phases. I did not observe 
noticeable differences on the domain size and registration in hybrid films incorporating PTX. 
Next, the effect of PTX on the film in-plane structure was investigated by GIWAXS. Figure 6.10 
displays the 2D X-ray diffraction maps of samples with and without PTX. The pure lipid film (A) shows 
well-developed in-plane diffraction spots along the qxy axis. These rod-shaped diffraction patterns that 
manifestly appear in (A) are typical diffraction patterns of two-dimensional lattice systems. Other films 
containing PTX or polymer (B-F) show broad and less number of scattering patterns compared to (A), 
reflecting structural transitions towards more fluid-like and short-range ordered molecular arrangements. 
Note that the intense reflection at qz ≈ 1.6 Å and qxy ≈ 1.2 Å comes from the silicon substrate not from the 
sample.103   
Figure 6.10F shows only one scattering peak at q = 1.5 Å-1 in contrast to Fig. 6.10A. This implies 
that the PTX encapsulation inside DPPC films induced a pronounced change in the molecular packing. PTX 
molecules suppressed long-range order of the lipid headgroups as indicated by the absence of multiple 
Bragg peaks. The lipid-polymer hybrid films without PTX (Fig.6.10E) and with PTX (Fig.6.10F) present 
the diffraction peaks of both Lβ
'  and Lβ phases coming from lipid tail ordering. Long-range order coming 
from the lipid head groups was significantly suppressed. The addition of both molecules (PTX and PBD-
PEO) disrupted the tight packing of DPPC molecules, forming a more disordered phase. The presence of 
PBD-PEO molecules induced a disordering of the DPPC headgroups and tails, however, showed little effect 
on the changes in molecular tilts compared to PTX molecules which effectively induced a transition to the 
untilted DPPC gel-phase (Lβ). Figure 6.11 shows the scattering from PTX-incorporating hybrid films at 
different lipid to polymer molar ratios. The loss of the DPPC gel phase peak in the GIWAXS regime was 
significant while the lamellar peaks coming from the stacks of DPPC bilayers exhibited intensity signals 
proportional to the DPPC content.  
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6.2.5 Distribution of Paclitaxel in hybrid films. 
The distribution of PTX drugs within the hybrid films was first investigated by CLSM. PTX 
conjugated with Oregon Green 488 (we termed PTX-Oregon) was used as a fluorophore version of a non-
fluorescent molecule PTX. It should be noted that PTX-Oregon has an increased water solubility compared 
to PTX molecules.104 The location of PTX-Oregon in hybrid films can be different from that of pure PTX 
in hybrid films. 
As seen in Fig. 6.12A, a non-homogeneous distribution of PTX-Oregon was observed in hybrid 
films. Green color indicates the location of PTX-Oregon in each of the depth-resolved z-scan image. The 
coexistence of lipid and polymer domains with domain boundaries may play a role in the selective 
partitioning of PTX in the hybrid films. A series of depth-resolved scans revealed that the PTX-incorporated 
region is not as perfectly aligned along the film normal (z) as seen for domains in hybrid films without PTX 
(Fig. 6.1A). Such heterogeneous distribution of PTX-Oregon across bilayers could be attributed to the 
complex domain boundary structures out-of-plane. Higher magnification CLSM images of hybrid films 
with PTX-Oregon can be found in Fig. 6.13. 
In Fig. 6.12B, 0.1 mol% of DiDC18(5) was incorporated to the films in order to label lipid regions 
with a dye having different emission and excitation properties to the PTX dye. DiDC18(5), however, did 
not locate exclusively at the lipid regions unlike NBD-DPPE. When two different channels of DiDC18(5) 
and PTX-Oregon were overlapped (c), one could observe non-overlapping regions where solely one color 
is presented. Such inhomogeneous distribution of two different dye molecules indicates heterogeneous 
distribution of the lipid and polymer molecules in hybrid films, implying complex interface structures of 
the hybrid films. The CLSM technique have limitations given that it provides qualitative location of PTX 
drugs at µm scale and that it cannot avoid the artifacts of fluorescent probes. To elucidate the preferential 
location of PTX drugs in the hybrid films, one needs an advanced technique. Thus, photo-thermal induced 
resonance (PTIR) experiments were performed in collaboration with Dr. Mohit Tuteja and Dr. Andrea 
Centrone at NIST. 
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PTIR experiments enabled to locate the distribution of PTX in a PTX loaded (0.05 molar fraction) 
hybrid DPPC/PBD-b-PEO (1:1 molar ratio) membrane with nanoscale resolution (Fig. 6.14). PTIR, also 
known as AFM-IR, is an emergent technique that combines the high spatial resolution of AFM with the 
composition specificity of infrared (IR) spectroscopy.105,106 The proportionality between the PTIR signal 
and the energy absorbed locally by the sample,107,108 as in conventional IR spectroscopy, allows material 
identification at the nanoscale by comparison with far-field IR spectral databases.106 Recent reviews105,106 
discuss the PTIR working principles and an ever growing list of applications spanning from biology109,110 
to materials science,111–114 and includes studies on the nanoscale distribution of drug-polymer blends.115,116 
Recently, PTIR has been extended to the visible range,117 enabling measurement of semiconductor bandgap 
at the nanoscale.118,119 Furthermore, the development of nano-sized picogram-scale probes capable of 
capturing the sample thermalization dynamics in PTIR experiments, has added the ability to measure local 
thermal conductivity of the sample.120  
The AFM topography (Fig. 6.14A) and contact resonance frequency (Fig. 6.14B) images of the 
PTX loaded hybrid film show the phase separated polymer rich (higher topography, lower frequency) and 
lipid rich (lower topography, higher frequency) domains. Figure 6.14B suggests that the polymer rich 
domains are softer (lower frequency) than the lipid domains because the AFM contact resonance frequency 
is proportional to the local sample stiffness.121 This observation corroborates Fig. 6.2A, where the thicker 
polymer domains display a lower phase value than the lipids due to the lower Young’s modulus of the 
polymer.122 
The Fourier-transform infrared (FTIR) spectra of pure PTX, DPPC, and PBD-b-PEO (Fig. 6.14C) 
show that the lipid and the polymer have very similar IR spectra (i.e., it is difficult to spectroscopically 
differentiate them). However, the PTX spectrum shows a few distinct bands that do not overlap with the 
polymer or the lipid bands, and these peaks: 1645 cm-1 (Amide I), 1602 cm-1 (C=C stretching), 1543 cm-1 
(amide II), and 1506 cm-1 (C=C stretching)123 were leveraged for the subsequent PTIR experiments. In 
addition to prominent polymer and lipid bands (≈ 1730 cm-1 and ≈ 1463 cm-1), representative PTIR spectra 
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(Fig. 6.14D) reveal the presence of PTX (see bands at 1650 cm-1, 1604 cm-1 and 1506 cm-1) in both the 
polymer and the lipid domains. Notably the amide I peak of PTX at 1650 cm-1 broadens upon the drug’s 
inclusion in the polymer, and broadens and weakens considerably upon the inclusion in the lipid (Fig. 
6.14D), perhaps suggesting a stronger interaction between the amide group in the drug and the lipid. In 
contrast the C=C stretching bands at 1604 cm-1 and 1506 cm-1 are relatively stronger for the PTX 
incorporated in the lipid phase than in the polymer phase, suggesting a stronger interaction of aromatic 
groups in PTX with the PBD block in the polymer than with the lipid phase. 
PTIR chemical maps are obtained by illuminating the sample at a given wavelength while scanning 
the AFM probe on the sample to enable the visualization of different components. However, it is known 
that sample locations with higher stiffness, characterized by higher contact resonant frequency (Fig. 6.14B), 
can provide a little stronger PTIR signal amplitude.124 Consequently, it is a common practice124 to analyze 
a ratio of PTIR maps obtained at two wavelengths (Fig. 6.14 E, F) to cancel out the effect of the sample 
stiffness variability on the PTIR signal intensity because such effect at each location is wavelength 
independent. The PTIR ratio map (Fig. 6.14E) of the 1650 cm-1 band (amide I of PTX) over the 1463 cm-1 
band (polymer and lipid) highlights the spatial distribution of PTX in the film and, particularly, the 
heterogeneous distributions in the polymer rich phase. Interestingly, it appears that the PTX concentration 
is somewhat enhanced along many boundaries between the polymer rich and lipid rich domains, thus 
corroborating our previous hypothesis.125 The PTIR ratio map (Fig. 6.14F) of the 1602 cm-1 band (C=C 
stretching of PTX) over the 1463 cm-1 band (polymer and lipid band) shows that the overall distribution of 
PTX in the lipid rich phase is homogeneous, however a slightly stronger intensity is observed along some 
lipid-polymer interfaces, perhaps suggesting again a slightly higher concentration of the drug in these 
regions. 
Next, I investigated the PTX release profiles from the films to figure out the potential application 
of domain structured films in substrate-mediated drug delivery.  
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6.2.6 Synergistic release of Paclitaxel from hybrid films 
Figure 6.15 presents PTX release profiles from supported multilayer films of pure lipid, pure 
polymer, and lipid-polymer hybrids obtained via RP-HPLC. The films incorporating 2 mol% PTX were 
presented because the PTX loading efficiency was close to 100 % for all films containing 2 mol% PTX. 
Therefore, the relative release rates of different film systems could be better compared with respect to 
domain structure-driven properties. The loading efficiencies for different samples and amount of PTX are 
summarized in Table 6.1. All drug release profiles showed two sequential stages, an initial fast release 
followed by a second slower release. The first release stage can be attributed to an initial burst effect126 
where PTX molecules promptly escape the outer layers of the film surface. Interestingly, the PTX release 
rate of hybrid films exceeded beyond that of pure lipid films and polymer films, not in between of those 
two control systems. This occurs without a structural change (e.g. the phase transition of lipids from a 
lamellar phase to an inverted hexagonal phase as seen in the chapter 4) suggesting a mechanism of 
membrane permeability enhancement that does not rely on phase transformations.  
Figure 6.16 includes the PTX release profiles of different films with varying PTX amount. For the 
films containing higher molar % of PTX (5 and 10 mol% tested, Fig. 6.16), the same trends (hybrid being 
the fastest and lipid the slowest) were observed. Although hybrid films comprise a combination of materials 
that can form single-component films (DPPC or PBD-b-PEO), they display a PTX release behavior that is 
not simply additive. This suggests that structural characteristics of hybrid films are responsible for the 
observed enhanced transmembrane permeability. Below, I discuss possible connections between phase-
separated domains, domain boundaries, and enhanced transmembrane permeability of hybrid films. 
To better understand the mechanism of PTX release kinetics, each of the drug release stages was 
fitted with various mathematical models, including zero order kinetics, first order kinetics, Higuchi 
model,127 Korsmeyer-Peppas model,128,129 and Hixson-Crowell model.130 Based on the correlation 
coefficient values R2, the Higuchi model turned out to be the most suitable model to describe the PTX 
release from our film systems. The simplified Higuchi model can be described by the following equation 
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Q = KH t1/2 where Q is the amount of drug released in time t and K is the Higuchi release rate constant. 
Figure 6.15 (A-1, A-2) show the experimental data plotted as cumulative percentage drug release versus 
square root of time. The Higuchi model showed good correlations with experimental data as given in Table 
6.2, indicating that drug release from the films was mainly diffusion-controlled with little effect from film 
swelling or dissolution. 
Our initial hypothesis was that the presence of lipid-polymer domain interfaces would provide an 
environment able to suppress interactions among PTX molecules, thereby reducing the formation of PTX 
crystals. To validate such hypothesis, I first checked if the PTX loading efficiency into the film (related to 
an initial rate of PTX crystal formation) increased for the hybrid films compared to lipid and polymer films. 
However as shown in Table 6.1, there were no noticeable differences in the PTX loading efficiencies 
between hybrid and pure films. Also, the presence of PTX crystals could not be confirmed from the PTX-
containing lipid, polymer, and hybrid films when I carried out GIWAXS experiments on the films under 
95% relative humidity. Only when I prepared aqueous solutions of vesicles of lipid, polymer, and hybrid 
materials, I could observe the formation of PTX crystals from the WAXS data as shown in Fig. 6.17 and 
Fig. 6.18. 
Free PTX molecules in excess water formed needle-like crystals and the diffraction patterns of PTX 
showed numerous peaks including intense peaks at 8.54°, 10.5°, 11.1°, 12.1°, 13.2° as reported from 
previous references.131–133 When 5 mol% PTX is incorporated, lipid and polymer vesicles have some portion 
of PTX molecules that eventually come out of the bilayer membrane and form crystals. Notably, hybrid 
samples did not show signs of PTX crystal formation. The reason why I didn’t observe PTX crystal peaks 
from the films may originate from the dynamics of PTX crystal formation in films where there is only a 
humidified atmosphere and not bulk water. The time scale of PTX nucleation, clustering, and aggregation 
events may be dependent on water content, number of membranes (thickness), among other factors. The 
detailed mechanism of PTX crystal formation is outside of the scope of this project.  
To further inspect PTX crystal formation in films, optical microscopy was employed (Fig. 6.19). 
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Since PTX crystals show characteristic needle-shape, they can be easily distinguished under the 
microscope. For example, Steffes et al.104 investigated the kinetic phase diagrams of PTX solubility in 
liposomes using differential interference contrast microscopy. Films prepared under the same conditions 
for PTX release studies were examined. After 16 h of hydration, PTX crystals were observed from lipid 
films but not from polymer and hybrid films. Our observation suggests that in hybrid films, there would be 
simply more PTX molecules available for release. A higher concentration gradient in the hybrid films would 
lead to an increased PTX permeability. PTX crystal formation is also indirectly reflected in the PTX release 
profiles where the final release amount did not reach 100% (Fig. 6.16). The hybrid films released more of 
the loaded drugs than the pure films. The remaining fraction of the drug could be either precipitated out of 
the membrane as crystal aggregates or present deep inside the film as small clusters. 
Such observations that PTX crystal formation is hampered in lipid-polymer hybrid films raised the 
next question: why are the hybrid films effective in impeding PTX crystal formation? Kang et al.101 
demonstrated, via molecular simulations, that PTX molecules in a model membrane display clustering 
which transform to larger aggregates over time. They also showed that the clustering events depend on the 
local environment such as the configuration of neighboring PTX molecules within the membrane. Based 
on the simulation study by Kang et al.101 and our observations, I speculate that hybrid films provide a local 
environment which helps to retain PTX as single molecular states, limiting nucleation and clustering events. 
There is another possibility contributing to an increased transmembrane permeability: loss of 
ordering of lipids upon interactions with co-existing polymers in-plane. The inclusion of polymers in the 
lipid film distorts packing of lipid molecules turning lipid molecular arrangements into more fluid-like and 
short-range ordering as studied by GIWAXS (Fig. 6.7 and Fig. 6.10). The inclusion of polymers in DPPC 
membranes causes a behavior in the membrane analogous to increasing the temperature105 in terms of 
inducing coexistence of the gel and fluid phases. The interface between gel and fluid phases has been 
associated to anomalous passive diffusion of ions across membranes due to dynamic fluctuations of the gel 
and fluid clusters.134–136 However, it should be noted that such interfacial regions have much smaller size 
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compared to those of lipid-polymer hybrid films. It is noteworthy that transport of ions through polymer 
membranes is also enhanced in the presence of membrane domains, called “confinement of pathway of 
transport”.137 The concept of leaky interfaces has been proposed in lipid-polymer systems by means of 
Monte Carlo simulations. Rabbel et al.138 showed that the local permeability of lipid bilayer membranes is 
strongly increased when a triblock copolymer is incorporated to the bilayer in the transmembrane state. 
Such increased permeability is attributed to a mismatch in the hydrophobicity between the copolymer 
middle block and lipid membrane core where a polymer with different hydrophobicity acts as a pore former. 
I conjecture that increased fluidity of the lipid region upon incorporation of polymers in the membranes 
would contribute to enhanced transmembrane permeability of PTX through the lipid-polymer hybrid films.
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6.3 Conclusions 
In this work, I have characterized the structure of lipid-polymer hybrid films showing 3D 
microphase-separation and demonstrated enhanced permeability of hydrophobic drugs incorporated into 
the hybrid films. Lipid-polymer hybrid films can assemble into multilamellar stacks when supported onto 
solid substrates. In each lamella, there is lateral microphase-separation of lipids and polymers. The layers 
are perfectly oriented parallel to the substrate and the domain alignment across layers is not random. Like-
domains stack up as in a smectic phase and the boundaries joining lipid-rich and polymer-rich domains 
show distinct morphologies. Phase boundaries occupy more area than the domains themselves to alleviate 
packing frustration arising from the height mismatch between polymer and lipid domains. Interestingly, 
these micro-phase separations in 3D serve as functional hotspots for transporting drugs across the bilayers. 
The hybrid films reveal much faster release rates of hydrophobic drugs (Paclitaxel) compared to single-
component films. Plausible mechanisms driving this synergistic release have been suggested in connection 
with the structure characteristics of the hybrid films. I speculate that two factors contribute to increased 
permeability of PTX from the hybrid films: i) an increase in the total concentration of PTX molecules 
available for release as a result of impeded PTX crystallization and ii) polymer-induced increase of 
membrane fluidity. 
The significance of this work is that it has broadened possible applications of lipid films by 
incorporating block-copolymers into the system. Just like in lipid-only systems in-plane phase separation 
is occurring due to local changes in the hydrophobic thickness of films but in a more drastic way. Multi-
stacking of hybrid membranes enables their use for substrate-mediated drug delivery applications as 
intralayer and interlayer domain correlations are directly impacting the transport of membrane-embedded 
drugs. This work also offers future research possibilities on functional lipid-polymer hybrid films beyond 
drug delivery where synergistic permeation of an embedded solute needs to be controlled. 
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6.4 Experimental Section 
6.4.1 Materials 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (16:0 PC or DPPC) and 1,2-dipalmitoyl-sn-glycero-
3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (16:0 NBD PE or NBD-DPPE) were 
purchased from Avanti Polar Lipids (Alabaster; AL, USA). Amphiphilic diblock copolymer, 
poly(butadiene-b-ethylene oxide) (PBD-b-PEO), was purchased from Polymer Source, Inc (Quebec, 
Canada). The catalog number is P19015-BdEO. Its average molecular weight (Mn) was reported to be 4000 
with PBD block (rich in 1,4 microstructure) 2500 and PEO block 1500, respectively. The reported 
polydispersity was 1.06. In this work, I selected PBD-b-PEO since the previous studies successfully 
demonstrated that the mixtures of phospholipids/PBD-b-PEO form phase-separated hybrid vesicles with 
domains.25,35 For biomedical applications, the use of biocompatible polymer blocks such as polyisobutylene 
or polyoxazoline is advised. Paclitaxel, its fluorescent conjugate Paclitaxel-Oregon Green 488, and 
DilC18(5) oil (1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindodicarbocyanine Perchlorate) were purchased 
from Thermo Fisher Scientific (Waltham; MA, USA). All solvents used were of high performance liquid 
chromatography (HPLC) grade and purchased from Sigma-Aldrich (St Louis; MO, USA). All chemicals 
and materials were used as received. 
6.4.2 Preparation of multi-lamellar films 
Multi-lamellar films composed of phospholipids, block copolymers, and their hybrid were prepared 
by either drop-casting or spin-coating methods. Typically, drop-cast films have thicknesses ranging from 
5-20 m and spin-coated films range from 200-500 nm. Samples used for substrate-mediated drug delivery 
were prepared by drop-casting so that there is control over the exact amount and ratio of materials being 
incorporated. Samples for CLSM and GISWAXS were also prepared by drop-casting. In the case of samples 
prepared for AFM and PTIR measurements, spin-coating was used to minimize AFM cantilever crashing 
onto rough sample surfaces. Lipids and polymers were dissolved in chloroform. Paclitaxel and its 
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fluorescent conjugate were dissolved in ethanol. A stock solution was prepared with the desired ratio of 
each component in mixtures including lipids, polymers, or paclitaxel molecules (concentration, 10-25 
mg/ml; solvent, chloroform/ethanol 4:1 volume ratio). The stock solution was either dropped onto the 
substrate followed by a solvent evaporation under a fume hood or spin-coated at 1000 rpm for 30 s. For 
complete solvent evaporation, samples were put into the vacuum desiccator overnight. Upon solvent 
evaporation, the amphiphilic nature of lipid and polymer molecules leads to self-assembly into well-
organized multi-lamellar films. The substrates used in the experiments were coverslips with a diameter of 
15 mm purchased from MatTek Corporation (Ashland; MA, USA). Before use, the coverslips were washed 
with ethanol and Milli-Q water for 15 min respectively in an ultrasonic bath and dried with a nitrogen gun. 
For AFM and X-ray scattering experiments, to ensure that substrates do not affect the overall structure of 
films and interpretation of the data, samples were also prepared onto cleaved Si wafers (~ 1cm2); <100> 
type that was purchased from University Wafer Inc (South Boston; MA, USA). I did not observe noticeable 
structural differences between samples prepared onto coverslips and silica substrates. Samples for NMR 
experiments were prepared using thin film hydration method.139 The stock solutions of phospholipids and/or 
block copolymers (25 mg/mL) were dissolved in chloroform in the desired molar ratio. The solutions were 
prepared in glass vials and the solvent was slowly dried with a nitrogen stream. For complete solvent 
evaporation, samples were put into the vacuum desiccator overnight. The films were hydrated with 
deionized water and incubated at 45 °C for 5h -12 h. The final concentration of ≈ 200 mM with the volume 
of ≈ 20 µL was transferred into NMR rotor inserts. 
6.4.3 Structure characterization of multi-lamellar films 
Confocal laser scanning microscopy (CLSM): CLSM images were obtained in water at room 
temperature to i) check the presence of phase separated domains and ii) identify the drug distribution in 
films using a Zeiss LSM 700 microscope (Carl Zeiss AG, Germany) with 20×/0.8 DIC, 40×/1.3 DIC and 
63×/1.4 Oil DIC objectives. A concentration of 0.1 mol% of 16:0 NBD-DPPE (Ex/Em 460 nm/535 nm) 
was used to label the lipid-rich phase and 0.2 mol% of Paclitaxel-Oregon Green 488 (Ex/Em 488 nm/518 
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nm) was used as a fluorescent model drug to represent the drug distribution in films. A concentration of 0. 
1 mol% of DilC18(5) oil was used in combination with Paclitaxel-Oregon Green 488. Images were 
processed using the Zen software (Carl Zeiss AG). For samples stained with single dye molecules, the 
pinhole was set to 1 Airy unit. For multi-channel experiments, the Paclitaxel-Oregon Green channel was 
set to 1 Airy unit and the other channel was adjusted to match the optical slice thickness as the Paclitaxel-
Oregon Green channel. 
Atomic force microscopy (AFM): Simultaneous height (topography) and phase imaging were 
performed on lipid, polymer, and hybrid films to i) obtain nanometer-scale information about the surface 
structure and to ii) identify different component phases of hybrid films. Especially, the phase boundaries 
where lipid domains and polymer domains meet were carefully investigated. For all measurements, a MFP-
3D AFM (Asylum Research; CA, USA) was operated in tapping mode in air at room temperature. 
Tap300AL-G cantilevers were used with a resonance frequency of 300 kHz and a force constant of 40 N/m 
(Budget Sensors; Sofia, Bulgaria). 
Grazing-incidence small/wide angle X-ray scattering (GISWAXS): GISAXS and GIWAXS 
experiments were conducted to study the multi-lamellar film structure and lipid hydrocarbon tail ordering 
as well as drug crystallization, respectively. The experiments were carried out at in-house X-ray setup 
(custom built with help of Forvis Technologies, CA, USA) and at 12-ID-B beamline, Advanced Photon 
Source (APS), Argonne National Laboratory. A custom built (with Forvis Technologies, Santa Barbara) 
equipment composed of a Xenocs GeniX3D Cu Kα ultralow divergence X-ray source (8 keV) was used, 
with a divergence of 1.3 mrad. The humidity and temperature control chambers were built by Forvis 
Technologies. At the 12-ID-B beamline APS, a 14 keV X-ray beam was focused on a 50 × 10 µm2 (H × V) 
area at an incident angle 0.05-0.2°. Pilatus2M (Dectris) and PerkinElmer XRPad 4343F detectors were used 
for GISAXS and GIWAXS measurements, respectively. The sample-to-detector distance was calibrated 
using a silver behenate powder standard. The specular beam intensity was attenuated along the z axis with 
a strip beam stop. The sample to detector distance for GISAXS was either 2 m or 3.6 m, and that for 
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GIWAXS was about 0.15 m. Multiple measurements were carried on the same sample in a humidity 
chamber (relative humidity > 95%), varying the incidence angle to determine the most appropriate operating 
angle. Experiments at the APS were performed at room temperature, and in-house experiments were 
performed at different temperatures (25 °C, 37°C, and 45 °C). The measured scattering patterns were 
analyzed using NIKA and IRENA, Igor-based package of tools for scattering data analysis.140 
Photo-thermal induced resonance (PTIR): PTIR spectra and images were obtained with a 
commercial PTIR instrument interfaced with a quantum cascade laser tunable from 1934 cm-1 (5.17 µm) to 
1136 cm-1 (8.80 µm). The PTIR laser illuminates the sample from the top at ≈ 20° angle from the sample 
plane. Commercially available 450 μm long and 50 μm wide gold-coated silicon AFM probes with a 
nominal spring constant between 0.07 and 0.4 N/m were used for all the PTIR experiments. A paclitaxel 
loaded (0.05 molar fraction) hybrid lipid-polymer film was spin coated onto ZnS flat substrate to minimize 
the background absorption contribution of the substrate. PTIR spectra and images were obtained by tuning 
the laser repetition rate to resonantly excite141 the AFM cantilever second bending oscillation mode. In 
contrast to the original implementation of the resonance enhanced PTIR method that used lock-in detection 
at the cantilever resonant frequency,141 a phase lock-in loop was used to better account for resonant 
frequency shifts as a function of location (or time) due variations in the sample-probe interactions. PTIR 
spectra were obtained by tuning the laser at intervals of 2 cm−1. Up to six spectra were acquired and averaged 
for each tip location, and smoothed by considering two adjacent points. AFM topography and PTIR maps 
were acquired simultaneously illuminating the sample at constant wavelength. Because the sample 
mechanical properties are known to influence the amplitude of the PTIR response,124 throughout the 
manuscript PTIR absorption map ratios were used, to cancel out the effect of the local mechanical properties 
of the sample on the data. 
6.4.4 Paclitaxel release study  
Film samples prepared onto 15 mm glass coverslips (n = 3) were placed into a 24-well cell culture 
plate with a well diameter of 15.6 mm. During entire release experiments, the well plate was shaken using 
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a plate shaker with a shaking speed of 100 rpm at room temperature. In each well, 1 ml of release medium 
PBS/ethanol 90/10 (% v/v) was added which has been used in previous work142 to achieve practical sink 
conditions for paclitaxel, a poorly water-soluble drug (solubility: 0.3 µg/ml143). At predetermined time 
points, the release medium was completely withdrawn and replaced with the same volume of fresh medium, 
maintaining the sink conditions throughout the release experiments. For the first 5 minutes, surface-attached 
paclitaxel not incorporated inside the membrane was removed by exposing and washing in the release 
medium. The drug loading efficiency was determined by the following equation: loading efficiency (%) = 
(total amount of drug – free drug in the medium)/total amount of drug × 100. The amount of paclitaxel 
released was quantified using a high-performance liquid chromatography (HPLC). HPLC analysis was 
conducted by Shimadzu LC system (LC-20AT) connected with a PDA detector (SPD-M20A). A 
Phenomenex Kinetex Ph-hexyl column (5 µm, 100 mm × 4.6 mm) was used for analysis. Acetonitrile/water 
60/40 (% v/v) served as a mobile phase, eluting the paclitaxel peak approximately at 1.3 min with a flow 
rate 1.5 mL/min from an injection volume of 20 µL with UV/Vis detector recorded at 229 nm. The area of 
the paclitaxel peak was integrated and compared to a standard calibration curve obtained in the 
concentration range of 0.1 – 10 µg/mL (regression value R2 = 0.9994871). The detection limit of paclitaxel 




Figure 6.1. Structural characterization of lipid-polymer hybrid films (1:1 molar ratio of DPPC to PBD-b-PEO). (A) 
Confocal laser scanning microscopy images of hybrid films in bulk water doped with NBD-DPPE (0.1 mol%). A 
series of images with height variation was taken to examine the phase separation in hybrid films at different depths. 
Binary spatial patterns continue across the bilayer membrane normal, implying the alignment of domains across 
multilamellar films. Scale bars = 50 µm. (B) Schematic illustration of hybrid films consisting of lipid (red) domains 
and polymer (dark blue) domains. (B-1) describes the case when the like-domains align on top of each other across 
layers. (B-2) depicts the random alignment of domains in neighboring layers. Each block represents a single bilayer 
of lipid or polymer, and the spaces between domains (sky blue) represent water layers. (C) GISAXS two-dimensional 
raw data of hybrid films (left) and one-dimensional I(q) profiles of hybrid, lipid, and polymer films (right) at > 95% 
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Figure 6.2. Confocal Laser Scanning Microscope (CLSM) Images of hybrid films in water doped with 0.1 mol% 
NBD-DPPE (A) 4:1 molar ratio of DPPC to PBD-b-PEO (B) 1:1 molar ratio of DPPC to PBD-b-PEO. The scale bars 
= 50 µm. 
A B




Figure 6.3. One-dimensional GISAXS I(q) plots for the hybrid 4:1 molar ratio of DPPC to PBD-b-PEO membranes 
equilibrated at different temperatures. Note the position of (001), (002) peaks associated with DPPC lipids upon 
temperature changes in comparison to the PBD-b-PEO polymer peaks. The transition temperature of DPPC lipids at 
which they undergo a transition from the gel to liquid phase is 41°C. Reflecting such a characteristic temperature, the 
DPPC peak positions do not change below 41°C but do move above 41°C. Upon cooling, the DPPC peaks go back to 
the original q positions. In contrast to the response of DPPC lipids to the temperature changes, PBD-b-PEO polymers 
with a glass transition temperature below 25°C show no changes in the peak locations at all temperatures tested. That 
is, the two sets of lamellar peaks–each associated with lipids or polymers–show a response to temperature changes 
that is characteristic to the corresponding phase; this further supports the coexistence of lipid-rich and polymer-rich 





























Figure 6.4. Surface characterization of hybrid films using topographic and phase-contrast imaging in AFM. (A) Phase 
contrast image overlaid onto pseudo-3D topography of hybrid films (4:1 molar ratio of DPPC to PBD-b-PEO). Note 
the high color contrast between different regions, indicative of the presence of different domains. Field of view = 10 
µm × 10 µm. (B, C) Phase contrast AFM images of hybrid films (4:1 molar ratio of DPPC to PBD-b-PEO) showing 
well-defined phase-separated domains. The units on the x-and y-axis in the plots are µm. (D) Cross-sectional profiles 
of the phase (top) and topography (bottom) along the arrow marked in (C). The background color reflects the 
corresponding phase contrast of each region.  
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Figure 6.5. AFM tapping mode images of PBD-b-PEO films, DPPC films, 4:1 molar ratio DPPC/PBD-b-PEO films, 
1:1 molar ratio DPPC/PBD-B-PEO films, 1:4 molar ratio DPPC/PBD-b-PEO films in height, amplitude, and phase 












Figure 6.6. 13C solid state NMR spectra of lipids, polymers, and lipid-polymer hybrids. Top: Molecular structure of 
lipid DPPC and polymer PBD-b-PEO with the carbon atom labeling. A) The combined DP (gray lines)-CP (blue 
lines)-INEPT (red lines) sets of DPPC (bottom), 9:1 molar ratio DPPC/PBD-B-PEO, 3:1 molar ratio DPPC/PBD-b-
PEO (middle), and PBD-B-PEO (top). All samples were measured at 25 °C. The spectrum of DPPC exhibits dominant 
CP signals compared to INEPT while that of PBD-b-PEO presents the opposite trend: strong INEPT signals without  
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(Continued – Figure 6.6.) 
CP. The peaks at 54.8 Hz/MHz (denoted by dashed lines) are enlarged in B) to emphasize the relative signal amplitudes 
of DP, CP, and INEPT. Resonances at 54.8 Hz/MHz corresponds to the DPPC headgroup moiety "γ". As PBD-b-PEO 
is incorporated into DPPC membranes, CP of headgroup "γ" decreases along with increased INEPT to DP ratios, 
indicating that the lipid headgroup becomes fluidic upon polymer incorporation. C) The CP spectra of DPPC (black, 
solid) and 9:1 molar ratio DPPC/PBD-b-PEO (blue, dotted) and 3:1 molar ratio DPPC/PBD-b-PEO (skyblue, solid). 
The spectra are normalized to equal intensity of the 33 Hz/MHz shift which is characteristic of the acyl chains adapting 
all-trans conformations. The significant line broadening is observed in the regions of 30-33 Hz/MHz for DPPC/PBD-
b-PEO hybrids, which can be attributed to the perturbed lipid acyl chain packing in the presence of polymer yielding 
a distribution of different conformations. D) The CP spectra of DPPC and 3:1 molar ratio DPPC/PBD-b-PEO are 
compared at two different temperatures, 25 °C and 37 °C. Spectra are labelled by compound name. The broad peak of 
DPPC/PBD-b-PEO differs from that of DPPC even at elevated temperature. The appearance of carbon peak at 31 
Hz/MHz from 3:1 molar ratio DPPC/PBD-b-PEO at 37 °C reveals that some portions of acyl chains in the hybrids 




Figure 6.7. (A) GIWAXS two-dimensional reciprocal space images of the films: (a) DPPC (b) PBD-b-PEO (c) 4:1 
molar ratio of DPPC to PBD-b-PEO hybrid (B) GIWAXS one-dimensional I(q) profiles of (a-c) films to compare the 
Bragg reflections along the in-plane direction (qxy). In (a), Bragg peaks assigned to a lipid headgroup unit cell are 
indicated by vertical dashed lines and their associated Miller indices. (C) Left: From the GIWAXS datasets, the 
integrated intensity of the gel phase peak was calculated and the relative peak area ratios of hybrid films to pure DPPC 
films were calculated (denoted by black square points). If DPPC lipids maintain the gel phase not affected by the 
presence of PBD-b-PEO, the area ratio should be proportional to the DPPC to PBD-b-PEO molar ratio (denoted by 
the red dashed line), which was not the case of our systems. Right: An illustration summarizing lipid in-plane phase 
transitions upon polymer incorporation. When polymer is present, only ≈ 25% of the lipids remain as gel-like phase 
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Figure 6.8. (A) Phase contrast image overlaid onto pseudo-3D topography of drug-incorporated hybrid films (1:1 
molar ratio of DPPC to PBD-b-PEO + 5 mol% PTX). Field of view = 10 µm × 10 µm. (B) GISAXS one-dimensional 































Figure 6.9. AFM tapping mode images of PTX-incorporated (5 mol%) PBD-b-PEO films, DPPC films, 4:1 molar 
ratio DPPC/PBD-b-PEO films, 1:1 molar ratio DPPC/PBD-b-PEO films, 1:4 molar ratio DPPC/PBD-b-PEO films in 













Figure 6.10. GIWAXS two-dimensional reciprocal space images of the films: (A) DPPC (B) DPPC + 5 mol% PTX 
(C) PBD-b-PEO (D) PBD-b-PEO + 5 mol% PTX (E) 4:1 molar ratio of DPPC to PBD-b-PEO hybrid (F) 4:1 molar 
ratio of DPPC to PBD-b-PEO hybrid + 5 mol% PTX. Note the difference between (A, E) and others; (A, E) show 



















Figure 6.11. (A-D) GIWAXS two-dimensional reciprocal space images of the PTX-incorporating films: (A) DPPC + 
5 mol% PTX (B) 4:1 molar ratio of DPPC to PBD-b-PEO + 5 mol% PTX (C) 1:1 DPPC: PBD-b-PEO + 5 mol% PTX 
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Figure 6.12. CLSM images of hybrid films (1:1 molar ratio of DPPC to PBD-b-PEO + 5 mol% PTX) in water, doped 
with PTX-Oregon 488 (0.2 mol%) (A) at selected depths (B) at different channels. DiDC18(5) was added at 0.1 mol%. 
The distribution of PTX drugs in the films was heterogeneous both in-plane and out-of-plane. Scale bars = 20 µm. 
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Figure 6.13. (A, B) CLSM images of 1:1 molar ratio of DPPC to PBD-b-PEO hybrid films with 5 mol% PTX, doped 
with 0.2 mol% PTX-Oregon Green 488. (A-1, B-1) PTX-Oregon Green 488 Channel. (A-2, B-2) Bright-field images. 





Figure 6.14. PTIR nanoscale chemical imaging. (A) AFM topography image and (B) AFM contact frequency image 
of a paclitaxel loaded (0.05 molar fraction) hybrid 1:1 molar ratio DPPC/PBD-b-PEO film. The features with higher 
topography and lower contact frequency identify the polymer reach domains. (C) Normalized FTIR spectra of PBD-
b-PEO (green), DPPC (blue) and paclitaxel (red). (D) Characteristic PTIR spectra (displayed with a common intensity 
scale) obtained in the color-coded positions identified in panel A. In addition to the polymer and lipid characteristic 
bands (1463 cm-1, 1730 cm-1), a few distinct and characteristic paclitaxel bands indicate that the drug is partitioned in 
both the polymer and lipid phases. (E)  PTIR ratio map obtained by dividing the intensity of the 1650 cm-1 PTIR map 
(paclitaxel amide I band) over the 1463 cm-1 PTIR map (polymer and lipid band) reveals the heterogeneous distribution 
of paclitaxel in the polymer rich phase. (F)  PTIR ratio map obtained by dividing the intensity of the 1602 cm-1 PTIR 







Figure 6.15. (A) Cumulative release profiles of PTX from 1:1 molar ratio of DPPC to PBD-b-PEO hybrid (black 
triangles), PBD-b-PEO (blue circles), and DPPC (red squares) films with 2 mol% PTX incorporated. The hybrid films 
showed significantly higher and faster PTX release compared to single-component control films. The PTX release 
profiles showed two characteristic release stages: initial fast release and slower release afterward. (A-1, A-2) The each 
stage of PTX release profile was plotted against the square root of time to show that PTX release follows diffusion-
controlled kinetics (Higuchi model97). The dashed lines indicate the linear relationship between the square root of time 
versus cumulative drug release. All values are the arithmetic mean ± SD, n = 3. 
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Figure 6.16. Cumulative release profiles of PTX from 1:1 molar ratio of DPPC to PBD-b-PEO hybrid films. (a-e) The 
left axis represents the % release, and the right axis shows the released mass (µg). The mass of the hybrid film was 
kept the same for all conditions and only the molar % of PTX to the film was varied. The lipid films displayed a burst 
release when a low molar percent of PTX was incorporated. (a, b) During the first 1 hour period, 20 % of PTX is 
released from the lipid films. (c-e) On the other hand, the lipid films showed slow release when a high molar percent 
of PTX was added, which could be attributed to the formation of PTX crystals. The hybrid films presented faster PTX 
release rates compared to lipid and polymer films. (f-h) Cumulative PTX release amount (µg) from each film at certain 
time points. Note that the release amount of PTX from the polymer and hybrid films increased showing a linear 
behavior upon increase in molar % of PTX incorporated, which was not the case for lipid-only films. Each point 
represents the arithmetic mean ± SD, n =3.
Time = 4 h Time = 16 h Time = 48 h(f) (g) (h)
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PTX 2 mol% PTX 5 mol% PTX 10 mol%(c) (d) (e)






























































































































































































































Sample Molar percent of PTX loaded in the films 
0.5 1 2 5 10 
Lipid 95.9 97.3 98.5 95.9 98.5 
Polymer 96.1 96.0 98.5 98.8 98.5 
Hybrid 98.3 95.8 99.5 98.7 97.5 
 
Table 6.1. PTX loading efficiencies (%) of different films with varying amount of PTX loaded. The hybrid films 
comprise 1:1 molar ratio of DPPC to PBD-b-PEO. The loading efficiency was defined by the following equation: 
loading efficiency (%) = (total amount of drug – free drug in the medium)/total amount of drug × 100.
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Lipid 3.112 0.9706 1.011 0.9734 
Polymer 5.764 0.9866 2.424 0.9979 
Hybrid 9.264 0.9986 3.984 0.9978 
 
Table 6.2. Results of Higuchi models applied to the PTX release profiles of lipid, polymer, and hybrid films. R2 is 




Figure 6.17. Transmission WAXS one-dimensional I (q or 2 theta) profiles of hybrid vesicles (1:1 lipid to polymer 
molar ratio), liposomes, polymersomes with 5 mol% PTX incorporated, and free PTX in excess water. Lipid and 
polymer samples showed sharp diffraction peaks associated with PTX crystals, indicating that single-component 
systems cannot efficiently entrap all the PTX molecules, resulting in undesirable PTX crystallization. Hybrid samples 
displayed no PTX crystal peaks. (*) peaks are from the lipid tail ordering. 
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Figure 6.18. Transmission WAXS two-dimensional data of liposomes, polymersomes, and hybrid vesicles without 
PTX incorporated and with 1 and 5 mol% PTX incorporated. Besides the lipid tail ordering diffraction at ≈ 1. 5 Å-1, 










Figure 6.19. Optical microscopy images of DPPC (A, B), PBD-b-PEO (C, D), and 1:1 molar ratio of DPPC to PBD-
b-PEO hybrid (E, F) films with 5 mol% PTX incorporated after 16 h of hydration. In case of lipid films (A, B), PTX 
crystals form bundles. Crystal formation was prominent in pure lipid films while polymer and hybrid films exhibited 
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The work presented in this dissertation was motivated by the limited application of lipid thin films. 
Until recently, lipid films have been mostly used as model systems to mimic organelle membranes. The 
goal of my dissertation work was to show that supported lipid-based materials have the potential to catalyze 
many substrate-mediated biomedical applications including small molecule delivery from surfaces. 
Lipid self-assembly behavior on solid support is interesting. The assembly on solid support 
involves long-range ordering and a net alignment of the lipid mesophases along a crystallographic direction. 
The key findings are that 1) the majority of the bulk lipid phases are retained but the phase boundaries are 
changed by the introduction of a solid substrate 2) surface-mediated phase transitions can be engineered by 
careful design of lipid composition and relative air humidity 3) Such characteristics of lipid thin films – 
distinct nanostructures with stimuli-responsive phase transitions – enable to stimulate the successful 
substrate-mediated gene delivery.  
Concurrent self-assembly of lipids and polymers brings new functionalities to the lipid-polymer 
hybrid film system. The micro-phase separation gives rise to peculiar phase behavior. Lipids and polymers 
partition into polymer-rich and lipid-rich domains that register across bilayers. The nanostructure of the 
hybrid film imposes an enhancement of drug permeability across the membranes, deviating from what is 
generally observed in single-component films.  
This dissertation work presents a new paradigm for designing substrate-mediated delivery system 
by underpinning film nanostructures as a central regulator of efficacy.  
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7.2 Outlook 
Lipids are biocompatible and possess the capability to self-assemble into various phases both in 
nature and in artificial systems. Lipid molecules are the structural motifs that comprise cell membranes, 
indicating that lipid self-assembled structures are versatile in terms of adapting to external 
stimuli/environmental changes. These characteristics should be very compelling arguments to investigate 
and exploit lipid materials beyond cell membrane models. One can envisage biocompatible lipid films 
becoming instrumental to the development of new medical devices requiring susceptibility in response to 
specific stimuli. Importantly, when lipids self-assemble onto a support, interesting structural features are 
observed such as specific orientation and stacking. Multicomponent lipid mixtures phase-separate into co-
existing domains and those domains stack up in registry, resulting in columnar alignment across lipid 
multilayers.1 
Lipid polymorphism as seen in the bulk is mostly retained for lipids prepared as supported films 
with the added complexity of the preferred orientation of the polymorphic phases. A theoretical framework 
to understand the orientation of lipid films has been established by Latypova et al.2 and Richardson et al.3 
in the context of thermodynamic minimization for surface energy. Further understanding on substrate 
effects will allow the engineering of on-demand structures and orientation. Substrate modification based 
on recent surface functionalization technologies is expected to play a key role in dictating the structure of 
lipid films (from a few layers adjacent to the substrate propagating to the entire film thickness).  
Artificial transplants, stents, scaffolds for tissue engineering, surface-based drug/gene delivery, and 
macro-scale drug delivery devices all necessitate biocompatible and functional coatings. A few, original 
studies that employ lipid materials in those applications have already demonstrated their great utility as 
reservoirs of several therapeutic cargos and their ability to release active species in response to stimuli. It 
should be noted that phase transformations in lipid films are fast and involve the conversion between 
systems that have dramatically distinct nanostructures, permeability, and diffusion behaviors, a feature that 
is less prominent in polymer systems.  
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Because lipids are so adaptable, however, this characteristic also constitutes a bottleneck for their 
application. One important aspect is the lack of mechanical robustness and stability when interfaced with 
hard materials or harsh environments. A clear future direction in this field will be the development of 
mechanically robust lipid-based materials capable of retaining the biocompatibility and the capacity to 
quickly transform into different structures as a function of specific environmental cues. There have been a 
few efforts to address this challenge by incorporating additional components such as lipid-silica or 
copolymers. The key in those processes is to maintain the functionality of the systems, in particular of the 
bioactive agents incorporated into the lipid-based films.  
It is anticipated that one of the most promising developments in the field will revolve around 
composite lipid-polymer hybrid materials, which is an emerging field that has experienced rapid growth 
over the past five years. Concurrent self-assembly of lipids and polymers into the same membrane results 
in hybrid membranes that show interesting and diverse phase behavior, spanning from homogeneous 
mixing to micro- and macro- phase separation. Inherent advantages provided by polymer systems include 
ease of composition engineering, tunable mechanical stability, and membrane permeability. These 
properties are expected to synergistically cooperate with the advantages provided by lipid systems such as 
biocompatibility and response to external stimuli. Incorporation of distinct functional species 
(hydrophobic/hydrophilic drugs, nanoparticles, or proteins) could be carefully directed to be co-assembled 
in certain membrane domains and released at different time points. Such location selectivity of functional 
components is one advantage conferred by introducing in-plane heterogeneities into the lipid membranes. 
The fact that those heterogeneities align in registry across a wide space field, offers an opportunity to control 
active species concentration by stacking layers at different thicknesses. Although the nanostructure and the 
orientation of the phases can be somewhat modulated and predicted there is still an enduring lack of control 
over the size, shape, and distribution of in-plane phase-separated membrane domains which should be 
addressed in future research. Multi-layered hybrid lipid-polymer films are essentially an unexplored 
material system which deserves further exploration. In addition, phase behavior studies of hybrid films have 
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been limited to planar membrane systems although a rich polymorphism akin to lipid-only or polymer-only 
systems should be expected. Structural and chemical diversities brought by the lipid-polymer hybrid films 
would broaden the application space of lipid-based films. To meet the rapidly rising demand for coatings, 
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